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ABSTRACT
Saviola, Anthony J. Proteomic Analyses of Snake Venoms With an Examination of
the Biological Roles and Anti-cancer Effects of Venom Disintegrins.
Published Doctor of Philosophy dissertation, University of Northern
Colorado, 2015.
For decades, snakes and snake venoms have been utilized in numerous
aspects of biological and biomedical research. Behaviorally, snakes have been
examined for their extraordinary chemosensory capabilities, providing a detailed
understanding of their foraging ecology and predatory responses. The presence of
a highly complex vomeronasal organ has enabled snakes to not only respond to,
but also discriminate between a high-range of heterospecific, conspecific,
predatory, and prey-derived chemical odors.
Snake venom has allowed for a transition in predatory behaviors, and this
often complex mixture of proteins and peptides has provided researchers with an
ever growing catalog of natural compounds that may be applicable as novel
therapeutics or as biomedical reagents. Research into venomous systems also
provides a detailed understanding of the biological roles of venom compounds, as
well as providing critical information necessary for the proper assessment and
treatment of snakebite.
The current work addresses several aspects of snake behavior and snake
venom toxinology and has four major objectives: i) to examine the chemosensory
responses of neonate, subadult and adult Prairie Rattlesnake (Crotalus viridis
iii

viridis) to various prey chemical stimuli, ii) to identify the chemical component(s) of
venom which allows for prey recovery during viperid predatory episodes, iii) to examine
the anti-cancer effects of a novel snake venom disintegrin towards various human derived
cancer cell lines and iv) to complete in-depth proteomic analyses of the neonate and adult
C. v. viridis and examine the efficacy of the current anti-venom treatment CroFab®
against this species’ venom.
Chapter I presents the objectives and aims of my dissertation work, and provides
background on chemosensory systems in squamates, and the numerous studies examining
prey relocation in viperid snakes. Further, this chapter addresses the importance of
examining the potential medicinal values of disintegrins as anti-cancer therapeutics, and
the utilization of proteomics to develop a better understanding of venom composition and
anti-venom efficacy. Chapters II focuses on the chemosensory responses of wild-caught
neonate, subadult, and adult C. v. viridis to natural and non-natural prey-derived chemical
odors. Results indicate that responses to chemical stimuli shift with snake age, correlating
with ontogenetic changes in snake diet. Chapter III examines this phenomenon in more
detail with a group of “stunted” C. v. viridis which had been in captivity since birth and
had only consumed neonate lab mice (Mus musculus). Further, these snakes were the age
of adults yet only the size of large juveniles, therefore they could not consume larger prey
normally taken by adult snakes. Results suggest that ontogenetic shifts in responsiveness
to natural prey chemical cues are innately programmed and are not based on body size or
feeding experience. Chapter IV identifies the venom component, disintegrins, which are
responsible for prey recovery during strike-induced chemosensory searching in Western
Diamondback Rattlesnakes (Crotalus atrox). In Chapter V, a novel disintegrin protein
iv

(named tzabcanin) was isolated from the venom of the Middle American Rattlesnake
(Crotalus simus tzabcan) and the cytotoxic and anti-adhesion properties of this protein
toward Colo-205 and MCF-7 cell lines was examined. Chapter VI also examines the anticancer effects of tzabcanin towards A-375 and A-549 cell lines, and by specifically
binding integrin αvβ3, tzabcanin inhibits cell migration and cell adhesion to vitronectin.
In Chapter VII, a detailed proteomic analysis of the venoms of four individual C. v.
viridis is presented, showing a novel trend in ontogenetic changes in venom composition,
as well as identifying which compounds are, and which are not, effectively
immunocaptured by the current anti-venom therapy used in the United States, CroFab®.

v

ACKNOWLEDGEMENTS
I would like to thank first my parents, Michael and Debra Saviola, and my sisters
Angela and Ashley for their overwhelming support throughout the years. I can only
imagine the stress involved of having a child, and a brother, with such a strong desire to
work with venomous snakes. A childhood dream has come true because you provided me
the opportunity to learn, and rarely said no whenever I brought home a new pet snake.
Thank you for everything you have done for me.
I thank my advisor, Steve Mackessy, for listening to every crazy research idea
that has come out of my mouth over the last five years, and most importantly helping me
come up with ways to test each of these ideas. Thank you for your patience, guidance,
and never-ending support. I truly could not have done this without having such a
supportive advisor. Thank you to my committee members, Judy Leatherman, Susan
Keenan, and Richard Hyslop for always taking the time to sit down, brainstorm, and help
me push through the many difficulties associated with graduate school. A special thank
you to Richard for dropping everything one afternoon and helping me during such a
pivotal time.
I thank Patrick Burns for always taking the time to help with so many aspects to
so many projects, and always keeping me company during the many late nights and
weekends in Ross Hall. I want to thank Juanjo Calvete for opening the door of his lab to

vi

me, and to all of the incredible scientists at Instituto de Biomedicina de Valencia for their
tremendous help. Thank you to Lauryn Benedict, Richard Carter, Greg DeKrey, Seth
Frietze, James Haughian, Ashis Mukherjee, Rob Reinsvold, and Mark Thomas for always
taking the time to talk research, and pick my brain on numerous aspects of my projects.
Thank you to Linda Black for being an incredible support throughout the years and being
a tremendous helping during a time of need. I would also like to thank Cindy Budde for
all of the administrative help that has been provided throughout the years.
Thank you to the incredible Mackessy lab mates who have brought such
enjoyment to the lab over the years. I would like to say a special thank you to Cassie
Modahl for all of the help with the molecular techniques, and to Anthony Gandara for the
continued statistical help over the years. Also thanks for the amazing conversations that
come with sharing an office with someone for so long.
Finally, thank you to my friends. I could not have done this without everyone.
Thank you all of your for dragging me out on weekends, or visiting me in the lab late
weekday nights, when I would insist that I just needed one more hour to work. Thank you
for sticking with me through all of this and making sure I still had a life, and a great one
at that.

vii

DEDICATION
My dissertation is dedicated to the memory of David Chiszar. As an advisor, collaborator,
and best friend, Dave taught me an appreciation for science, snakes, and life that will
always be with me. His selflessness opened the door and has allowed for this dream to
come true.

viii

TABLE OF CONTENTS
CHAPTER
I.
II.

INTRODUCTION .......................................................................................1
ONTOGENETIC SHIFT IN RESPONSE TO PREYDERIVED CHEMICAL CUES IN PRAIRIE
RATTLESNAKES (CROTALUS VIRIDIS
VIRIDIS) ...................................................................................................12
Abstract ......................................................................................................13
Introduction................................................................................................14
Materials and Methods...............................................................................16
Results........................................................................................................19
Discussion ..................................................................................................22
Acknowledgements....................................................................................26
References..................................................................................................26
Table ..........................................................................................................31
Figure .........................................................................................................32

III.

CHEMOSENSORY RESPONSE IN STUNTED PRAIRIE
RATTLESNAKES (CROTALUS VIRIDIS VIRIDIS)................................33
Abstract ......................................................................................................34
Introduction................................................................................................34
Materials and Methods...............................................................................36
Results........................................................................................................38
Discussion ..................................................................................................39
Acknowledgements....................................................................................41
References..................................................................................................42
Table ..........................................................................................................46
Figure .........................................................................................................47

ix

IV.

MOLECULAR BASIS FOR PREY RELOCATION
IN VIPERID SNAKES ..............................................................................48
Abstract ......................................................................................................49
Background ................................................................................................50
Results........................................................................................................52
Discussion ..................................................................................................54
Conclusions................................................................................................58
Methods......................................................................................................59
Abbreviations.............................................................................................64
Acknowledgments......................................................................................64
References..................................................................................................64
Tables.........................................................................................................71
Figures........................................................................................................75

V.

DISINTEGRINS OF CROTALUS SIMUS TZABCAN
VENOM: ISOLATION, CHARACTERIZATION
AND EVALUATION OF THE CYTOTOXIC
AND ANTI-ADHESION ACTIVITIES OF
TZABCANIN, A NEW RGD
DISINTEGRIN ..........................................................................................79
Abstract ......................................................................................................80
Introduction................................................................................................80
Materials and Methods...............................................................................84
Results........................................................................................................92
Discussion ..................................................................................................94
Conclusion ...............................................................................................101
Acknowledgments....................................................................................101
References................................................................................................102
Figures......................................................................................................109

x

VI.

TZABCANIN, A SNAKE VENOM DISINTEGRIN FROM
CROTALUS SIMUS TZABCAN, INHIBITS αVβ3
MEDIATED CELL ADHESION AND
MIGRATION IN MELANOMA
(A-375) AND LUNG (A-549)
CANCER CELLS ....................................................................................117
Abstract ....................................................................................................118
Introduction..............................................................................................118
Materials and Methods.............................................................................122
Results......................................................................................................127
Discussion ................................................................................................129
Acknowledgments....................................................................................133
References................................................................................................133
Figures......................................................................................................139

VII.

COMPARATIVE VENOMICS OF THE PRAIRIE
RATTLESNAKE (CROTALUS VIRIDIS VIRIDIS)
FROM COLORADO ...............................................................................144
Abstract ....................................................................................................145
Introduction..............................................................................................146
Materials and Methods.............................................................................150
Results and Discussion ............................................................................157
Concluding Remarks................................................................................168
Acknowledgements..................................................................................170
References................................................................................................170
Table ........................................................................................................184
Figures......................................................................................................185

VIII.

CONCLUSIONS .....................................................................................193

REFERENCES ............................................................................................................198
APPENDIX..................................................................................................................238

xi

LIST OF TABLES
Table
2.1

Mean Snout-vent Length and Body Mass (± SEM) for the
65 rattlesnakes tested ....................................................................................31

3.1

Mean Snout-vent Length and Body Mass (± SEM) for the
11 C. v. viridis tested.....................................................................................46

4.1

Rattlesnakes Discriminate Between Non-envenomated
and Envenomated Mice................................................................................71

4.2

Prey Discrimination is Associated with Non-enzymatic
Fractions........................................................................................................71

4.3

Supplemental Table: Raw Data ....................................................................72

7.1

Percent Abundance of Protein Families in
C. v. viridis Venom .....................................................................................184

xii

LIST OF FIGURES
Figure
2.1

Mean Number of Tongue Flicks Over 60 Seconds ......................................32

3.1

Comparison of Log10 Transformed TFAS...................................................47

4.1

Discrimination of Envenomated Prey is not
Dependent on Enzymatic Toxins ..................................................................75

4.2

Peak III Consist of Only 7kDa Peptides .......................................................76

4.3

N-terminal Sequence of Peak III Peptides ....................................................77

4.4

Reducing SDS-PAGE Analysis of Size Exclusion
Chomatography Fractions.............................................................................78

5.1

Size Exclusion Chomatography of Crude
C. s. tzabcan Venom ...................................................................................109

5.2

RP-HPLC Purification and Mass Determination by
MALDI-TOF-MS of C. s. tzabcan Venom
Disintegrins .................................................................................................110

5.3

RP-HPLC Polishing and Mass Determination of
Tzabcanin....................................................................................................111

5.4

cDNA Sequence and Predicted Amino Acid
Sequence of C. s. tzabcan Disintegrins.......................................................112

5.5

Amino Acid Sequence Comparison of C. s. tzabcan
Disintegrins with Selected Disintegrins......................................................113

5.6

Percent Cell Viability of Colo-205 and MCF-7 Cells ................................114

5.7a

The Effect of Tzabcanin on Cell Adhesion to
Fibronectin .................................................................................................115

5.7b

The Effect of Tzabcanin of Cell Adhesion to
Vitronectin ................................................................................................115
xiii

5.8

Percent Binding Inhibition of Cells to Immobilized
Tzabcanin....................................................................................................116

5.9

Molecular Modeling of Tzabcanin..............................................................116

6.1

Percent Binding Inhibition of A-375 and A-549
Cells to Immobilized Tzabcanin .................................................................139

6.2

Percent Viability Following 24-hour Incubation
with Tzabcanin............................................................................................140

6.3

The Effects of Tzabcanin on Cell Adhesion to
Vitronectin ..................................................................................................141

6.4

Inhibition of A-375 and A-549 Cell Migration...........................................142

6.5

Tzabcanin Inhibits Binding of Anti-αvβ3 to A-375
and A-549 Cells .........................................................................................143

7.1

Geographic Distribution of C. v. viridis.......................................................185

7.2

Characterization of the Venom Proteomes of
C. v. viridis...................................................................................................186

7.3

Combined Samples Representing Three Age
Classes of C. v. viridis.................................................................................187

7.4

Age-related Changes in SVMP and Myotoxin ............................................188

7.5

Protein Family Composition of Primary
C. v. viridis Venoms....................................................................................189

7.6

Antivenomic Analysis on a CroFab®
Affinity Column..........................................................................................190

7.7

Western blot and SDS-PAGE Analysis ......................................................191

7.8

Reducing SDS-PAFE of Secondary Samples .............................................192

xiv

CHAPTER FORMAT AND ATTRIBUTION
My dissertation is comprised of six research chapters, each of which is a
manuscript intended for publication. Because of this, each chapter is formatted for the
journal in which they have been published or submitted to. In regards to experimental
design, data collection, writing and revising of the manuscripts I am the main contributor
for each. However, my committee chair Stephen P. Mackessy and several other research
collaborators are co-authors. Chapter’s II and III have been published separately in the
journal Current Zoology. Chapter IV has been published in the journal BMC Biology.
Chapter V is in revision in the journal Biochimie, and chapter VI is formatted for
submission to Toxicon. Chapter VII has been published in the Journal of Proteomics.

xv

1

CHAPTER I
INTRODUCTION
For decades, squamates (lizards and snakes) have been considered as nontraditional yet key organisms in numerous facets of biological and biomedical research.
Snakes have been especially well studied with regards to their evolution (Castoe et al.
2008, 2013; Vonk et al. 2013) ecology (Wastell and Mackessy 2011; Shipley et al. 2013;
Barbour and Clark 2012; Chiszar et al. 2014), behavior (Chiszar et al. 1977; Burghardt
1971; Clark 2004a; Saviola et al. 2010, 2011, 2012), physiology (Secor 2005, 2008;
Riquelme et al. 2011) and toxinology (Mackessy 1988, 2010; Calvete et al. 2009a, 2011;
Lomonte et al. 2014). To date, approximately 3496 species of extant snakes are
recognized (reptile.database.org), inhabiting every major continent with the exception of
Antarctica and occupying virtually all habitats globally (Greene 1997). Extreme
phenotypic and molecular plasticity among such a diversity of species has made snakes
ideal organisms for diverse research in the biological, biochemical, physiological and
even physical sciences.
Snake behavior has also been studied in depth with regards to their complex
chemosensory systems, and their ability not only to recognize but also discriminate
between chemical stimuli is well established (Burghardt 1970, 1971; Chiszar et al. 1992).
Chemoreception in snakes modulates a diversity of behaviors including general
exploratory behaviors (Chiszar et al. 1980), mate selection (Kubie et al. 1978; Shine et al.
2003), foraging and prey location (Chiszar et al. 1992; Clark 2004a) and predator,
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heterospecific and conspecific recognition (Weldon and Burghardt 1979; Burger 1989;
Gutzke et al. 1993; Clark 2004b). This chemical recognition is typically mediated by
rapid tongue flicking, activated by the detection of volatile chemical cues by the nasal
olfactory system (Burghardt 1970; Saviola et al. 2010) or by visual or thermal stimulation
(Chiszar et al. 1981; Saviola et al. 2011, 2012). Consequently, tongue flicking delivers
volatile and non-volatile stimuli to the vomeronasal organ located in the roof of the upper
jaw (Halpern 1992; Schwenk 1995), allowing for definitive analysis of chemical
information (Cowles and Phelan 1958; Halpern 1992).
Snakes consume a diversity of invertebrate and vertebrate prey items and this prey
preference may vary between species (Greene 1997) as well as between age classes of the
same species (Klauber 1956; Mackessy 1988). As limbless gape-limited predators, snakes
can only consume prey by swallowing it whole; therefore, head size is a critical limiting
factor of prey consumption (Shine 1991). As a result, ontogenetic shifts in prey
preference generally occur and are correlated with snake size. For instance, neonate
rattlesnakes generally consume small ectothermic prey (lizards, invertebrates), whereas
subadult and adult rattlesnakes often take larger endothermic prey (birds, mammals;
Klauber 1956; Mackessy 1988; Hammerson 1999). Likewise, shifts in responsiveness to
prey chemical cues (Mushinsky and Lotz 1980), as well as prey-handling behaviors, may
also exist (Mackessy 1988; Hayes 1991). Non-venomous snakes utilize constriction or
jaw-holding behaviors to subdue prey (Savitzky 1980; Kardong et al. 1996; Bealor and
Saviola 2007), whereas venomous snakes deliver a bolus of toxins, either by a strike-andhold method as seen in rear-fanged colubrids, neonate vipers and elapid snakes, or
employing a strike-and-release behavior as documented in the majority of adult viperid
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snakes (Mackessy 1988; Hayes 1991). Hence it is likely that natural selection influences
specific chemosensory and predatory responses, allowing for successful capture of
preferred prey (Tinbergen 1951; Cooper 2008).
Biological Roles of Venoms
Snake venoms are a complex mixture of proteins and peptides (Mackessy 2010)
that have allowed for the transition from a mechanical (constriction) to a chemical
(venom) means of subduing prey (Savitzky 1980; Kardong et al. 1996). This mixture of
enzymatic and non-enzymatic toxins is not only critical to the foraging success of the
snake, but venoms are continuously being investigated by researchers to elucidate overall
venom composition and complexity and to identify novel biological roles and
pharmacological activities of individual compounds. An ongoing question dealing with
snake venom toxinology addresses the biochemical complexity of individual proteins and
the sometimes numerous protein isoforms that are sometimes found within the venom of
an individual species (Jia et al. 1996). These proteins not only act in concert with each
other, but individual compounds may also demonstrate discrete biological effects
(Weldon and Mackessy 2012; Peichoto et al. 2007; Heyborne and Mackessy 2013).
The venoms of viperid snakes (vipers and pit vipers) contain an abundance of
proteins critical for the immobilization, killing and predigestion of prey, including many
that interfere with the hemostatic system and coagulation cascade (Mackessy 2008).
However, it has been shown that viper venoms also assist in the relocation of prey items
during predatory episodes (Duvall et al. 1978; Chiszar et al. 1983, 1992, 1999, 2008).
Rattlesnakes and other pitvipers are ambush predators which strike, envenomate and
release prey (Clark 2004a; Chiszar et al. 1992). This predatory strategy allows for
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minimal contact or retaliation from potentially dangerous prey items, yet requires the
additional task of relocating prey that may wander several meters or more from the attack
site before succumbing to the venom’s effects. By using rapid tongue flicking (strikeinduced chemosensory searching) to detect, and the vomeronasal organs to analyze
volatile and non-volatile chemical cues (Halpern 1992; Schwenk 1995), snakes must also
differentiate between the trail deposited by the prey before and after envenomation has
occurred, as well as the trails left inadvertently by other potential prey and non-prey
sources. Several hypotheses have addressed the source of chemical cues used to
discriminate between trails of struck and unstruck prey. Cues emanating from the mouse
when it is punctured during the predatory strike, as well as other potential chemical cues
such as urine or volatiles from venom left on the prey’s integument, have been examined,
with results indicating that such cues are not utilized by snakes (Lavin-Murcio et al.
1993; Chiszar et al. 1991, 1992; Hayes et al. 1992). These previous results indicated that
venom must be injected into tissues to initiate a release of chemical odor(s), permitting
discrimination of envenomated prey and their trails.
A convenient bioassay of vomeronasal chemoreception was previously developed
for evaluating preference towards envenomated (E) vs. non-envenomated (NE) mouse
carcasses, with snakes showing high rates of tongue flicking directed toward E carcasses
(strike-induced chemosensory searching, SICS; Chiszar et al. 1992, 1999, 2008;
Greenbaum et al. 2003). This preference holds when envenomation occurs by a
conspecific or by a closely related heterospecific (Chiszar et al. 2008), or when
lyophilized conspecific venom is injected into previously euthanized prey (Chiszar et al.
1999). Therefore, venoms represent not only a rapid-acting chemical means of
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dispatching potentially fractious prey (Kardong et al. 1996); they also greatly increase the
perceptibility of the envenomated prey carcass (Chiszar et al. 1992, 1999). However, the
specific component(s) of snake venom allowing for successful recovery of prey has not
been identified.
Compositional Diversity of Venoms – Sources of
Novel Compounds
In addition to understanding the roles of venom compounds during predation, the
identification and characterization of these proteins offers significant insights for basic
research, clinical diagnosis of human envenomations, and anti-venom production
strategies (Gutiérrez et al. 2009; Calvete et al. 2009b). A recent proteomic approach,
termed venomics (venom proteomics) (Juárez et al. 2004; Calvete et al. 2009b), provides
in-depth analyses of venom composition, advancing the knowledge necessary for
efficient snakebite treatment and anti-venom production and efficacy (Calvete et al.
2009a, 2009b; Lomonte et al. 2008). Human envenomation due to snakebite is a global
issue, often neglected by health authorities around the world (Gutiérrez et al. 2006,
2007). Estimates as high as 2.5 million envenomations and over 125,000 deaths have
been reported (Chippaux 1998); however, more recent estimations suggest approximately
1,841,000 envenomations resulting in 20,000 deaths, yearly (Kasturiratne et al. 2008).
These numbers are largely based on hospital records, and with the vast majority of bites
impacting agricultural workers in low income countries in Africa, Asia, and Central and
South America, victims may seek traditional treatments or die before reaching
appropriate health care (Gutiérrez et al. 2006). Therefore, the actual occurrence of
envenomation may be significantly higher than reported. Further, victims may have
permanent physical disability following snakebite, drastically impacting their overall
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quality of life. Snakebite in the United States is rare, and it is estimated that there are
approximately 9000 venomous snake bites reported annually (O’Neil et al. 2007), with
roughly 99% of these bites from viperid snakes (Jucket and Hancox 2002). Human
envenomations may pose a serious or potentially deadly emergency, and early therapeutic
use of antivenom is necessary if severe envenomation is suspected. In the United States,
the antivenom CroFab® (Crotaline Polyvalent Immune Fab(ovine)) is commonly
administered during envenomation cases. CroFab® is produced in sheep immunized with
one of the following North American snake venoms: Agkistrodon piscivorus (Water
Moccasin), Crotalus adamanteus (Eastern Diamondback Rattlesnake), C. atrox (Western
Diamondback Rattlesnake), and C. scutulatus (Mojave Rattlesnake) (Price and Sanny
2007). Surprisingly, the most widely distributed rattlesnake in North America, the Prairie
Rattlesnake (C. v. viridis), is not one of the species utilized for CroFab® production.
Adequate treatment of snakebite is dependent on the ability of the antivenoms to reverse
the pathological symptoms induced by venom. Therefore, knowledge on venom
composition and inter- and intraspecies venom variability is critical for assessment of
antivenom efficacy and treatment of snakebite.
Not only can proteomic methodologies be utilized to increase our overall
understanding of venom composition for efficient treatment of snakebite, but these
techniques can be further applied to identify venom compounds exhibiting potential
medicinal value. Toxins-to- drugs have been an emphasis of research in the last decade
(Fox and Serrano 2007; Mukherjee and Mackessy 2013; Saviola et al. 2014), and several
novel compounds developed from the poisons and venoms of animals are currently in
clinical trials and use (Fox and Serrano 2007; Takacs and Nathan 2014). Viperid snake
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venoms in particular have been a useful source of several protein drugs and additional
novel protein drug leads. For example, one class of snake venom proteins, known as
disintegrins, has led to the design of two current therapies on the market. Integrilin
(eptifibatide), used to treat acute coronary ischemic disease, and tirofiban (aggrastat), an
anti-platelet aggregation drug, were both designed based on the structure of two snake
venom disintegrins, barbourin (Scarborough et al. 1993) and echistatin (Gan et al. 1988),
respectively. Additionally, the dimeric disintegrin contortrostatin from the Southern
Copperhead (Agkistrodon contortrix contortrix) has demonstrated promising anti-cancer
effects towards numerous cancer cell lines (Zhou et al. 2000; Lin et al. 2010).Therefore,
further analyses of snake venoms may provide additional novel sources of proteins for
potentially useful therapeutics.
Integrins and Cancer Therapies
In 2014, it was estimated that there were approximately 1.6 million new cancer
cases and over 580,000 cancer-related deaths in the United States alone (Siegel et al.
2014). Cancer cells, and normal cells, rely on cell-cell and cell-extracellular matrix
interactions, mediated by an important class of α/β heterodimeric proteins known as
integrins (Cheresh 1992; Desgrosellier and Cheresh 2010). Integrins form by the
appropriate pairing of one of 18 α with one of 8 β subunits, creating 24 potential integrin
receptors with varying affinities toward numerous extracellular matrix proteins
(Desgrosellier and Cheresh 2010). Some integrins, such as αvβ3, have been shown to be
overexpressed 50-100 fold in cancerous cells (Gehlsen et al. 1992), and specific subunits,
such as β3, may not even be expressed in normal tissues (Stallmach et al. 1992;
Desgrosellier and Cheresh 2010). Integrins are essential for tumor angiogenic activity,
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proliferation and metastasis (Clark and Brugge 1995; Serini et al. 2006). Tumor
dependence on angiogenesis is also well documented (Folkman 2007), and formation of
new blood vessels is required for delivering nutrients to as well as providing a means of
removing waste from tumors. Extracellular matrix proteins such as fibronectin and
vitronectin also play critical roles in tumor formation and progression, as fibronectinintegrin interactions in cancer cells may lead to resistance to numerous chemotherapeutic
agents as well as increased tumorigenesis (Ruoslahti 1999; Rintoul and Sethi 2002;
Knowles et al. 2013). In addition, vitronectin has also been shown to play a role in tumor
progression and invasion (Marshall and Hart 1996; Hurt et al. 2010; Pola et al. 2013).
Therefore, isolating compounds that have potential integrin-blocking activity and antiangiogenic functions may be a novel approach to controlling cancer cell proliferation and
metastasis (Folkman 2006).
Disintegrins are small (4-15 kDa) non-enzymatic proteins currently isolated only
from the venoms of vipers (e.g., Calvete 2005). Classified by their number of disulfide
bonds and amino acids, disintegrins are grouped into short (~ 41-51 residues, 4 disulfide
bonds), medium (~ 70 residues, 6 disulfide bonds), long (~ 84 resides, 7 disulfide bonds)
and dimeric (~ 67 resides each, with 10 disulfide bonds), with a fifth group including the
disintegrin domain of P-III snake venom metalloproteinases (Calvete 2005; Calvete et al.
2010). Disintegrins exhibit an Arg-Gly-Asp (RGD) domain that is also found within
many extracellular matrix (ECM) proteins such as fibronectin and vitronectin (Buckley et
al. 1999). Subsequently, disintegrins have been shown to selectively block αIIbβ3, α5β1,
αvβ3, αvβ5, α2β1, and numerous other classes of integrin receptors (see Calvete et al. 2010
for a review). Previous work with disintegrins has shown promising effects at inhibiting
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pathways critical for metastasis (Zhou et al. 2000; Lin et al. 2010; Sánchez et al. 2009).
However, disintegrins may show significant activity at inhibiting one class of integrins,
yet fail to show an effect on other classes of integrins. It has been shown that the amino
acids adjacent to the integrin inhibitory tripeptide sequence are critical to integrin binding
affinity (Scarborough et al. 1993). Therefore, there is a continued need to isolate and
purify novel disintegrins and other useful proteins which may demonstrate different
integrin-blocking activities and have potential anti-cancer effects.
The work presented herein addresses all of the topics reviewed above with the
following objectives: (i) examine the ontogenetic shift in chemosensory responses of
Prairie Rattlesnakes (Crotalus viridis viridis) to a variety of prey stimuli, (ii) identify the
venom compound(s) allowing for prey relocation during viper predatory episodes, (iii)
identify and characterize a new snake venom disintegrin and examine the potential anticancer effects of this protein against human-derived cancer cell lines, and (iv) complete
in-depth proteomic analyses of neonate and adult C. v. viridis, allowing for identification
of toxins that may pose a severe threat during human envenomation and for assessment of
antivenom efficacy. The primary aims of my doctoral research are as follows:
Aim 1: Identify venom compound(s) responsible for prey relocation during viperid
predatory episodes. Viper venoms allow these snakes to strike, envenomate, and release
prey; however, the compound(s) responsible for prey relocation has yet to be identified. I
hypothesize that venom metalloproteinases, an abundant enzyme family in viper venoms,
assist in prey relocation by vomeronasal chemoreception.
Aim 2: Complete in-depth proteomic analyses of venoms of Crotalus viridis viridis.
Full proteomic analyses of venoms will allow for me to characterize and identify
compounds that constitute the entire venom composition of a single species. These results
will allow me to identify species that may pose a threat to humans due to snakebite
envenomation as well as effectively assessing anti-venom efficacy by determining which
compounds may or may not be recognized by the currently administered anti-venom.
Proteomic characterization of venom compounds will also allow for me to identify any
novel toxin drugs that may exhibit potential clinical use.

10

Aim 3: Examine potential anti-cancer effects of a novel snake venom disintegrin
towards several cancer cell lines. Toxin drugs have been an emphasis of research in the
last decade, with several novel compounds derived from venoms currently in clinical
trials and use. Snake venoms in particular have been a useful source of several protein
drugs and additional novel protein drug leads. Venom disintegrins have demonstrated
significant anti-neoplastic activity by binding to, and inhibiting integrin receptors in
cancer cells, yet the specificity of which integrin(s) are recognized by disintegrins may
vary drastically. I hypothesize that a novel disintegrin will recognize and bind integrin
receptors over-expressed in cancer cell lines and inhibit critical pathways involved in
metastasis.
Chapter II of this dissertation examines the ontogenetic shift in chemosensory
responsiveness to prey derived chemical cues in three age classes of C. v. viridis. In
Chapter III, I follow up the study of Chapter II by examining chemosensory responses in
a group of C. v. viridis who chronologically were the age of adult rattlesnakes, but the
size of large neonates. In addition, the snakes studied in this chapter had never fed on
natural prey items, and only had taken neonate or juvenile lab mice (Mus musculus). In
Chapter IV, I identify the chemical component of snake venom, a small non-enzymatic
class of proteins called disintegrins, as the relocation molecule, allowing for
envenomated prey discrimination and successful recovery of prey during adult viperid
predatory episodes. Chapter V describes the isolation and characterization of a new
disintegrin isolated and characterized from the venom of the Middle American
Rattlesnake (Crotalus simus tzabcan), named tzabcanin. Further, I examine the ability of
tzabcanin to inhibit adhesion of human breast (MCF-7) and colon (Colo-205) cancer cell
lines to the extracellular matrix proteins fibronectin and vitronectin. Chapter VI examines
the anti-cancer effects of tzabcanin towards human melanoma (A-375) and lung (A-549)
cell lines, further identifying integrin αvβ3 as one of the primary binding sites of
tzabcanin. In chapter VII, I conduct a detailed proteomic analysis to examine the venom

11
proteome of two neonate (male and female) and two adult (male and female) C. v. viridis,
allowing for identification of variation in venom composition between age and sex
groups; additionally, the efficacy of the current anti-venom treatment used in the United
States, CroFab®, is evaluated using antivenomic and Western blot methods. Finally, I
conclude with Chapter VIII by providing a summary of all six research chapters and
addressing possible areas of continued research on these current topics.
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Abstract
Snakes often have specialized diets that undergo a shift from one prey type to
another depending on the life stage of the snake. Crotalus viridis viridis (prairie
rattlesnake) takes different prey at different life stages, and neonates typically prey on
ectotherms, while adults feed almost entirely on small endotherms. We hypothesized that
elevated rates of tongue flicking to chemical stimuli should correlate with particular prey
consumed, and that this response shifts from one prey type to another as individuals age.
To examine if an ontogenetic shift in response to chemical cues occurred, we recorded
the rate of tongue flicking for 25 neonate, 20 subadult, and 20 adult (average SVL =
280.9, 552, 789.5 mm, respectively) wild-caught C. v. viridis to chemical stimuli
presented on a cotton-tipped applicator; water-soluble cues from two ectotherms, (prairie
lizard, Sceloporus undulatus, and house gecko, Hemidactylus frenatus), two endotherms,
(deer mouse, Peromyscus maniculatus and lab mouse, Mus musculus), and water controls
were used. Neonates tongue flicked significantly more to chemical cues of their common
prey, S. undulatus, than to all other chemical cues; however, the response to this lizard’s
chemical cues decreased in adult rattlesnakes. Subadults tongue flicked with a higher rate
of tongue flicking to both S. undulatus and P. maniculatus than to all other treatments,
and adults tongue flicked significantly more to P. maniculatus than to all other chemical
cues. In addition, all three sub-classes demonstrated a greater response for natural prey
chemical cues over chemical stimuli of prey not encountered in the wild (M. musculus
and H. frenatus). This shift in chemosensory response correlated with the previously
described ontogenetic shifts in C. v. viridis diet. Because many vipers show a similar
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ontogenetic shift in diet and venom composition, we suggest that this shift in prey cue
discrimination is likely a general phenomenon among viperid snakes.
Introduction
Squamate reptile response to prey is often associated with chemical cues of prey
integument, visual cues, or visual-thermal cues associated with prey movement
(Burghardt, 1970; Ford and Burghardt, 1993; Cooper, 1995). Reliance on chemical cues
by lizards and snakes is also critical in mate selection, exploratory behavior, predator
identification, prey choice and location, and kin selection (Kubie et al., 1978; Chiszar and
Scudder, 1980; Weldon and Burghardt, 1979; Chiszar et al., 2008; Clark, 2004; Pernetta
et al., 2009), and many studies have examined chemical cue discrimination and
chemosensory responses to multiple chemical cue sources. Chemical cue discrimination
between extracts of multiple prey types is often correlated with evolutionary changes in
diet, such that snake response to prey cues is greatest to that of most commonly taken
prey (Cooper and Burghardt, 1990; Cooper, 1994, 1997, 2008; Clark, 2004). Since snakes
are gape-limited predators, swallowing prey whole, head size is a limiting factor in what
can be consumed. Therefore, shifts in prey taken as well as response to specific prey cues
may also change as snakes increase in age and size (Mushinsky and Lotz, 1980).
Neonate rattlesnakes primarily take smaller ectothermic prey such as lizards and
anurans, and adults often specialize on larger endotherms such as rodents and birds
(Klauber, 1972; Mackessy, 1988; Mackessy et al., 2003). Rattlesnakes are ambush
predators, and the use of chemical cues in ambush site selection has been examined, and
likewise selection of ambush sites is correlated with the presence of chemical cues of the
most commonly consumed prey (Clark, 2004; LaBonte, 2008). During predatory events,
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adult rattlesnakes use visual-thermal cues to strike, envenomate, and release endotherm
prey (Hayes and Duvall, 1991; Kardong, 1992), inducing strike-induced chemosensory
searching (SICS) and further use of chemical stimuli to relocate the envenomated carcass
(Chiszar et al., 1977; 1992). However, neonate rattlesnakes demonstrate different prey
handling behaviors. Mackessy (1988) noted that neonate pacific rattlesnakes (Crotalus
oreganus helleri and C. o. oreganus) often hold onto small ectotherm prey and therefore
do not have the task of relocating prey after venom has taken its course. Hayes (1991)
showed that juvenile C. v. viridis released small endotherm prey after the strike; however,
the duration of holding onto prey was much longer than that seen in medium or large C.
v. viridis. Therefore, although extended contact with prey may increase risk of retaliation
from struggling prey, the prolonged holding behavior may be advantageous for neonate
feeding success, perhaps by allowing more venom to enter prey or by limiting the
distance released prey can retreat before succumbing.
The prairie rattlesnake Crotalus v. viridis is one of three species of rattlesnakes
found in Colorado, with a broad distribution throughout most of the state at elevations
under 2,890 m (Hammerson, 1999). The diet of C. v. viridis in Colorado consists
primarily of the lesser earless lizard Holbrookia maculata, prairie lizard Sceloporus
undulates and plains spadefoot toad Spea bombifrons, as well as endotherms such as
western harvest mouse Reithrodontomys megalotis and deer mouse Peromyscus
maniculatus; other prey are also taken (Hammerson, 1999). As with many other species
of rattlesnakes, ontogenetic shifts are seen in prey type taken, and neonates primarily
consume ectotherms, while adults primarily specialize on small mammals (Mackessy,
1988; Hammerson, 1999). Prairie rattlesnakes therefore represent a species for which
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many aspects of behavior, sensory processes, ecology and venom toxinology have been
well studied, and it can serve as a model for behavior of rattlesnakes generally.
Tongue flicking in snakes is a stimulus-seeking behavior and is the main process
for delivering volatile and non-volatile cues to the vomeronasal organs (Halpern, 1992),
which mediate definitive analysis of chemical information (Cowles and Phelan, 1958;
Schwenk, 1995). Tongue flicking is activated by detection of volatile chemical cues by
the nasal olfactory system and by visual, thermal, or vibratory stimulation (Burghardt,
1970; Chiszar et al., 1981; Ford and Burghardt, 1993; Saviola et al., in Press); therefore,
the rate of tongue flicking can be used as a convenient measure of a snake’s response to
any or all of these stimuli. In this paper we present data from laboratory experiments
examining the responses of neonate, subadult, and adult wild-caught prairie rattlesnakes
to aqueous extracts from two ectotherms (S. undulatus and H. frenatus) and two
endotherms (P. maniculatus and M. musculus) to determine if an ontogenetic shift in
response to chemical cues occurs within this species. In addition, we examine if C. v.
viridis can discriminate between prey extracts of natural (S. undulatus and P.
maniculatus) and non-natural (H. frenatus and M. musculus) prey items. This latter point
is of interest because both of these non-natural prey are taken by C. v. viridis in captivity;
indeed, M. musculus of various sizes are probably the most common food items in
captivity.
Materials and Methods
Study Animals
The snakes used in this study consisted of 65 wild-caught C. v. viridis from
Weld Co., Colorado, USA. Snakes were classified as neonates (n=25), subadults (n=20),
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and adults (n=20) based on snout-vent length (SVL) and body mass (Table 2.1), which
were measured immediately after testing. Snakes were randomly collected using snake
hooks from two den sites that were frequently visited by our lab group. All snakes were
housed in groups based on age (size) classification from visual inspection, as actual
measurements and associated handling were not conducted until after testing. Snakes
were tested approximately 48 hrs and within 96 hrs after being brought into captivity.
Snakes were released at the exact location of capture and were in captivity for no more
than 10 days. Snakes were maintained with water ad libitum, and none of the snakes were
fed during their time in captivity. The laboratory was maintained at 26–28°C and the
photoperiod was automatically controlled on a 12: 12 Light: Dark cycle.
Experimental Design
The test cages for neonate and subadult rattlesnakes consisted of glass terraria
(51×28×48 cm); adults were tested in larger glass terraria (122×33×35 cm). Testing cages
contained paper flooring, and paper was wrapped around the transparent sides. Cages
were cleaned prior to and between tests with Quatricide-PV®, a commercial disinfectant
and deodorant. Before testing, a snake was placed into the test cage, the top was affixed,
and the subject was allowed to acclimate undisturbed for 10 min.
Trials began by gently opening the lid of the testing cage, and using forceps we
placed a cotton-tipped applicator containing one of five chemical cue extracts 1 cm from
the snake’s snout (Cooper and Burghardt, 1990). Trials were of 60 sec duration, and we
counted tongue flicks directed at the cotton-tip applicator simultaneously using a hand
counter. To minimize stress to the animals and to keep them in captivity for as little time
as possible, trials were separated by 10 min, during which the lid was affixed to the cage
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and the snake was left undisturbed. However, this short duration between trials did not
influence subsequent tongue flicking, as indicated by an absence of trials effects in
statistical tests.
Chemical extracts of deer mouse P. maniculatus, lab mouse M. musculus, prairie
lizard S. undulatus, and house gecko H. frenatus, were prepared by placing intact prey
(entire animal) in 1ml of distilled water per gram of prey for 10 minutes (Clark, 2004).
Extracts were always used within 1 hr of preparation. Distilled water was used as a
control, and we added an additional control treatment of opening and closing the lid of
the testing cage. This additional control consisted of an observer opening the lid of the
testing cage for 60 secs, counting tongue flicks, and closing the lid of the cage. This
treatment was included to take into consideration any effect of opening the test cage as
well as the observer being present in front of the snake that may have led to elevated
levels of tongue flicking.
Statistical Analysis
Data were analyzed by Chi-square (χ² ) and repeated-measures, and mixed
analyses of variance (ANOVA) followed by Newman-Keuls Range Test (NKRT, 5%).
Repeated-measures ANOVA and mixed ANOVA (treating conditions as a repeated
measures factor and age as a between-subjects factor) were completed since we have
multiple observations on each individual and three age-groups of individuals. The
concept of analyzing data by both non-parametric and parametric statistics is based on the
desire to see different methodologies converge on a common outcome, thus strengthening
our conclusions (Siegel, 1956).
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Results
The mean number of tongue flicks toward chemical extracts during the 60 sec
trials varied markedly among treatments and age groups of snakes (Fig. 2.1). For
neonates, 19 of 25 snakes directed more tongue flicks at S. undulatus extract than toward
any other prey extract (χ²1 = 6.76, P <0.01). Repeated-measures ANOVA revealed a
significant effect of prey cue type (F5, 120 = 16.74, P < 0.01) and NKRT showed that S.
undulatus extract received significantly more tongue flicks than all other treatments.
Also, H. frenatus extract received more tongue flicks than the two control treatments; no
other pairwise comparisons were significant. The six means, ordered from low (openand-close control) to high (S. undulatus extract), were 1.4, 2.3 (water control), 4.2 (P.
maniculatus extract), 4.3 (M. musculus extract), 7.9 (H. frenatus extract), and 13.7,
respectively. Fifteen pairwise comparisons are possible. The differences (observed
ranges, ORs) between the highest mean and all others were significant, since the least
significant range (LSR) was 5.08, and all ORs exceeded this value. The two control
means were significantly lower than the mean for H. frenatus extract, because the ORs
were greater than the LSR of 4.86 (all Ps <0.05).
For subadult C. viridis, response to S. undulatus and P. maniculatus extracts were
significantly higher than some but not all other treatments. Response to S. undulatus
extract was as strong as was seen in the neonates, but response to P. maniculatus extract
was equally strong in the subadults. A significant effect of treatments (extracts) was
revealed by ANOVA (F5, 95 = 8.64, P <0.01) and NKRT revealed that the means for the
S. undulatus extract and for the P. maniculatus extract were significantly higher than the
means for the two control treatments. No other differences between treatments were
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significant. The mean numbers of tongue flicks, ordered from low (open-and-close
control) to high (S. undulatus extract), were 2.8, 3.6 (water control), 7.7 (M. musculus
extract), 8.8 (H. frenatus extract), 12.7 (P. maniculatus extract), and 14.4, respectively.
The LSRs for comparisons with P. maniculatus and S. undulatus extracts were 6.19 and
6.47, respectively, and the ORs for both control means were greater than these values;
hence, these differences were significant (all Ps <0.05). All treatments except for P.
maniculatus and H. frenatus extracts had ORs with S. undulatus extract that were greater
than LSR = 6.47. Therefore, these three treatment means (the two controls and M.
musculus extract) differed significantly from the mean for S. undulatus extract (all Ps
<0.05). Mean response to M. musculus extract did not differ significantly from P.
maniculatus extract (OR=5.0, LSR=6.19, P >0.05). Mean response to H. frenatus extract
differed significantly from the open-and-close control (OR=6.0, LSR=5.83, P<0.05). No
other pairwise comparisons were significant.
For adult C. v. viridis, ANOVA indicated a significant effect of treatments (F5, 95
= 12.24, P <0.01). NKRT showed that the two controls did not differ from each other, but
both of these means differed significantly from all others. Most conspicuously, the mean
for responses to P. maniculatus extract was significantly higher than all other means.
This was confirmed by Chi-square (χ²1 = 5.00, P <0.05) and NKRT. In addition, 17 of 20
adults had higher scores for P. maniculatus than for M. musculus extract (χ²1 = 9.8, P
<0.01), indicating that adults discriminated between natural and non-natural prey cues.
The six means, arranged from low (open-and-close control) to high (P. maniculatus
extract), were 2.8, 3.3 (water control), 7.0 (M. musculus extract), 7.1 (H. frenatus
extract), 8.1 (S. undulatus extract), and 12.9. The LSR for comparisons involving the
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latter mean was 4.26, and all ORs were higher than this value, including that for M.
musculus extract. Hence, P. maniculatus extract generated significantly more tongue
flicks than all other conditions. The LSR for comparisons involving S. undulatus extract
was 4.07, and both controls had ORs that were larger (all Ps <0.05). The mean for the
open-and-close control generated ORs that were higher than the LSRs for M. musculus
and H. frenatus extracts (3.49, 3.83, respectively, Ps < 0.05). The mean for the water
control had an OR with the mean for M. musculus extract that exceeded the
corresponding LSR (3.49; P <0.05). No other pairwise comparisons were significant.
Integrating all three sub-analyses into a single 3 (age) x 6 (treatments) mixed
ANOVA, treating age as a between-subjects factor and treatments as a repeated-measures
factor, demonstrated that the age effect was not significant (F2, 62 = 1.47, P >0.05). The
overall means across extracts for the age groups were similar and did not differ
significantly. The significant effect of extracts (F5, 310 = 54.89, P <0.01) was primarily
due to the fact that the controls were lower than the other treatments. The interaction of
age × treatments was significant (F10, 310 = 38.21, P <0.01). When comparing the 18
means with each other using NKRT, the S. undulatus extract had the highest means for
neonates and subadults (significantly higher than for the adults); conversely, P.
maniculatus extract had the highest means for adults (significantly higher than for
neonates). Applying NKRT to the 18 means (see the lists of means from the three
previous sub-analyses) from this 3× 6 mixed ANOVA produced 153 pairwise
comparisons. First, all control means (from both controls and all three age groups) had
ORs that did not exceed the corresponding LSRs. The highest OR in this subset of 15
contrasts was 2.2, whereas the corresponding LSR was 4.76. So, none of these treatments
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differed from each other. The highest means were for the S. undulatus extracts presented
to subadults and to neonates, and these means had significantly higher ORs with all
means except for P. maniculatus extracts presented to adult and subadult snakes. The
highest of these latter ORs was 4.8, while the corresponding LSR was 5.10. Hence, the
means for S. undulatus extracts presented to subadults and to neonates were significantly
higher than all but these last two means. Additionally, the means for S. undulatus
presented to subadults and neonates did not differ from each other (OR = 0.3, LSR =
5.18). The mean for P. maniculatus extract presented to adult snakes was higher than all
other means except for P. maniculatus extract presented to subadults, and S. undulatus
extracts presented to neonates and subadults (ORs = 0.2, 0.8 and 1.5, respectively; LSRs
= 5.49, 5.45, and 5.57, respectively). In short, this set of comparisons agrees with those
reported above in showing that the youngest snakes tongue flicked most strongly towards
S. undulatus extract, whereas the adult snakes tongue flicked the most to P. maniculatus.
Subadult snakes tongue flicked approximately equally to both S. undulatus and P.
maniculatus extracts.
Discussion
Natural selection can be expected to influence chemosensory responses of snakes
to stimuli that are most likely to lead to capture of prey (Tinbergen, 1951; Cooper, 2008).
Evolutionary shifts in snake diet have been well documented and are further correlated
with shifts in response to specific cues associated with such prey (see Cooper, 2008).
Whether this response is a learned or heritable trait has been examined in several species,
and studies have indicated that prey generalists demonstrate learning behavior such that
increased response is directed toward cues of the diet being fed to the snake (Burghardt,
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1993). Prey specialists, on the other hand, may exhibit chemosensory responses only to
specific prey, with such behavior exhibiting little flexibility, as is characteristic of
heritable responses (Arnold, 1981; see also Cooper, 2008). The majority of rattlesnakes
demonstrate different feeding strategies at different life stages; for example, gut content
analyses indicated that juvenile pacific rattlesnakes had a diet consisting of more than
50% ectotherms, whereas adult snakes had exclusively mammals in their diet (Mackessy,
1988).
Neonate C. v. viridis showed a significantly higher rate of tongue flicking for
chemical extract of S. undulatus when compared to all other treatments, including a nonprey lizard species H. frenatus extract. These results indicate that neonates discriminated
between natural S. undulatus and non-natural H. frenatus lizard prey chemical cues.
Interestingly, Chiszar and Radcliffe (1977) found that neonate C. v. viridis born in
captivity exhibited no significantly different responses to chemical extracts of lizard and
lab mouse M. musculus when compared to the control. However in this study, snakes
were naïve, never having been fed prior to testing. Further, these snakes had never seen
nor smelled prey, and snakes were tested immediately following the shed of natal skins
(about 10 days following parturition). In comparison, in the current study, snakes
certainly had feeding experience before they were caught, and that the observed
difference between the results of these two studies is likely due to prior predatory
experience among snakes in our study.
Subadult C. v. viridis responded with a higher rate of tongue flicking to both S.
undulatus and P. maniculatus extracts and adult C. v. viridis tongue flicked significantly
to the extract of P. maniculatus when compared to all other treatments. As with the
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neonates, rate of tongue flicking to chemical extract of native prey P. maniculatus was
higher than that seen for non-native prey (M. musculus), indicating that adults also
discriminated between natural and non-natural endothermic prey cues. Collectively, these
results reveal a shift in chemosensory responses, presumably correlated with prey
commonly taken between neonatal and adult life stages of C. v. viridis (Hammerson,
1999). Subadult snakes showed elevated levels of tongue flicking to both S. undulatus
and P. maniculatus, indicating that the emergence of the adult response is not associated
with an immediate decline of earlier dietary predilections. Indeed, although adult C. v.
viridis mostly take endothermic prey, they are known to take S. undulatus and other
ectotherms opportunistically throughout life (Hammerson, 1999).
Responses of rattlesnakes to chemical stimuli during ambush site selection
demonstrate that rattlesnakes rely on prey chemical cues for ambush foraging strategy.
Prairie rattlesnakes assumed ambush postures, both in the field and in the laboratory, in
response to potential prey extracts (Duvall et al., 1990; Theodoratus and Chiszar, 2000),
and dusky pygmy rattlesnakes Sisturus miliarius barbouri in the field selected ambush
sites based on presence of extracts of their most taken prey, leopard frogs Rana pipiens
(Roth et al., 1999). In addition, yearling timber rattlesnakes C. horridus born in captivity
responded significantly to chemical extracts of natural prey items, even though snakes
were fed exclusively lab mice (Clark, 2004). LaBonte (2008) further showed that ambush
site selection shifted from ectotherm to endotherm cues with increased snake age in
southern pacific rattlesnakes C. o. helleri. All of these results are consistent with our data
reported here which indicate a shift in responsiveness to age-appropriate prey.
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In addition to shifts in diet and chemosensory responses to prey, ontogenetic
shifts in venom composition have also been documented, as neonate venoms often
contain more toxic components, while adult venoms, which are less toxic, contain higher
levels of pre-digestive and digestive enzyme toxins (Fiero et al., 1972; Mackessy, 1988,
2008). This shift in venom composition is correlated with prey surface-to-volume ratios.
With smaller body sizes and longer limbs, ectotherms are structurally easier to digest than
endotherm prey, and many of the higher mass lytic components of rattlesnake venoms
(specifically metalloproteinases) are more abundant in venoms of adult snakes
(Mackessy, 1988, 2008). It therefore appears that concomitant changes in several aspects
of behavior and physiology occur as rattlesnakes age.
Our results support the hypothesis that chemosensory responses stages of C. v.
viridis are highly correlated with chemical cues of prey commonly taken at different life.
Similarly, Mushinsky and Lotz (1980) found that the plain-bellied water snake Nerodia
erythrogaster shifted response preference from fish to frog extract at approximately 8
months of age. Anurans make up nearly 85% of the diet of large N. erythrogaster,
whereas fish are primarily taken by smaller snakes, indicating that the shift in
chemosensory response as snakes mature closely follows actual dietary shifts (Mushinsky
and Lotz, 1980). Additionally, feeding experience has been shown to lead to shifts in
chemosensory responses. Burghardt et al. (2000) showed that an isolated population of
Thamnophis sirtalis with a natural diet primarily of earthworms, but fed exclusively fish
in captivity, exhibited a stronger response to fish cues at the end of the experimental
period. It should be stressed that the present study was not designed to assess the extent
of flexibility within each of the life stages. These studies are needed before we can
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conclude that neonates and adults exhibit different specialized strategies, each relatively
resistant to modification. However, prairie rattlesnakes are clearly differentially
responsive to chemical cues derived from prey typical of a given life stage, and this
ontogenetic change may be typical of other rattlesnakes which show age-related changes
in diet.
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Table
Table 2.1: Mean snout-vent length and body mass (± SEM) for the 65 rattlesnakes tested.
________________________________________________________________________
Snout-vent length (mm)
Mass (g)
Neonate

280.9 (3.6)

13.4 (0.5)

Subadult

552.0 (7.0)

103.0 (4.9)

Adult
789.5 (10.9)
334.5 (15.1)
________________________________________________________________________
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Figure 2.1: Mean Number of Tongue Flicks Over 60 Seconds. Mean number of tongue
flicks per minute ± standard error of the mean (SEM) from neonate, subadult, and adult
prairie rattlesnakes toward extracts of four different prey types and two control
treatments.
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Abstract
Rattlesnakes use chemical stimuli in ambush site selection and for relocation of
envenomated prey through strike-induced chemosensory searching. Shifts in
responsiveness to prey chemicals have been documented in many snakes, and often
correlate with prey commonly taken as snakes increase in age and size as well as
geographical locations of the species. For instance, neonate rattlesnakes that prey
primarily on ectotherms responded most strongly to chemical cues of commonly taken
lizard prey, whereas adult rattlesnakes that prey primarily on small mammals responded
significantly to chemical cues of commonly taken rodents. In the current study, 11 Prairie
Rattlesnakes Crotalus viridis viridis which were classified as large neonates based on
measures of snout-vent length (SVL) and body mass, yet chronologically were at or near
adulthood, were tested for their responsiveness to chemical extracts of natural and nonnatural prey items. Although the snakes had eaten only neonate lab mice (Mus musculus),
they responded significantly more to chemical cues of natural prey items and particularly
to chemical cues of prey normally taken by subadults (Peromyscus mice and Sceloporus
lizard). These results suggest that ontogenetic shifts in responsiveness to natural prey
chemical cues are innately programmed and are not based on body size or feeding
experience in C. v. viridis. This does not imply, however, that growth and experience are
without effects, especially with novel prey or rare prey that have experienced recent
population expansion.
Introduction
It is well established that many squamate reptiles, especially snakes, are excellent
at recognizing and discriminating between chemical cues of prey sources (Burghardt,
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1970; Cooper et al., 1990, Chiszar et al., 1992; Clark, 2004). Behavioral plasticity has
also been documented, as shifts in responsiveness to prey-derived cues often correlate
with shifts in diet as snakes increase in age and size (Mushinsky and Lotz, 1980; Cooper,
2008; Saviola et al., 2012a). Saviola et al. (2012a) found that neonate prairie rattlesnakes
Crotalus viridis viridis responded most strongly to chemical cues from prairie lizard prey
Sceloporus undulatus, whereas adult C. v. viridis responded less strongly to these cues
and more strongly to chemical cues from deer mice Peromyscus maniculatus. Subadults
responded strongly to both lizard and rodent cues. These chemosensory response patterns
also correlated with the natural prey most commonly taken by the three age groups
(Hammerson, 1999; Mackessy, 1988).
Rattlesnakes are ambush predators that use chemical cues in ambush site selection
and visual-thermal cues to deliver the envenomating strike (Chiszar et al., 1981; Kardong
and Mackessy, 1991; Kardong, 1992; Clark, 2004). Following the strike and release of
prey, rapid tongue flicking (strike-induced chemosensory searching) detects volatile and
non-volatile chemical cues, allowing for relocation of the envenomated carcass (Chiszar
et al., 1977, 1992). Prey-handling behaviors also vary as neonates typically hold on to
lizard prey (Mackessy, 1988), whereas adults release rodent prey immediately after the
strike (Mackessy, 1988; Hayes, 1991). Likewise, shifts in venom composition are often
seen, as neonate rattlesnakes tend to have higher concentrations of toxic venom
components, and less pre-digestive enzymes such as metalloproteinases, which are
typically in much higher abundance in venoms of adult rattlesnakes (see Mackessy, 2008
for a review).
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The present sample of C. v. viridis were collected as neonates in 2008 from the
same population and location as the snakes studied by Saviola et al. (2012a), but the
present animals had been underfed and, as a consequence, had not grown at a normal rate.
It has been documented that prey preference correlates with skull shape and size in
snakes (Vincent et al., 2004, 2009), and with maximum gape and head size being limiting
factors in prey consumption, underfeeding and consumption of small prey may drastically
inhibit snake growth. Based on measures of snout-vent length (SVL) and body mass, the
present snakes were between the neonate and subadult categories defined by Saviola et al.
(2012a), whereas chronologically the animals were at or near adulthood (Klauber, 1972).
Hence, we were provided with a unique opportunity to assess whether the same shift in
response to chemical cues occurred in these snakes as occurred in the snakes studied by
Saviola et al. (2012a). This question is of additional interest for at least two reasons: (1)
the present snakes had never encountered P. maniculatus or S. undulatus, as they had
eaten only neonatal and adolescent lab mice (Mus musculus; 3−10g, 2−3cm in length) in
captivity, and (2) because of the size of the stunted snakes, they were incapable of
swallowing adult P. maniculatus (or adult M. musculus). Hence, if the stunted snakes
nevertheless respond strongly to chemical cues derived from adult P. maniculatus, the
implication would be that the transition described by Saviola et al. (2012a) was not
dependent upon experience with natural prey but may be innately programmed.
Materials and Methods
Eleven C. v. viridis captured in Weld County, CO, October 8, 2008 (approx. one
month after parturition) were maintained in captivity for approximately four years (at the
time of this study). The snakes were underfed, but cage sanitation and drinking water
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were not neglected. During this period, snakes were offered M. musculus neonates and
adolescents, as the snakes were and still are incapable of ingesting adults. Saviola et al.
(2012a) classified wild caught neonates, subadults and adults as shown in Table 3.1. The
present snakes had mean SVL of 349.1 mm and mean mass of 27.4 g, significantly higher
than the means for the neonates of Saviola et al. (t34 = 9.52 and 9.75, respectively, Ps
<0.01) but also significantly lower than the means for subadults (t29 = 18.73 and 11.09,
respectively, Ps <0.01). Accordingly, the present sample would be classified as large
neonates or small subadults, but not as adults, although chronologically these snakes
would be nearing adulthood (Klauber, 1972). All snakes were maintained in individual
plastic terraria (51 × 28 × 48 cm) and provided hide boxes, paper floor coverings and
water ad libitum. The laboratory was maintained at 26−28 °C, and the photoperiod was
automatically controlled on a 12:12 light-dark cycle.
Chemical extracts of five adult potential prey organisms (P. maniculatus, M.
musculus, S. undulatus, Side-blotched Lizard, Uta stansburiana, and Common House
Gecko, Hemidactylus frenatus) were prepared by placing intact prey in one ml distilled
water per gram of prey for 10 min (Clark, 2004). Extracts were always used within one hr
of preparation, and distilled water was used as a control. Trials began by gently opening
the lid of the terrarium. Using forceps, a cotton-tipped applicator containing one of the
extracts or water was placed one cm from the snake’s snout (Cooper and Burghardt,
1990). During the next 60 sec we counted the number of tongue flicks aimed at the
applicator and the latency to strike if this occurred. Tongue flicking in squamates is
activated by detection of chemical stimuli by the nasal olfactory system, or by visual,
thermal or vibratory cues and is the main process for delivering volatile and non-volatile
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cues to the vomeronasal organs, which mediates definitive analysis of chemical
information (Burghardt, 1970; Halpern, 1992; Schwenk 1995; Saviola et al., 2011,
2012b). Therefore, measuring tongue flicking in snakes is a useful assay for measuring a
snake’s response to any or all of these cues. Trials were separated by at least 24 hr, and
the six chemical cues were presented in a different random order for each snake. Each
cage was cleaned prior to and between trials with Quatricide-PV®, a commercial
disinfectant and deodorant. Snakes were always left undisturbed after a trial and allowed
to come to rest after the cage lid was opened in preparation for the next trial.
Data were converted to tongue-flick-attack (TFA) scores in order to account for
strikes (Cooper and Burghardt, 1990); four strikes occurred during all trials. So, TFA
scores were essentially the same as the number of tongue flicks during the 60 sec tests.
We used a log-10 transformation to normalize the data and to achieve homogeneity of
variance in the six conditions.
Inferential analyses used Chi-square (χ²) and repeated-measures analyses of
variance (ANOVA) followed by non-orthogonal contrasts. Alpha was set at 0.01 for these
contrasts to control type I errors. Use of both nonparametric and parametric tests was
predicated on our desire to see different statistical tools converge on the same
conclusions. Comparisons of characteristics of the present snakes with those of Saviola et
al. (2012a) used t-tests.
Results
Nine of the eleven snakes had their highest TFA scores with P. maniculatus or
S. undulatus cues as opposed to the other four cues (χ²1 = 4.44, P < 0.05), including M.
musculus, the only prey offered in captivity and likely the only prey ever eaten by these
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snakes. All snakes had higher TFA scores for the three potential prey extracts (M.
musculus, H. frenatus, U. stansburiana) as opposed to the water control (χ²1 = 11.00, P <
0.01).
The six means shown in Figure 3.1 differed significantly by repeated-measures
ANOVA (F5,50 = 3.92, P < 0.01). Non-orthogonal contrasts revealed that the mean of the
five extracts combined differed significantly from the mean for water (F1,50 = 9.06, P <
0.01). The means of P. maniculatus and S undulatus extracts were significantly higher
than the means of all other extracts combined, including the mean for M. musculus
extract (F1,50 = 22.30, P < 0.01). The latter means did not differ significantly among
themselves (F1,50 = 3.56, P > 0.05).
Discussion
Rattlesnakes use chemical stimuli in both ambush site selection (Duvall et al.,
1990; Clark, 2004; LaBonte, 2008) and relocation of prey during strike-induced
chemosensory searching (Chiszar et al., 1977). Therefore, understanding how
chemosensory responsiveness varies during the development of the snakes is important
for understanding the behavior and ecology of these species. Although the present snakes
had eaten only M. musculus, the response to P. maniculatus had developed more-or-less
on the same schedule as that of normally fed adult snakes, while the response to S.
undulatus extract had not dropped significantly, as is seen in wild-caught snakes (see
Saviola et al., 2012a). Further, the only strikes observed during trials were toward these
native prey extracts (P. maniculatus and S. undulatus, two strikes towards each). Hence,
these snakes behaved like normal subadults, even though they were closer to the size
range of neonates and could not ingest adult mice.

40
Development of response to chemical cues of natural prey might be innately
programmed, or experience with these or similar items might be required. In the present
case, the responses to P. maniculatus and S. undulatus extracts were of normal intensity,
even though the snakes probably had never seen or eaten these prey. This is suggestive of
and might be taken as evidence for innate ontogenetic programming. It remains possible
that feeding on M. musculus provided sufficient surrogate cues to promote development
of response to P. maniculatus extracts. However, if this is true, then why did the snakes
not respond strongly to M. musculus extracts? We cannot resolve this conundrum on the
basis of present data, but we can provide two hypotheses: (1) response to P. maniculatus
cues developed innately, perhaps even earlier than usual because of hunger and
underfeeding, and (2) this sensitivity to rodent cues may have been the reason the snakes
accepted M. musculus (rather than the other way around). Although captivity may
influence chemosensory responses it has been documented that long-term captive
rattlesnakes (C. atrox, C. durissus, C. horridus, C. vegrandis, C. unicolor) demonstrate
no significant differences in strike-induced chemosensory searching when compared to
wild-caught rattlesnakes (Chiszar et al., 1985). Similarly, long-term captivity did not
appear to affect the ability of C. o. oreganus to strike, dispatch, or relocate prey normally
(Alving and Kardong, 1994).
There is evidence that snakes can acquire responsiveness to new or unusual
foods if the snakes are fed such foods but not their usual fare (Burghardt et al., 2000), and
our data for M. musculus extracts agree with this finding. It is also known that naïve
neonatal snakes respond to chemical extracts of natural foods (Cooper et al., 1990), and
our data for S. undulatus extracts agree with those of Burghardt (working with garter
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snakes). The data for P. maniculatus extracts suggest that ontogenetic appearance of
response to prey normally taken later in life does not require experience with that prey.
Similarly, adult C. horridus born and raised in captivity showed significant responses to
chemical cues of preferred natural prey, even though these snakes were fed entirely M.
musculus, never encountering natural prey items (Clark, 2004).
Being gape-limited forces snakes to consume prey that are small enough for
them to swallow, and chemosensory responses to prey cues have been shown to correlate
with the most commonly consumed prey and with the foraging ecology of the snake (see
Cooper, 1995, 2008; Saviola et al., 2012a, b). In Colorado, neonate C. v. viridis prey
primarily on small ectotherms such as the lesser earless lizard Holbrookia maculata,
prairie lizard S. undulates and plains spadefoot toad Spea bombifrons; however, shifts to
endotherm prey such as the western harvest mouse Reithrodontomys megalotis and deer
mouse P. maniculatus occur in subadult and adult snakes (Hammerson, 1999). Although
responsiveness to chemical cues changes over snake age, which typically correlates with
increased size, our study demonstrates that C. v. viridis respond to chemical cues of prey
most commonly taken in adulthood, regardless of the snakes’ size, and we infer that
changes in chemosensory responsiveness by C. v. viridis are innate.
Acknowledgements
We thank the landowners (Loose family) for permission to work with snakes on
their land, and Anthony Gandara and Christopher Rex for their assistance with this
project.

42

References
Alving WR, Kardong KV, 1994. Aging in snakes: Results of long-term captivity on
rattlesnake (Crotalus viridis oreganus) predatory behavior. Zoo Biology 6: 537544.
Burghardt GM, 1970. Chemical perception in reptiles. In: Johnson Jr JW, Moulton DG,
Turk A eds. Communication by Chemical Signals.

New York: Appleston-

Century-Crofts, 241-308.
Burghardt GM, Layne DG, Konigsberg, L, 2000. The genetics of dietary experience in a
restricted natural population. Psychol. Sci. 11: 69-72.
Chiszar D, Radcliffe CW, Scudder K, 1977. Analysis of the behavioral sequence emitted
by rattlesnakes during feeding episodes. I. Striking and chemosensory searching.
Behav. Biol. 21: 418-425.
Chiszar D, Taylor SV, Radcliffe CW, Smith HM, O’Connell B, 1981. Effects of chemical
and visual stimuli upon chemosensory searching by Garter Snakes and
Rattlesnakes. J. Herp. 15: 415-424.
Chiszar D, O’Connell B, Greenlee R, Demeter B, Walsh T, Chiszar J, Moran K, Smith
HM, 1985. Duration of strike-induced chemosensory searching in long-term
captive rattlesnakes at National Zoo, Audubon Zoo, and San Diego Zoo. Zoo
Biology 4: 291-294.
Chiszar D, Lee RKK, Radcliffe CW, Smith HM, 1992. Searching behaviors by
rattlesnakes following predatory strikes. In: Campbell JA, Brodie ED Jr eds.
Biology of the Pitvipers, Selva, Tyler, Texas, 369-382.

43
Clark RW, 2004. Timber rattlesnakes (Crotalus horridus) use chemical cues to select
ambush sites. J. Chem. Ecol. 30: 607-617.
Cooper WE Jr, 1995. Foraging mode, prey chemical discrimination, and phylogeny in
lizards. Anim. Behav. 50: 973-985.
Cooper WE Jr, 2008. Tandem evolution of diet and chemosensory responses in snakes.
Amphibia-Reptilia 29: 393-398.
Cooper WE Jr, Burghardt GM, 1990. A comparative analysis of scoring methods for
chemical discrimination of prey by squamate reptiles. J. Chem. Ecol. 16: 45–65.
Cooper WE Jr, Buth DG, Vitt LJ, 1990. Prey odor discrimination by ingestively naïve
coachwhip snakes (Masticophis flagellum). Chemoecology 1: 86-91.
Duvall D, Chiszar D, Hayes WK, Leonhardt JK, Goode MJ, 1990. Chemical and
behavioral ecology of foraging in prairie rattlesnake (Crotalus viridis viridis). J.
Chem. Ecol. 16: 87-101.
Halpern M, 1992. Nasal chemical senses in reptiles: structure and function. In: Gans C,
Crews D eds. Biology of the Reptilia. Physiology E, Hormones, Brain, and
Behavior, Vol. 18. Chicago, Illinois: University of Chicago Press, 423-523.
Hammerson G, 1999.

Amphibians and Reptiles in Colorado. University Press of

Colorado, Niwot, CO and Colorado Division of Wildlife.
Hayes WK, 1991. Ontogeny of striking, prey-handling and envenomation behavior of
prairie rattlesnakes (Crotalus v. viridis). Toxicon 29: 867-875.
Kardong KV, 1992. Proximate factors affecting guidance of the rattlesnake strike. Zool.
J. Anat. 122: 233–244.
Kardong KV, Mackessy SP, 1991. The strike behavior of a congenitally blind rattlesnake.

44
J. Herp. 25: 208-211.
Klauber LM, 1972. Rattlesnakes: Their Habits, Life Histories, and Influence on Mankind.
2 Vols. 2nd ed. Berkeley: University of California Press.
LaBonte JP, 2008. Ontogeny of prey preference in the southern Pacific rattlesnake,
Crotalus oreganus helleri. In: Hayes WK, Beaman KR, Cardwell MD, Bush SP
eds. The Biology of Rattlesnakes. Loma Linda, U.S.A.: Loma Linda University
Press, 169-174.
Mackessy SP, 1988. Venom ontogeny in the Pacific rattlesnakes Crotalus viridis helleri
and C. v. oreganus. Copeia 1988: 92-101.
Mackessy SP, 2008. Venom composition in rattlesnakes: trends and biological
significance. In: Hayes WK, Beaman KR, Cardwell MD, Bush SP eds. The
Biology of Rattlesnakes. Loma Linda, U.S.A.: Loma Linda University Press, 495510.
Mushinsky, HR, Lotz, KH, 1980. Chemoreceptive responses of two sympatric water
snakes to extracts of commonly ingested prey species. Ontogenetic and ecological
considerations. J. Chem. Ecol. 6: 523-535.
Saviola AJ, Lamoreaux WE, Opferman R, Chiszar D, 2011. Chemosensory response of
the threatened eastern indigo snake (Drymarchon couperi) to chemical and visual
stimuli of Mus musculus. Herpetological Conservation and Biology 6: 449-454.
Saviola AJ, Chiszar D, Mackessy SP, 2012a. Ontogenetic shift in response to preyderived chemical cues in prairie rattlesnakes Crotalus viridis viridis. Current
Zoology 58: 548-554.

45
Saviola AJ, McKenzie VJ, Chiszar D, 2012b. Chemosensory responses to chemical and
visual stimuli in five species of colubrid snakes. Acta Herpetologica 7: 91-103.
Schwenk K, 1995. Of tongues and noses: Chemoreception in lizards and snakes. Trends
Ecol. Evol. 10: 7–12.
Vincent SE, Herrel A, Irschick DJ, 2004. Sexual dimorphism in head shape and diet in
the cottonmouth snake (Agkistrodon piscivorus). J. Zool. Lond. 264: 53-59.
Vincent SE, Brandley MC, Herrel A, Alfaro ME, 2009. Convergence in trophic
morphology and feeding performance among piscivorous natricine snakes. J.
Evol. Biol. 22: 1203-1211.

46
Table
Table 3.1: Mean Snout-vent Length and Body Mass (± SEM) for the 11 C. v. viridis
Tested. Bold lettering indicates subject classifications and data from Saviola et al.
(2012a; Chapter II).
________________________________________________________________________
Snout-vent length (mm)
Mass (g)
Current Subjects (n=11)
Neonate (n=25)
Subadult (n=20)
Adult (n=20)

349.1 (7.1)
280.9 (3.6)
552.0 (7.0)
789.5 (10.9)

24.7 (2.0)
13.4 (0.5)
103.0 (4.9)
334.5 (15.1)
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Figure

Figure 3.1: Comparison of Log10 Transformed TFAS. A. Log10 transformation of mean
tongue flicks attack score (TFAS) ± standard error of the mean (SEM) for 11 stunted C.
v. viridis toward 5 different prey types and water control. B. Log10 transformation of
mean TFAS ± SEM towards chemical cues of natural prey items for wild-caught neonate,
subadult, and adult C. v. viridis from Saviola et al. (2012a). Dissimilar letters above
histogram bars indicate significant differences between responses; same letters indicate
no significant differences.
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Abstract
Vertebrate predators use a broad arsenal of behaviors and weaponry for
overcoming fractious and potentially dangerous prey. A unique array of predatory
strategies occur among snakes, ranging from mechanical modes of constriction and jawholding in non-venomous snakes, to a chemical means, venom, for quickly dispatching
prey. However, even among venomous snakes, different prey handling strategies are
utilized, varying from the strike-and-hold behaviors exhibited by highly toxic elapid
snakes to the rapid strike-and-release envenomation seen in viperid snakes. For vipers,
this mode of envenomation represents a minimal risk predatory strategy by permitting
little contact with or retaliation from prey, but it adds the additional task of relocating
envenomated prey which has wandered from the attack site. This task is further
confounded by trails of other unstruck conspecific or heterospecific prey. Despite
decades of behavioral study, researchers still do not know the molecular mechanism
which allows for prey relocation. During behavioral discrimination trials (vomeronasal
responsiveness) to euthanized mice injected with size-fractionated venom, Crotalus atrox
responded significantly to only one protein peak. Assays for enzymes common in
rattlesnake venoms, such as exonuclease, L-amino acid oxidase, metalloproteinase,
thrombin-like and kallikrein-like serine proteases and phospholipase A2, showed that
vomeronasal responsiveness was not dependent on enzymatic activity. Using mass
spectrometry and N-terminal sequencing, we identified the proteins responsible for
envenomated prey discrimination as the non-enzymatic disintegrins crotatroxin 1 and 2.
Our results demonstrate a novel and critical biological role for venom disintegrins far
beyond their well-established role in disruption of cell-cell and cell-extracellular matrix

50
interactions. These findings reveal the evolutionary significance of free disintegrins in
venoms as the molecular mechanism in vipers allowing for effective relocation of
envenomated prey. The presence of free disintegrins in turn has led to evolution of a
major behavioral adaptation (strike-and-release), characteristic of only rattlesnakes and
other vipers, which exploits and refines the efficiency of a pre-existing chemical means
of predation and a highly sensitive olfaction system. This system of a predator chemically
tagging prey represents a novel trend in the coevolution of predator-prey relationships.
Background
Coevolution within predator-prey interactions has led to adaptations that are
advantageous for either prey capture or predation avoidance. In predators, these traits
may be under strong selection leading to successful capture of prey [1, 2], but they are
relatively under-studied compared to the mechanisms involved in anti-predator
adaptations [3]. Darwin [4] suggested that diversification of predators may be largely
based on selection on predatory behaviors, and adaptations to observable phenotypic
characteristics that are advantageous to prey capture are commonly examined. For
example, evolution of craniofacial asymmetries has shown to increase predation success
in scale-eating cichlids [5] as well as in snail-eating snakes [6]. Phenotypic plasticity
undoubtedly plays a critical role in diversification of predators and prey, often leading to
adaptations in behavior, life history, physiology and morphology of species [7]. Further,
competition, predation and utilization of dangerous prey have been proposed as the most
significant factors of selection on organisms [8]. The ability of predators to adapt to
dangerous prey, such as garter snake (Thamnophis sirtalis) resistance to tetrodotoxin
(TTX) of Taricha newts [2], provides strong evidence for a coevolutionary arms race
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between predators and prey. However, adaptations in predatory behaviors to avoid
complete retaliation from dangerous prey may be rare. Nevertheless, natural selection can
be expected to lead to adaptations influencing behaviors that are most advantageous to
prey capture [1], and further examination of the molecular mechanisms allowing for these
large scale behavioral adaptations is critical for understanding coevolution between
predator-prey interactions. Many studies examining phenotypic plasticity in species
address various forms of plasticity separately, yet this variety may have significantly
different ecological consequences [9]. Among venomous snakes, venom characteristics
are under positive directional selection [10], and the presence of specific venom
components may have played a critical role in diversification of predatory behaviors of
several snake taxa.
Rattlesnakes and other vipers demonstrate one of the most advanced modes of
predation among vertebrates, utilizing a strike-and-release mode of envenomation. This
behavior provides the benefit of minimal contact or retaliation from potentially dangerous
prey, but adds the additional task of locating the trail left behind by the envenomated prey
that may wander several meters or more from the attack site. By using rapid tongue
flicking (strike-induced chemosensory searching) to detect, and the vomeronasal organs
to analyze volatile and non-volatile chemical cues [11], snakes must then differentiate
between the trail deposited by the prey before and after envenomation has occurred, as
well as the trails left inadvertently by other potential prey and non-prey sources. Several
hypotheses have addressed the source of chemical cues used to discriminate between
trails of struck and unstruck prey. Cues emanating from the mouse when it is punctured
during the envenomating strike, as well as other potential chemical cues, such as urine or
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volatiles from venom left on the prey’s integument, have been examined, yet are not
utilized by snakes [12-15]. These previous results indicate that venom must be injected
into tissues to initiate a release of chemical odor(s), permitting discrimination of
envenomated prey and their trails. A convenient bioassay of vomeronasal
chemoreception was previously developed for evaluating preference towards
envenomated (E) vs. non-envenomated (NE) mouse carcasses, with snakes showing high
rates of tongue flicking directed toward E carcasses (strike-induced chemosensory
searching, SICS [15-18]). This preference holds when envenomation occurs by a
conspecific or by a closely related heterospecific [17], or when lyophilized conspecific
venom is injected into previously euthanized prey [18]. Therefore, venoms represent not
only a rapid-acting chemical means of dispatching potentially fractious prey [19]; they
also greatly increase the perceptibility of the envenomated prey carcass [15, 18].
However, the specific component(s) of snake venom allowing for successful recovery of
prey and further diversification of prey handling behaviors has not been identified.
Results
To determine which component(s) of venom allows for rattlesnakes to
differentiate between envenomated (E) and non-envenomated (NE) prey, we offered
western diamondback rattlesnakes (Crotalus atrox) E and NE mouse carcasses; E mice
were injected with either crude venom or with fractionated protein or peptide peaks of
crude venom (extracted from conspecifics). Non-envenomated mice were injected with a
saline control. When artificial envenomation occurred with whole crude venom, the mean
number of tongue flicks was significantly greater for the E mouse (t = 3.67, df = 6, P
<0.01; Table 4.1). When total number of tongue flicks were converted to percentage of
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tongue flicks (to control for natural variation in absolute tongue flick rate between
snakes), results confirmed that C. atrox directed significantly more tongue flicks at the E
than at NE mice (t = 3.76, df = 6, P <0.01) (Table 4.1). These results agree with
numerous studies of vomeronasal response of rattlesnakes to E versus NE prey [15, 17,
18], including a previous study performed using the same pool of C. atrox venom as used
in this report [18].
To test snake responses toward fractionated protein and peptide peaks, crude C.
atrox venom was separated using low-pressure size exclusion liquid chromatography, and
four major protein peaks, labeled I, IIa, IIb and III, as well as three downstream peptide
peaks, were resolved (Figure 4.1A). When mouse carcasses were envenomated with
either Peaks I, IIa, IIb or the peptide peaks, there was no significant difference between
the mean number of tongue flicks or the percentages of tongue flicks directed towards
either the E or NE carcasses (Table 4.2; see also Table 4.3). However, for Peak III, there
were significantly more tongue flicks directed towards the E mouse (t = 4.24, df = 10, P
<0.01; Table 4.2), and the mean percentage of tongue flicks toward the envenomated
carcass (68%) was also significantly higher than the null (t = 5.78, df = 10, P <0.01;
Table 3.2). Analysis of variance (ANOVA) indicated a significant main effect of
conditions (F = 4.63, df = 4, 54, P <0.01). The Newman-Kewls range test also revealed
that the mean for Peak III was significantly higher than the means for Peaks I, IIa, IIb and
the peptide peaks (P <0.05), which did not differ significantly among themselves (P
>0.05). Further, in 10 out of 11 Peak III trials, snakes tongue flicked more towards the E
mouse (χ2 = 3.68, df = 1, P = 0.05), whereas for Peaks I, IIa, IIb and the combined
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peptide peaks, there was no preference shown over the E mouse or the NE mouse (χ2 =
0.264, 0.045, 0.2 and 0.05, respectively; all df’s = 1, all Ps >0.05).
We next sought to examine the components in Peak III that produced this
significant vomeronasal response. Because metalloproteinase enzymes are prevalent
components of most viper venoms [20] and because they would still catalyze degradation
of non-living E mouse tissues, we hypothesized that these enzymes would be responsible
for “tagging” of E prey. Assays for enzymes common in rattlesnake venoms
(exonuclease, L-amino acid oxidase, metalloproteinase, thrombin-like and kallikrein-like
serine proteases, and phospholipase A2: [21]) indicated that all of these activities were
confined to Peaks I through IIb (Figure 4.1A). SDS-PAGE (Figure 4.4) and mass
spectrometry of Peak III (Figure 4.1B) revealed only peptides with masses of
approximately 7.5 kD. Further analysis of Peak III through reverse-phase high pressure
liquid chromatography (HPLC) yielded two peaks (Figure 4.2A) that were subjected to
Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) mass
spectrometer analysis. These results yielded masses of 7,440.35 Da (Figure 4.2B) and
7,383.29 Da (Figure 4.2C), respectively, indicating that the proteins isolated were the
disintegrins crotatroxin 1 and crotatroxin 2. N-terminal sequencing of Peak III proteins
confirmed the identity of these disintegrins (Figure 4.3).
Discussion
Determining the molecular mechanisms leading to large-scale adaptations of
predatory behaviors, including, in this case, relocation of prey, is critical for
understanding predator-prey interactions, evolutionary biology and natural history of pit
vipers. Our findings show that the venom disintegrins crotatroxin 1 and 2 alone allowed
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C. atrox to distinguish between envenomated and non-envenomated prey sources,
presumably by altering the chemical odor of prey integument. Crotatroxins are mediumsized monomeric disintegrins with approximate masses of 7.4 kDa and contain 71 to 72
amino acids with six disulfide bonds, differing only by the presence of an additional Nterminal alanine in crotatroxin 1 ([22]; see also Figure 4.3). Disintegrins are nonenzymatic and are produced by the proteolytic posttranslational processing of the Cterminal domain of P-II snake venom metalloproteinases [23]. The presence of dimeric
disintegrins in other viperid venoms has also been documented; however, only mediumsized monomeric disintegrins appear to be present in C. atrox venom [24]. It is currently
unknown if dimeric disintegrins will produce the same type of vomeronasal response as
the monomeric disintegrins did in this current study. A primary activity of disintegrins is
the inhibition of platelet aggregation by selectively binding integrin receptors expressed
on cell surfaces [25]. The majority of monomeric disintegrins, including crotatroxins 1
and 2, contain an active Arg-Gly-Asp (RGD) sequence [26], which has been shown to
block numerous classes of integrin receptors with a high degree of selectivity. Therefore,
the action of crotatroxins which results in successful relocation of envenomated prey via
SICS likely involves an integrin binding mechanism and further release of volatile cues
detectable by rattlesnakes.
Rattlesnake venoms are classified as either type I venoms, containing high
metalloproteinase activity and lower toxicity, or type II venoms, containing low
metalloproteinase activity and higher toxicity [21]. Although some strike-and-release
rattlesnakes, such as C. scutulatus scutulatus (type A) and C. tigris, contain less than
0.1% venom metalloproteinases, proteomic studies have identified disintegrins in their
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venoms [27, 28]. These species possess type II venoms with potent lethal toxicity, so the
possibility of prey wandering a significant distance from the attack site before it has
succumbed to venom is much less likely than species exhibiting type I venom, making
relocation following a strike less challenging for these highly toxic rattlesnakes.
Disintegrins make up approximately 2% (by mass) of the total venom proteins/peptides
of crude C. atrox venom, though the abundance of this protein (and other venom
compounds) may vary between individual snakes. The utilization of a relatively minor
venom component to “tag” envenomated prey may also explain the “overkill method”
[29] employed by venomous snakes. It has long been observed that many taxa of
venomous snakes inject prey with amounts of venom which vastly exceed the mouse
model LD50, often by several orders of magnitude [14, 30]. In part, this “excessive”
dosage is explained by differential sensitivity of various prey to specific toxins [31] and
venoms [32], induced by coevolutionary responses of both prey and their snake predators
[33]. For example, some prey species are much less affected by venoms, while others are
highly sensitive (cf. frogs and lizards [34]). However, another important factor, in
particular, among the strike-and-release predators, such as most viperids, is the need to
discriminate between competing prey trails (E and NE rodents), selecting the one leading
to the previously envenomated prey. This is likely a main reason why rattlesnakes use
apparently large quantities of venom - to achieve a “minimum perceptible dose” [18].
Venoms consist of a myriad of proteins and peptides that may vary based on age,
geographic locations and prey preference of the snake [35]. This complexity of venom
composition, coupled with the fact that many species specialize on specific prey, likely
result in selective pressures on venom characteristics, leading to the evolution of

57
advantageous venom phenotypes and predatory behaviors [36]. On a trophic level, the
roles of disintegrins and many other proteins found in venoms still remain relatively
unknown. In whole venom, disintegrins which have not been proteolytically processed
could potentially assist in the targeting of PII snake venom metalloproteinases (SVMPs)
to specific integrin receptors in cell membranes [37], giving rise to chemical changes
recognized by the snakes. Lys49 phospholipase A2s have also been suggested to act as a
tag of envenomated prey [38]; however, we have demonstrated that neither the
metalloproteinase-containing nor the PLA2-containing fractions of C. atrox venom
elicited prey relocating responses.
To the best of our knowledge, all pit vipers that have been tested have shown
significant preference for envenomated prey [for example, 15-18], indicating that
disintegrins in other venoms, not just those in C. atrox, assist in prey relocation for other
pit viper species. But not all snake venoms contain disintegrins. How are prey relocated
in these cases? Atractaspis species (mole “vipers”) use a unilateral slashing
envenomation behavior to feed on neonatal rodents within nests and burrows [39], and
prey escape after envenomation is highly improbable. Elapids are typically strike-andhold predators [40], with venoms rich in rapid-acting three-finger toxins [35], and so the
presence of a “relocator protein” in these venoms is not likely advantageous. Similarly,
neonate rattlesnakes that generally strike-and-hold prey [41] produce much smaller
amounts of venom and have significantly lower concentrations of metalloproteinases, the
protein family that releases free disintegrins, when compared to venoms of subadult and
adult rattlesnakes [21, 41].
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A major selective advantage for the evolution of free disintegrins among viperid venoms
(apparently exclusively) is provided by their role in prey relocation.
Natural selection undoubtedly has influenced snake responses to stimuli that are
most likely to lead to successful capture or, as in this case, successful relocation of prey
[1, 42]. Further, this preference for envenomated prey is an adaptive mechanism that
facilitates optimal foraging efforts, leading to rapid relocation of prey after it has
succumbed. Snakes often will not attend to a second prey offered after the initial
envenomating strike, suggesting that chemical cues arising from the struck prey may be
focusing foraging efforts and redirecting the snake from additional, potentially
confounding chemical cue sources [43]. Our results strongly indicate that for C. atrox,
disintegrins have evolved into multifunctional proteins which evoke vomeronasallysalient cues, enabling the snake to relocate envenomated prey after the strike. Therefore,
in addition to immobilizing, killing and predigesting prey, another biological role of
venoms in rattlesnakes is for prey relocation.
Conclusions
These findings provide an important biological role for a non-lethal venom
protein which has little apparent relevance to the well-characterized roles of disintegrins
in disrupting cell-cell and cell-extracellular matrix interactions. Thus, in order to
understand the evolution of animal venoms and venom compositional variation, it will be
important to consider possible selective advantages conferred by specific venom
components to the behavior and ecology of the animals which produce them, in addition
to the more apparent pharmacological effects. At present, it is unknown how the
crotatroxins create an olfactory “mark” that snakes are able to recognize, but we
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hypothesize that integrin-mediated release of chemical cues from prey stimulate the
vomeronasal system of snakes. Studies now in progress are aimed at determining the
mechanism(s) by which disintegrins interact with prey tissues and facilitate relocation of
envenomated prey by rattlesnakes.
Methods
Materials
BioGel P-100 resin was obtained from BioRad, Inc. (San Diego, CA, USA).
Matrix for MALDI-TOF-MS, enzyme substrates, buffer salts and all other reagents were
analytical grade or better and were obtained from Sigma Chemical Co. (St. Louis, MO,
USA).
Experimental Animals
Behavioral trials were performed as approved by the Institutional Animal Care
and Use Committee of the University of Colorado at Boulder. Eight C. atrox, all adult
long-term captive snakes, were fed bi-weekly on live or pre-killed mice (Mus musculus).
Snakes were never fed on the day of trials, which occurred 7 to 10 days after the last
feeding session, and all trials were randomized and separated by at least 14 days. Snakes
were housed individually in glass aquaria (61.0 x 41.0 x 44.5 cm) containing a paper
floor, water bowls and hide boxes. We maintained the snakes on a 12:12 L:D cycle and at
26 ± 2°C. Inbred Swiss/Webster mice (Mus musculus) were culls from colonies
maintained by the University of Colorado Department of Molecular, Cellular and
Developmental Biology and were euthanized by CO2 asphyxiation and frozen at -20°
until used in this study [17]. The magnitude of SICS towards natural rodent prey such as
Peromyscus maniculatus (deer mice) does not differ compared to lab mice (M. musculus)
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[44], and the strain of lab mice used also does not influence results. On testing days,
similar size and sex mice were thawed and warmed by electrical heaters until skin
temperature was 38 ± 1°C before injection and subsequent testing.
Experiment 1
Venoms were manually extracted, centrifuged to pellet insoluble material, frozen,
lyophilized and stored at -20°C until used [41]. Lyophilized venom was reconstituted on
the day of testing by dissolving 10 mg of crude venom in 100 µL of deionized water.
During a test day, C. atrox were allowed to strike and envenomate prey carcasses
suspended from long forceps to initiate strike-induced chemosensory searching [15].
Since rattlesnakes release prey after the strike, this envenomated mouse was removed
from the snakes’ cages and discarded, and that mouse never touched the floor or walls of
the cage. The test apparatus, a 4 x 10 cm metal base with two wire mesh baskets
approximately 4.0 cm apart, containing both an envenomated mouse injected with 100
µL of reconstituted venom and a non-envenomated mouse [17, 18], was placed into the
snake’s cage. The 100 µL volume of reconstituted venom is comparable to the volume of
venom injected during a predatory strike [14]. Two injections (each containing 50 µL)
were made in the thoracic region, dorsal and ventral to the shoulder blade, in areas most
commonly struck during predatory episodes [45]. The control (non-envenomated) mouse
was injected in the same regions with 100 µL of deionized water. Trials (10-minute trial
duration) started as soon as the test apparatus was placed in the cage, with observers
counting tongue flicks directed within 1 cm of either the envenomated or the nonenvenomated mouse. All tongue flicking was recorded double blind to the condition;
therefore, the observer was unaware of which mouse carcass was injected with the
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control or venom sample, as well as which condition was being tested. Tongue flicking in
snakes represents a stimulus-seeking behavior that is the main process for delivering
volatile and non-volatile cues to the vomeronasal organs [11]. Since tongue flicking is
activated by the detection of volatile cues by the nasal olfactory system, or visual,
thermal or vibratory stimuli, measuring the rate of tongue flicking is an accurate and
convenient assay of nasal as well as vomeronasal chemoreception in snakes [11, 46].
Cages and test apparatus were cleaned between trials.
Experiment 2. Low-Pressure Size
Exclusion Chromatography
Lyophilized venom (250 mg, from the same venom pool used in Experiment 1)
was dissolved in 1.0 mL HEPES buffer solution (10 mM, pH 6.8, with 60 mM NaCl and
5 mM CaCl2) and briefly centrifuged at 9,000 rpm to pellet and remove insoluble
material. This solution was then fractionated by size exclusion chromatography using a
90 x 2.8 cm column of BioGel P-100 equilibrated with the same HEPES buffer.
Fractionation occurred at a flow rate of 6.3 mL/hr at 4°C, and 30-minute fractions were
collected. Elution of size-fractionated protein and peptide peaks was monitored at 280
nm.
Enzyme Assays of Fractionated
Venom
All BioGel fractions (10 µL/assay, in duplicate) were assayed for several enzymes
common to most rattlesnake venoms [21], including exonuclease (phosphodiesterase), Lamino acid oxidase, caseinolytic metalloproteinase, thrombin-like and kallikrein-like
serine proteinases and phospholipase A2, as described previously [47].
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Behavior Trials Using Fractionated
Venom
Fractions of Peaks I to III were pooled separately, dialyzed in a 14 kDa cutoff
membrane tubing (Peak I) or in a 3.5 kDa cutoff membrane tubing (Peaks IIa, IIb and III)
against 2 x 2 liters of ddH2O, lyophilized and stored frozen at -20°C until use. Similar to
Experiment 1, the experimental (“envenomated”) mouse was injected with one of the
four fractionated protein peaks (1.25 mg protein in 100 µL, reconstituted in ddH2O) or
the combined peptide peaks (1.5 mg in 100 µL), and a non-envenomated control was
injected with 100 µL ddH2O. When testing with fractionated venom, the number of
subjects was limited by the quantity of protein in each peak. To induce SICS, each snake
struck a mouse suspended by forceps just prior to placement of the apparatus; again, this
mouse was immediately removed and discarded, never having touched the floor or walls
of the cage. Trials began when the test apparatus containing E and NE carcasses was
placed into the cage, again with 10-minute trials.
The mean number of tongue flicks directed towards the E and NE mouse
carcasses for whole crude venom and each peak were compared using a two-sample t-test
and Chi-square analysis (χ2). For all trials, the numbers of tongue flicks were converted to
percentages (that is, percent tongue flicks emitted to E and NE mice) by dividing the
number of tongue flicks aimed at the E carcass by the total number of tongue flicks for
both carcasses. These data were analyzed by single sample t-tests in which mean percent
tongue flicks directed toward envenomated mice were compared to 50%, the expected
value under the null hypothesis. Rate of tongue flicking can be highly variable among
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snakes, so converting rate of tongue flicking to percentages places all snakes on the same
scale. In addition, to achieve homogeneity of variance among conditions, we used a Log10
transformation to normalize data, which was analyzed by analyses of variance (ANOVA)
followed by Newman-Keuls range test.
Mass Determination by Mass
Spectrometry
Peak III from size exclusion (BioGel P-100 column) was desalted using C4
ZipTips (Millipore Inc., Billerica, MA, USA) and analyzed using a Bruker Ultraflex
MALDI-TOF mass spectrometer (Proteomics and Metabolomics Facility, Colorado State
University, Fort Collins, CO, USA) operating in linear mode. Protein (approximately 0.5
µg) was spotted onto a sinapinic acid matrix (10 mg/mL 50% acetonitrile, 0.1%
trifluoroacetic acid; 1.0 µL) and spectra were acquired in the mass range of 3.0 to 25
kDa.
Purification by Reverse-phase High
Performance Liquid
Chromatography
(RP-HPLC)
Peak III was then further fractionated by reverse-phase high pressure liquid
chromatography. Two hundred microliters (1.0 mg/mL) were injected onto a Grace
Vydac Reverse Phase C18 (4.6 x 250 mm) column equilibrated with buffer A (0.1%
Trifluoroacetic acid (TFA) in water). Absorbance was measured at 280 nm and proteins
were eluted using a shallow gradient of 20% to 28% buffer B (80% acetonitrile in 0.1%
TFA) over 50 minutes, with a flow rate of 1.0 ml/min. Peaks eluting at approximately
23% buffer B (fraction 13 - major peak; fraction 14 - minor following peak) were
collected, dried in a Savant speedvac (ThermoScientific, Rockford, IL, USA), and stored
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at -20°C. Masses of proteins in fractions 13 and 14 were determined using a Bruker
Ultraflex MALDI-TOF mass spectrometer (Bruker Corporation, Fremont, CA, USA) as
above.
N-terminal Sequencing of RP-HPLC
Purified Proteins
Samples of Peak III for sequencing were reduced with dithiothreitol and alkylated
with iodoacetamide as described previously [48]. The first 30 resides of sequence were
obtained using an ABI Procise sequencer (Life Technologies/Applied Biosystems, Grand
Island, NY, USA), and sequence obtained was subjected to Basic Local Alignment
Search Tool (BLAST) at the National Center for Biotechnology Information (Bethesda,
MD, USA) [49].
Abbreviations
E, Envenomated; HPLC, high-pressure liquid chromatography; MALDI-TOF,
Matrix-assisted laser desorption/ionization time-of-flight; NE, Non-envenomated; RGD,
Arg-Gly-Asp acid; SICS, strike-induced chemosensory searching; SVMP, Snake venom
metalloproteinase; TFA, Trifluoroacetic acid; TTX, tetrodotoxin
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Tables
Table 4.1: Rattlesnakes Discriminate Between Non-envenomated and Envenomated
mice. directed at non-envenomated (NE) and envenomated (E) mice by Crotalus atrox
when mice were envenomated by whole crude venom. Single-sample t-test was
conducted on mean percentages where mean percent to E mice were compared with 50%,
the value expected under the null hypothesis; df = 6. Because the two means are not
independent, the same t value but with the opposite sign would be obtained for each
mean. For raw data, see Additional file 1, Table S1. ** P <0.01.
Sample
Venom (n = 7)

NE
32 (8.45)
29

E
83 (15.9)
71 (5.65)

t
3.67**
3.76**

Table 4.2: Prey Discrimination is Associated with Non-enzymatic Fractions. Mean
number of tongue flicks and mean percent (lower values) tongue flicks (s.e.m.) directed
at non-envenomated (NE) and envenomated (E) mice by Crotalus atrox when mice were
envenomated using BioGel Peaks I, IIa, IIb, III or combined peptide peaks. Singlesample t-test was conducted on mean percentages in which mean percent tongue flicks to
E mice were compared with 50%, the value expected under the null hypothesis. Because
the two means within each paired comparison are not independent, the same t-value but
with the opposite sign would be obtained for each mean. For raw data, see Additional file
1, Table S1. ** P <0.01.
Fraction
Peak I
Peak IIa
Peak IIb
Peak III
Small peptide peaks (combined)

NE
67.4 (11.9)
51
72.9 (15.6)
50
73.3 (18.4)
49
25.3 (5.1)
32
33.0 (7.7)
49

E
68.7 (12.3)
49 (5.3)
59.0 (12.7)
50 (7.0)
69.2 (15.3)
51 (4.3)
53.6 (7.7)
68 (3.2)
52.7 (24.6)
51 (11.7)

t
0.09
0.22
0.70
0.01
0.22
0.25
4.24**
5.78**
0.79
0.12

df
16
10
9
10
8
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Table 4.3. Supplemental Table: Raw data: Number of tongue flicks toward envenomated
(E) or non-envenomated (NE) mice.
Experiment 1 - Whole Venom
Subject
1
3
4
5
6
7
8

E mouse
46
119
129
86
17
66
119

NE mouse
50
33
71
16
13
9
35

Proportion to Experimental
.48
.78
.65
.84
.57
.88
.77

Experiment 2 – Peak I
Subject
1
2
3
5
6
7
1
6
1
3
2
8
8
1
1
8
8

E mouse
32
138
129
107
59
204
53
41
56
40
0
96
37
66
24
53
33

NE mouse
61
1
175
138
115
89
69
20
48
20
11
72
114
108
45
27
33

Proportion to Experimental
.34
.99
.42
.44
.34
.70
.43
.67
.54
.67
.00
.57
.25
.38
.35
.66
.50
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Experiment 2 – Peak IIa
Subject
1
8
3
4
5
6
7
3
3
1
3

E mouse
67
31
30
39
25
11
63
122
69
148
45

NE mouse
56
183
36
116
30
0
126
63
86
64
42

Proportion to Experimental
.54
.14
.45
.25
.45
1.0
.33
.66
.45
.70
.52

Experiment 2 – Peak IIb
Subject
1
5
7
8
1
3
2
1
8
3

E mouse
47
32
38
56
189
22
64
98
91
55

NE mouse
51
32
21
28
71
17
92
124
204
93

Proportion to Experimental
.48
.50
.64
.67
.73
.56
.41
.44
.31
.37

Experiment 2 - Peak III
Subject
1
2
3
4
5
6
7
8
3
1
9

E mouse
89
40
51
67
37
105
14
48
33
51
55

NE mouse
20
18
51
52
11
48
12
13
20
27
7

Proportion to Experimental
.82
.69
.50
.56
.77
.69
.54
.79
.62
.65
.89

74
Experiment 2 – Peptide Peaks
Subject
1
2
3
6
4
5
1
6
2

E mouse
120
46
15
23
7
9
30
225
0

NE mouse
82
25
2
24
39
19
34
19
53

Proportion to Experimental
.59
.65
.88
.49
.15
.32
.47
.92
.00
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Figures

Figure 4.1: Discrimination of Envenomated Prey is not Dependent on Enzymatic Toxins.
(A) Size exclusion fractionation of 250 mg crude C. atrox venom on a 90 x 2.8 cm
BioGel P-100 column equilibrated with HEPES/NaCl/CaCl2 buffer. Fractionation
occurred at a flow rate of 6.3 mL per hour at 4ºC, and eluting proteins/peptides were
followed by absorbance at 280 nm. Enzyme activities common to rattlesnake venoms
were assayed and are limited to the first two peaks. Arrow indicates the peak containing
crotatroxins 1 and 2 (Peak III). (B) MALDI-TOF-MS analysis of peptides in BioGel size
exclusion Peak III. Approximately 0.5 µg protein was spotted onto sinapinic acid matrix
and analyzed using a mass window of 3 to 25 kD. Several peptides with masses typical of
monomeric disintegrins (7,245 to 7,655 Da) were present, but no larger proteins were
observed.
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Figure 4.2: Peak III Consist of Only of 7 kDa Peptides. (A) Reversed-phase
chromatography of Peak III from the gel filtration step (BioGel P-100). Two hundred
microliters was injected onto a Vydac C18 (4.6 x 250 mm) column, and disintegrin peaks
were eluted at 23% buffer B (13 to 14 minutes). (B) MALDI-TOF-MS analysis of
crotatroxin 1 from the reverse-phase chromatography purification step (fraction 13).
Mass of 7,440.35 was observed for crotatroxin 1. (C) MALDI-TOF-MS analysis of
crotatroxin 2 from the reverse-phase chromatography purification step (fraction 14).
Mass of 7,383.29 was observed for crotatroxin 2.
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Figure 4.3: N-terminal Sequence of Peak III Peptides. N-terminal sequencing confirms
identity with crotatroxins (CT) 1 and 2. Note that CTs 1 and 2 are identical in sequence
except for the additional N-terminal alanine residue in CT1. Protein sequencing of the
relocator peak showed lower yield (approximately 3 pmol, compared to approximately
6.5 pmol for residues 2 to 6) and presence of an N-terminal alanine at residue 1,
indicating that both CTs were present. No secondary sequence (indicative of potential
contaminant proteins) was observed.
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Figure 4.4: Reducing SDS-PAGE Analysis of Size Exclusion Chromatography Fractions.
Ten micrograms of protein (reduced with DTT) from each size exclusion peak (BioGel
P100) were loaded onto a 12% acrylamide NuPage gel. Following electrophoresis, the gel
was fixed and stained with 0.1% Coomassie Brilliant Blue R250 using standard methods,
destained and photographed. MW standards = Invitrogen Mark 12. Circled faint bands
indicate carryover contamination of metalloproteinases (darkest bands) from lanes 2 and
4, respectively. Note that lane 5 is the only peak containing disintegrin bands (dark pair,
red bracket); peptides were not visualized and are smaller than the resolution capability
of the gel.
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Abstract
Disintegrins are small non-enzymatic proteins common in the venoms of many
viperid snakes. These proteins have received significant attention due to their ability to
inhibit platelet aggregation and cell adhesion, making them model compounds in drug
development and design investigations. The present study used a combination of
molecular and proteomic techniques to screen the venom of the Middle American
Rattlesnake (Crotalus simus tzabcan) for novel disintegrins. Six disintegrin isoforms
were identified, and the most abundant, named tzabcanin, was further isolated and
characterized. Tzabcanin consists of 71 amino acids, has a mass of 7105 Da (by MALDITOF mass spectrometry) and contains the canonical RGD binding domain. Tzabcanin
was not cytotoxic to MCF-7 cells but showed weak cytotoxicity to Colo-205 cells
following a 24 hr incubation period. Tzabcanin inhibited cell adhesion of both cell lines
to immobilized fibronectin and vitronectin, and cell adhesion to immobilized tzabcanin
was inhibited when cells were incubated with a cation chelator (EDTA), indicating that
integrin-tzabcanin binding is specific. This study provides a detailed analysis of the
purification and characterization of tzabcanin and provides sequence and mass data for
the multiple disintegrins present in the venom of C. s. tzabcan.
Introduction
Snake venoms are a complex mixture of proteins and peptides exhibiting an array
of biochemical and pharmacological functions [1]. These bioactive molecules have
allowed for a trophic transition from a mechanical (constriction) to a chemical (venom)
means of subduing prey [2] via the dysregulation of many homeostatic mechanisms
simultaneously. Because venoms consist of ‘usurped’ regulatory compounds, they have
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also been subjected to detailed screenings in the search for novel compounds which may
be utilized as biomedical tools and reagents [3–5]. Further, research into venomous
systems provides unique insights of the biological roles of venom compounds [6–8] and
increases the ability to devise effective clinical treatment of human envenomations
[9,10].
Venoms likely evolved from the modification and differential expression of
endogenous proteins with normal physiological functions early in the evolution of
advanced snakes [11–13]. The vast majority of venomous snakes belong to three
families: the highly toxic Elapidae and Viperidae, and the diverse, but generally less
toxic, polyphyletic clade “Colubridae” [1,14,15]. Proteomic analyses of species within
the family Viperidae demonstrate that venoms may contain up to 100 different
compounds (including various isoforms), yet the majority can classified into a small
number of protein families which dominate overall venom protein composition [1,16].
While snake venom metalloproteinases (SVMPs), serine proteinases, phospholipases A2
and myotoxins account for the majority of proteins in most rattlesnake venoms,
technological advances in proteomic [17] and transcriptomic [18–20] methodologies have
allowed for the identification of less abundant and lesser known venom compounds, such
as ohanin-like toxins, phospholipase B, and glutaminyl cyclase, in several viperid venoms
[e.g. 21–23].
Disintegrins are common constituents of viperid venoms and are small (4-16 kDa)
non-enzymatic, cysteine-rich proteins that result from a post-translational cleavage of the
P-II class of SVMPs [24]. From a predation perspective, disintegrins may aid in the
circulation of other venom compounds throughout prey by binding integrins αIIbβ3 and
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inhibiting platelet aggregation [25,26]. We have recently shown that disintegrins also
have an important functional role during envenomation, facilitating prey relocation by
altering chemical cues emanating from envenomated prey and allowing for prey recovery
via strike-induced chemosensory searching [8]. Structurally, disintegrins are classified
based on their polypeptide length and number of disulfide bonds [27]. Short disintegrins
consist of 41 to 51 amino acid residues and 4 disulfide bonds, whereas medium
disintegrins are approximately 70 amino acids and have 6 disulfide bonds. The vast
majority of disintegrins that have been characterized and studied belong to this medium
size class. The third group, long disintegrins, is composed of 84 amino acids and 7
disulfide bonds. The fourth group, which consists of the homo- and heterodimeric
disintegrins, has subunits of approximately 67 amino acids, including 10 cysteines which
are involved in 4 intra-chain disulfide bonds and 2 interchain cysteine linkages [27,28].
Despite the fact that disintegrins are relatively conserved, significant differences
are seen with respect to their binding affinity towards integrin receptors. These
disintegrin-integrin interactions are primarily mediated by the disulfide-defined integrinbinding loop containing an RGD, KGD, MVD, MLD, MGD, WGD, or VGD sequence
[27,29,30]. Although the amino acid residues adjacent to this binding motif also influence
binding affinity [31], it has been suggested that the conserved aspartate residue in the
tripeptide binding site is responsible for binding to the specific β integrin subunit,
whereas the first two residues determine the affinity to the specific α integrin subunit
[32]. The majority of characterized disintegrins contain an Arg-Gly-Asp (RGD) sequence
which has been shown to block integrin αIIbβ3 on platelet membranes, in addition to
integrins α5β1, α8β1, αvβ1 and αvβ3 (among others) which are expressed on many cell
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membranes [33]. These disintegrin-integrin interactions have been shown to disrupt
adhesion between cells and various ECM and plasma proteins such as fibronectin
vitronectin, fibrinogen, laminin, and certain collagen [34 –37]
The use of venom compounds as potential therapeutics has long been an area of
interest among venom researchers. Disintegrins in particular have been explored for
biomedical applications due to their potent integrin blocking activity. In fact, two antiplatelet drugs currently on the market, tirofiban (aggrastat), and integrilin (eptifibatide),
were both designed based on the structures of the venom disintegrins echistatin [38] and
barbourin [31], respectively. Further, disintegrins have received significant attention for
their anti-metastatic and anti-angiogenic properties [34–36,39–43] demonstrating their
potential applications as an anti-cancer therapeutic. Contortrostatin, a homodimeric RGD
disintegrin purified from the venom of Agkistrodon contortrix contortrix [34,35,39], and
several monomeric RGD-containing disintegrins, such as colombistatin [36], have been
shown to significantly inhibit experimental metastasis and cellular adhesion to specific
ECM proteins. The pharmacological potential of these compounds provides a strong
motivation to examine snake venoms for novel disintegrins that may have application in
biomedical research and drug discovery efforts.
The current study was aimed at screening the venom of the Middle American
Rattlesnake (Crotalus simus tzabcan) for novel disintegrins by a combination of cDNA
analysis of transcripts and multistep liquid chromatography and mass spectrometry-based
analysis of venom proteins. We isolated and characterized the most abundant disintegrin
present in C. s. tzabcan venom and examined its cytotoxicity and ability to inhibit cell
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adhesion of human colon adenocarcinoma (Colo-205) and breast adenocarcinoma (MCF7) cell lines.
Materials and Methods
Snakes, Venoms and
Biochemicals
Two adult Crotalus simus tzabcan were housed individually at the University of
Northern Colorado Animal Resource Facility (UNC-IACUC protocol #0901C-SM-ML).
Venom was extracted as previously described [44], pooled, and samples were centrifuged
(1000 rpm for 5 min), lyophilized and stored at -20 °C until use. Matrigel (356234) was
purchased from BD Biosciences (Franklin Lakes, NJ, USA). Fibronectin (F0895),
vitronectin (V8379), and all additional buffers and reagents (analytical grade or better)
were purchased from Sigma-Aldrich, Inc. (St. Louis, MO, USA). Protein gels, mass
standards and electrophoretic reagents were obtained from Invitrogen-Life Technologies
(Grand Island, NY, USA).
Size Exclusion Liquid
Chromatography
(SE-LC)
Two-hundred and fifty milligrams of lyophilized venom were dissolved in 3.0 mL
HEPES buffer solution (10 mM, pH 6.8, with 60 mM NaCl and 5 mM CaCl2) and
centrifuged at 3000 rpm for 5 min to pellet and remove insoluble material. This solution
was then fractionated by low pressure size exclusion chromatography using a 90 x 2.6 cm
column of BioGel P-100 medium (BioRad Inc., Hercules, CA, USA) equilibrated with
the same HEPES buffer. Fractionation occurred at a flow rate of 6.0 mL/hr at 4 °C, and
30 min fractions were collected. Elution of size-fractionated protein and peptide peaks
was monitored at 280 nm using a Beckman DU640 spectrophotometer.
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Reverse Phase High Performance
Liquid Chromatography
(RP-HPLC)
Using two additional RP-HPLC methods, peak 6 from SE chromatography was
further purified using a Phenomenex Jupiter C18 (250 x 4.6 mm, 5 µm) column on a
Waters HPLC system using Empower software. The Cl8 column was equilibrated with
95% of 0.1% TFA in water (solvent A) and 5% of 80% acetonitrile in 0.1% TFA in water
(solution B) and elution was achieved as follows: 95% solvent A and 5% solvent B for 10
minutes; linear gradient to 85% A and 15% B over 1 minute; linear gradient to 60% A
and 40% B over 65 minutes; linear gradient to 100% B over 2 minutes; isocratic at 100%
B for 5 minutes; linear gradient to 95% A and 5% B over 2 minutes. The peak containing
tzabcanin (RP-HPLC peak 2) was further purified using the same C18 column and a
shallower gradient. Elution was achieved as follows: 95% A and 5% B, with a linear
gradient to 79% A and 21% B over 10 minutes; linear gradient to 75% A and 25% B over
40 minutes; linear gradient to 100% B over 2 minutes; isocratic at 100% B for 5 minutes;
linear gradient to 100% A over 2 minutes; isocratic at 100% A for 5 min. Fractions were
collected using a Waters Fraction Collector II at a flow rate of 1.0 ml/min, and protein
peaks were monitored at 220 and 280 nm using a Waters 2487 Dual Absorbance
Detector. Fractions were collected, lyophilized, and stored at -20 °C until further use.
One-dimensional SDS-PAGE
Electrophoresis
Crude C. s. tzabcan venom and SE-LC and RP-HPLC fractions were assessed for
the number and relative molecular masses of protein components by SDS-PAGE under
reducing (DTT) conditions using NuPAGE 12% Bis-Tris gels and MES running buffer
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(electrophoresed for approx. 45 min) as described previously [8]. Twenty-four µg of
crude venom or 3 µL SE-LC aliquots were added to each lane, and Mark 12 standards
were used for mass estimation. For RP-HPLC fractions, 3 µg of lyophilized protein were
resuspended in 1X reducing LDS buffer, placed into lanes on a NuPage 12% Bis-Tris gel
and electrophoresed as above. Gels were stained with Coomassie Brilliant Blue
overnight, destained and scanned with an HP Scanjet 4570C.
Mass Analysis (MALDI-TOF-MS)
And N-terminal Sequencing
Mass determinations of lyophilized protein samples obtained by RP-HPLC were
analyzed using a Bruker Ultraflex MALDI-TOF/TOF mass spectrometer (Proteomics and
Metabolomics Facility, Colorado State University, Fort Collins, CO) operating in linear
mode. Protein samples (~0.5 µg) were spotted onto a sinapinic acid matrix (10 mg/mL
50% acetonitrile, 0.1% trifluoroacetic acid; 1.0 µL) and spectra were acquired in the mass
range of 3.0-25 kDa. For N-terminal sequencing, approximately 50 µg of purified
tzabcanin was reduced with dithiothreitol and alkylated with iodoacetamide as previously
described [45]. Clean up and isolation of the reduced and alkylated product was
accomplished by RP-HPLC using a Vydak C18 column as above, with a flow rate of 1.0
mL/min and a gradient (1%/min) of 5-50% ACN. Protein fractions were collected and
dried via a Speed Vac and N-terminal sequencing (Edman degradation) was performed
on an ABI Procise 494 protein sequencer (Protein Structure Core Facility, University of
Nebraska Medical Center, Omaha, NE) to obtain the first 30 amino acid residues. The
sequence obtained was subjected to Basic Local Alignment Search Tool (BLAST) at the
National Center for Biotechnology Information (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
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RNA Isolation, cDNA Synthesis,
And 3’ RACE
RNA isolation, cDNA synthesis, and 3′ RACE of the C. s. tzabcan disintegrins
was accomplished following methods of Modahl et al., 2015 (in review). Briefly, RNA
was purified from approximately 6 mg of lyophilized venom resuspended in 1 mL of
TRIzol (Life Technologies, CA, USA) following the manufacturer’s recommended RNA
protocol, with the addition of a 4 °C overnight incubation in 300 µL ethanol containing
40 µL 3 M sodium acetate to increase RNA yields. cDNA synthesis from total RNA was
accomplished using the 3′ RACE System (Life Technologies, CA, USA) following the
manufacturer’s protocols. The oligo(dT) adaptor primer (provided with the kit) initiates
reverse transcriptase cDNA synthesis at the poly(A) region of mRNA and effectively
selects for polyadenylated mRNAs from the total RNA preparation. Two sets of 3′ RACE
sense primers were designed to obtain C. s. tzabcan disintegrin sequences. The first sense
primer (5′-GGAGAAGARTGTGACTGTGGC-3′) was designed from the tzabcanin Nterminal sequence, and the second sense primer (5′GAGGTGGGAGAAGAWTGYGACTG-3′) was modified from a previous primer [46]
by the addition of degenerate base pairs, determined from multiple sequence alignments
of a diversity of disintegrins from the NCBI database, including multiple C.
adamanteus, C. viridis viridis, Agkistrodon piscivorus, Bothrops neuwiedi, Echis
pyramidum, Echis coloratus and E. carinatus metalloproteinase PII sequences. Each
sense primer was used in a reaction with the 3′ RACE system AUAP antisense primer 5′GGCCACGCGTCGACTAGTAC-3′. Twenty-three µL of PCR SuperMix High Fidelity
polymerase (Life Technologies, CA, USA) was used with 1 µL of cDNA template and
0.5 µL of each primer (sense and antisense). PCR was done with seven touchdown cycles
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of 94 °C for 25 seconds, 52 °C for 30 seconds, and 68 °C for two minutes. Thirty
additional cycles followed at 94 °C for 25 seconds, 48 °C for 30 seconds, and 68 °C for
two minutes with a final 68 °C extension for five minutes. The amplified products were
electrophoresed on a 1% agarose gel, and bands of the estimated disintegrin size were
removed and purified using the Wizard SV gel and PCR clean-up system (Promega,
USA).
Cloning and Sequencing of
Disintegrins
Amplified cDNA was ligated into the pGEM-T Easy Vector System (Promega,
Inc.) and transformed into Escherichia coli DH5 α competent cells and grown on
nutrient-rich agar plates overnight at 37°C. Recombinant plasmids were selected from
agar plates, ten E. coli colonies were picked from each PCR and placed into 2 mL LB
broth treated with 1 µL/mL ampicillin, and shaken overnight at 37°C. Plasmids of each E.
coli colony were than purified using the Quick Clean 5M Miniprep Kit (GenScript, Inc)
and sent for sequencing at the DNASU facility (Arizona State University, AZ, USA)
using Big Dye V3.1 chemistry with samples processed on an Applied Biosystems
3730XL Sequence Analysis Instrument.
Cell Lines and Culture Conditions
Cancer cells, growth media, fetal bovine serum (FBS) and cell viability assay kits
were purchased from American Type Cell Culture (ATCC; Manassas, VA, USA).
Human colorectal adenocarcinoma cells (Colo-205; ATCC CCL-222) were maintained
with ATCC-formulated RPMI-1640 medium supplemented with 10% FBS, and human
breast adenocarcinoma cells (MCF-7; ATCC HTB-22) were maintained with Eagle’s
Minimum Essential Medium (EMEM) growth medium supplemented with 10% FBS and
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10 µg/mL human recombinant insulin. Both cell lines were maintained in 75 cm2 flasks
as a monolayer culture in a humidified 5% CO2 air incubator at 37 °C. Subcultivation of
cells was performed according to ATCC instruction, using trypsin-EDTA (0.05% trypsin
and 0.02% EDTA).
Cytotoxicity Assays
To examine the possible cytotoxicity of tzabcanin, as well as crude C s. tzabcan
venom, the colorimetric MTT [3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2Hteyrazolium bromide] assay was performed [47; see also 48]. One hundred µL aliquots of
Colo-205 and MCF-7 cells, at a density of 5.0 x 105 cells/ml with complete media, were
plated in 96-well cell culture plates and incubated with various concentrations of
tzabcanin (0.22–14 µM), crude C. s. tzabcan venom (20 µg), or 10 µL of 0.01 M
phosphate buffered saline (PBS, pH 7.2, as a control) at 37 °C for 24 hr. After 24 hr, 10
µL of MTT was added to the treated cells and plates were returned to 37 °C for 2 hr.
Following incubation, 100 µL of Detergent Reagent (ATCC) were added to cells, which
were then incubated at room temperature overnight in the dark. The plate was gently
shaken and the absorbance read at 570 nm using a SpectraMax 190 plate reader. Assays
at each tzabcanin concentration were performed in triplicate and each assay was repeated
at least twice. Percent cell viability was calculated by the following formula:
[(absorbance of treatment cells) - (absorbance of medium blank)/(absorbance of control
cells) - (absorbance of medium blank)] x 100, and all values are reported as mean ±
standard error of the mean.
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Cell Adhesion Inhibition
Assays
Inhibition of Colo-205 and MCF-7 cell binding to the extracellular matrix
proteins fibronectin and vitronectin, and the basement membrane matrix Matrigel was
measured as previously described [49]. Triplicate wells of Immulon-II 96 well microtiter
plates were coated with either 100 µl of fibronectin (0.5 µg per well), vitronectin (0.3 µg
per well), or Matrigel (0.5 µg per well) dissolved in 0.01M PBS, pH 7.2, and allowed to
incubate overnight at 4 °C. Fluid was then removed and unbound proteins were removed
by washing wells three times with 1% bovine serum albumin (BSA) in PBS, and
unbound sites were blocked with 2.5% BSA in PBS (1 hr incubation at 37 °C). Both
Colo-205 and MCF-7 cells were harvested as mentioned above and resuspended in
serum-free medium containing 1% BSA at concentrations of 5 x 105 cells/mL. Cells were
treated with various concentrations of tzabcanin (0.22-14 µM) and allowed to incubate at
37 °C for 1 hr immediately prior to seeding. The blocking solution was aspirated, wells
were washed 2X with 100 µL 1% BSA in PBS, and 100 µL cells were seeded in the
coated microtiter plate wells. Following a 1 hr incubation at 37°C, unbound cells were
removed by gentle washing (3X) with 1% BSA in PBS, and then 100 µL of serum-free
medium containing MTT (5:1, vol/vol) and 1% BSA was added to the wells. Following
incubation at 37°C for 2 hr, 100 µL of Detergent Reagent was added to the wells and
cells were incubated overnight in the dark at room temperature. The plate was gently
shaken and the absorbance read as above. The percent inhibition was calculated by
[(absorbance of control-absorbance of treatment)/absorbance of control] x 100. Assays at
each tzabcanin concentration for all cell lines were performed in triplicate and each assay
was repeated at least three times to confirm results.
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Inhibitions of Cell Binding to
Immobilized Tzabcanin
Because integrin binding interactions are dependent on divalent cations [50,51],
cells were incubated with varying concentrations of a cation chelator (disodium EDTA)
to examine if tzabcanin binding occurs specifically via integrin receptors. Purified
tzabcanin (20 µg/mL) was resuspended in PBS and 100 µL aliquots were add to
Immulon-II 96 well microtiter plates and incubated overnight at 4°C. Following
overnight incubation, wells were washed and blocked as described above. Further, both
Colo-205 and MCF-7 cells were treated as mentioned above except before addition to the
disintegrin treated wells, cells were incubated for 60 min at 37°C with serum-free
medium containing 1% BSA and various concentrations of EDTA. Cells were then added
to the disintegrin treated wells and the adhesion assay was performed as described above.
All assays were completed in triplicate and replicated at least 3 times.
Molecular Modeling
Three dimensional structure of tzabcanin was modeled from the primary structure
using the I-TASSER server (http://zhanglab.ccmb.med.umich.edu/I-TASSER/) as
described previously [7]. A viperid venom disintegrin with known solution structure was
identified by I-TASSER as an appropriate template model (salmosin: Protein Database
accession number 1L3X A). Figures were created using Discovery Studio Visualizer
v3.1.1.11157 (Accelerys Software Inc., San Diego, CA).
Statistical Analyses
Data were analyzed by Analysis of Variance (ANOVA) followed by Tukey’s
post-hoc test using R version 2.15.2. All p values <0.05 were considered as statistically
significant.
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Results
Isolation and Masses of C. s.
Tzabcan disintegrins and
N-terminal Sequencing
of Tzabcanin
Following SE chromatography, 9 major peaks were collected (Fig. 5.1) which
were assessed by reduced SDS-PAGE (Fig. 5.1 inset) to identify proteins in the ~7kDa
range, as this is the general mass of monomeric disintegrins [28,36,37,40]. Peak 6 yielded
one protein band in this mass range (Fig. 5.1 inset), and was further fractionated by RPHPLC chromatography, yielding 5 additional protein fractions that eluted between 22 and
28% solution B (Fig. 5.2a). Following reducing SDS-PAGE, all five fractions showed
masses of approximately 7 kDa (Fig. 5.2b). The spectra obtained by MALDI-TOF
indicate the presence of six disintegrin isoforms in C. s. tzabcan venom (Fig. 5.2C). The
most prominent of these disintegrins (RP-HPLC Peak 2) was further purified by an
additional RP-HPLC step (Fig. 5.3a), yielding one protein peak eluting at approximately
23% solvent B. This protein, with molecular mass of 7105.0 Da (Fig. 5.3b), was named
tzabcanin. It was subjected to Edman degradation N-terminal sequencing, yielding the
sequence GEECDCGSPANPCCDAATCKLRPGAQCADGLCCD and was assessed for
cytotoxicity and inhibition of Colo-205 and MCF-7 cell adhesion to fibronectin,
vitronectin and Matrigel.
cDNA Sequencing Analysis
Six cDNA sequences were obtained, ranging from 210 to 222 bp in length and
coding for six protein isoforms varying from 69 to 73 amino acids (Fig. 5.4). NCBI
protein BLAST analyses indicated that all amino acid sequences obtained belong to the
disintegrin family. Five of the six sequences contain twelve cysteine residues,
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characteristic of medium sized disintegrins [28]; tzbdis-4 contains only 11 cysteine
residues. All six sequences also express the canonical RGD binding motif. Fig. 5.5
shows the alignment of the amino acid sequences from the six disintegrins and the Nterminal sequence in comparison with sequences of disintegrins purified from other
viperid venoms. Tzabcanin, the most abundant of the six disintegrin isoforms, contains
71 amino acids, begins with a Gly, ends with an Ala, and shares 97% sequence identity to
the disintegrin basilicin [P31981].
Cytotoxicity
Crude C. s. tzabcan venom (20 µg/100 µL) exhibited potent cytotoxicity towards
both Colo-205 and MCF-7 cell lines, with approximately 35 and 26% cell viability,
respectively, remaining after 24 hr incubation (both p< 0.001; Fig. 5.6). However,
tzabcanin caused only a slight decrease in Colo-205 cell viability at concentrations of
1.75 µM and 3.5 µM (both p<0.05) and at 14 µM (p<0.01); 7 µM tzabcanin also resulted
in a decrease in cell survival, but this treatment level failed to reach significance
(p>0.05). Tzabcanin failed to exhibit significant cytotoxicity towards MCF-7 cells
(p>0.05).
Inhibition of Cell Adhesion In vitro
Fibronectin and vitronectin support adhesion to Colo-205 and MCF-7 cells.
Results indicate that tzabcanin inhibits adhesion of both cell lines to fibronectin and
vitronectin in a dose-dependent manner (Figs. 5.7a & b). The greatest inhibition was
observed for MCF-7 cells binding to fibronectin (81% binding inhibition at 14 µM; IC50
= 6.9 µM), and although adhesion of Colo-205 cells to fibronectin was hindered, the IC50
was twice as high (14 µM). Similarly, tzabcanin inhibited adhesion of both cell lines to
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vitronectin (Fig. 5.7B); the highest binding inhibition was observed with Colo-205 cells
(62% binding inhibition at 3.5 µM; IC50 = 6.6 µM), but inhibition of MCF-7 cell
adhesion failed to reach 50% (44% binding inhibition at 14 µM). Matrigel supported
adhesion in both cell lines, but tzabcanin failed to inhibit adhesion (data not shown).
Tzabcanin Binds to Colo-205 and
MCF-7 Cells via Integrins(s)
Binding of both Colo-205 cells and MCF-7 cells to immobilized tzabcanin was
inhibited when cells were incubated with varying concentrations of EDTA (Fig. 5.8).
Approximately 95% inhibition of MCF-7 cell binding to immobilized tzabcanin was
achieved at 5 mM EDTA (IC50 = 2.01 mM), and 55% binding inhibition of Colo-205
cells to tzabcanin was achieved at 5 mM EDTA. These results suggest that tzabcanin
binds to both of these cell lines via integrin receptors.
Molecular Modeling of Tzabcanin
Like other medium disintegrins, tzabcanin adopts a semi-globular configuration,
and the RGD integrin-binding domain is presented on the surface of the molecule (Fig.
5.9). The accessibility of this integrin-binding loop is believed to be critical to the binding
efficiencies of disintegrins; in addition, a similar integrin-binding motif is found in the
disintegrin-like domain of many P-III SVMPs [52] and is also likely functionally very
important [53].
Discussion
Due to their potential as lead compounds for binding and blocking integrin
receptors, disintegrins have become one of the most studied venom protein families to
date. In the current study, a combination of molecular and proteomic techniques were
utilized to screen the venom of C. s. tzabcan for potentially novel disintegrins. In addition
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to disintegrins, SDS-PAGE of crude C. s. tzabcan venom and SE fractions showed
masses indicative of venom compounds such as LAAOs, SVMPs, serine proteases and
PLA2s, which were confined to SE-HPLC peaks 1-5; these venom proteins were also
observed in a recent proteomic analysis of C. s. tzabcan venom [54]. These enzymes have
also been documented in the venom proteome of the closely related C. simus [55] and C.
simus simus [56], and they are common to the venoms of numerous other Crotalus
species [1]. SE peak 6 yielded one protein mass of approximately 8 kDa by SDS-PAGE
and was subjected to an additional RP-HPLC step, yielding 5 additional protein peaks,
each exhibiting molecular masses in the range of monomeric disintegrins as determined
by both SDS-PAGE and MALDI-TOF mass spectrometry. When combined with cDNA
analyses, results suggest the presence of numerous disintegrin isoforms with masses
ranging from 7105 to 7637 Da, and 69 to 73 amino acids in length. The molecular
masses, cysteine pattern, and polypeptide length places these disintegrins in the mediumsize classification as described by Calvete et al. [27,28]. Further, although MALDI-TOF
mass analysis indicates the presence of six isoforms which correlate with the six cDNA
sequences, caution must be taken with attempting to assign the RP-HPLC peaks to the
specific translated amino acid sequences reported here without further independent amino
acid sequence data. Only RP-HPLC peak two, the most abundant of the disintegrins
present, was further characterized by N-terminal sequencing and correctly assigned to the
complete amino acid sequence obtained from cDNA sequences.
Disintegrin functionality is primarily due to interactions between the tripeptide
binding loop, often containing an RGD sequence, and the specific integrin receptor.
Molecular modeling demonstrates that this motif in tzabcanin is accessible to the solvent
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and is therefore available for ligand binding, as expected among disintegrins which are
proteolytically processed from P-II SVMPs. In P-III SVMPs, which express a disintegrinlike domain, it has been suggested that the distinct disulfide bond arrangement near the
integrin-binding motif may lead to a very different functionality [52,57]. Further,
although the P-III SVMP BjussuMP-I exhibits an RGD sequence in the disintegrin-like
domain [58], the majority of P-III SVMPs express an XCD sequence [57], likely
contributing to different integrin-binding affinities. For example, the disintegrin-like
domain of alternagin-C contains an ECD binding motif and exhibited potent activity
against integrin α2β1, yet failed to show activity towards integrins αIIbβ3, α1β1, α5β1, α4β1,
α9β1, or αVβ3 [59]. Likewise, it has been suggested that in P-II SVMPs that fail to release
the disintegrin domain, the presence of the metalloproteinase domain may sterically alter
the accessibility of the RGD motif, lowering integrin-binding activity [57]. Binding
specificity and affinity is also influenced by the amino acid residues flanking this
tripeptide sequence, as well as characteristics of the C-terminal region of the protein
[28,60]. Of the six disintegrins reported here, four contain an RGDW binding motif, and
two, including tzabcanin, contain an RGDN binding region. One of these disintegrins,
tzbdis-1, contains a Glu29 in the N-terminal region of the protein, whereas the other five
disintegrins contain an Asp at this position. The presence of this Glu, in addition to a Lys
at position 43 in tzbdis-1, are the only dissimilarities between this disintegrin and
tzabcanin, both of which contain an RGDN binding domain and identical C-terminal
sequences. However, these two amino acid differences in the N-terminal region of the
protein likely do not influence activity of the disintegrins. Tzbdis-4, on the other hand,
contains an additional N-terminal Glu at position 1, Val at position 2, an Arg at position
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26, and completely lacks Cys27 which, when present, forms a disulfide bond with Cys58
located in the C-terminal region of the disintegrin. As integrin inhibitory activity is
dependent on the appropriate pairing of cysteine residues [61], the deletion of this
disulfide bond likely abolishes inhibitory activity of this specific disintegrin [62].
Differences in the C-termini regions are apparent when comparing RGDW to
RGDN disintegrins. All RGDW disintegrins (tzbdis-3-6) reported here contain an Asn at
position 53, Thr at position 58, and the sequence GLYG at the C-terminal end of the
protein. Further, tzbdis-6 contains an Arg at position 62, whereas all other C. s. tzabcan
disintegrins contain a Gln at this position. In contrast, the two RGDN disintegrins, tzbdis1 and tzabcanin, contain a Pro at position 53, Arg at position 58, and end with the
sequence HFHA. Combined with the substitution of a Trp with Asn at a position carboxyl
to the RGD sequence, these additional differences in the C-terminal regions may
significantly influence disintegrin activities. Disintegrins expressing RGDW domains
often show high affinity to αIIbβ3 integrins, whereas RGDN show higher selectivity
towards both α5β1 and αvβ3 integrins [31,32,60].
Tzabcanin has a mass of 7105 Da and shares high amino acid identity with
basilicin from C. basiliscus venom. Basilicin has an additional alanine at the N-terminus,
a Glu at position 29 and Lys at position 43, whereas tzabcanin contains an Asp and Thr at
these positions, respectively. Both disintegrins also have identical RGDN and C-terminal
sequences. Yet even with identical binding regions, structural discrepancies in the Cterminal region can alter biological activity. Differences in ADP-induced platelet
aggregation have been documented between colombistatin and cotiarin, both RGDN
disintegrins that differ only by the presence of a Tyr72 in colombistatin, whereas cotiarin
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exhibits His72 [36]. Of the RGDW disintegrins present here, it is hypothesized that
tzbdis-3 and 5, due to their identical RGDW and C-terminal regions, may exhibit very
similar, if not identical, biological activity, yet may be somewhat different from tzbdis-6.
Likewise, due to the identical RGDN and C-termini regions, both tzbdis-1 and tzabcanin
likely exhibit very similar biological activity.
Although crude C. s. tzabcan venom was highly toxic to both Colo-205 or MCF-7
cell lines, purified tzabcanin showed very low levels of cytotoxicity to Colo-205 cells and
failed to exhibit cytotoxicity at concentrations as high as 14 µM following 24 hr
treatment of MCF-7 cells. Disintegrin-induced apoptosis in HUVEC cells has been
documented with rhodostomin [63] as well as with accutin [64]; however, the ability of
disintegrins to induce apoptosis varies between cancer cell lines. Lucena et al. [42] found
that the recombinant RGDN disintegrin, r-viridistatin, failed to induce apoptosis in SK-12
melanoma cells, and the disintegrin rhodostomin did not induce apoptosis of MDA-MB231 cells [65]. Similarly, the homodimeric disintegrin contortrostatin was found to lack
cytotoxicity toward MDA-MB-435 cells in vitro [35]. However, recently Lucena et al.
[43] showed that recombinant disintegrins r-virdistatin 2 and r-mojastin 1 induced
apoptosis in approximately 20% of human pancreatic adenocarcinoma (BXPC-3) cells.
Therefore, the slight decrease in Colo-205 cell viability in the presence of high
concentrations of tzabcanin could be due to induction of apoptosis, or a loss of membrane
integrity, ultimately leading to antiproliferative effects. On the other hand, the potent
toxicity of crude venom towards both cell lines is likely due to the presence of LAAOs,
SVMPs, and PLA2s, which are abundant in C. s. tzabcan venom and have been shown to
exhibit a combination of cytotoxic and apoptotic activities [66–68]. Similarly, Bradshaw
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et al. [48] also showed that the venom of C. s. tzabcan venom was significantly cytotoxic
to both MCF-7 and human melanoma (A-375) cell lines.
Integrins are critical to cell attachment, migration and invasion, and their
significance in cancer progression is being examined extensively [69,70]. Integrin
engagement to ECM proteins induces cell proliferation and may prevent apoptosis in
some cancers, demonstrating the significance of cell adhesion in tumor progression and
survival. αv integrins, in addition to α5β1, α8β1, and αIIbβ3, mediate cell adhesion to
various ECM proteins, often by recognition of the tri-peptide RGD binding motif [71].
These integrin-ligand interactions are dependent on divalent cations, especially Mn2+and
Mg2+, to support ligand binding [50]. Ca2+, on the other hand, fails to support binding, yet
it greatly regulates ligand adhesion supported by Mn2+and Mg2+ [50]. The inhibition of
both Colo-205 and MCF-7 cell binding to immobilized tzabcanin in the presence of a
cation chelator (EDTA) indicates that tzabcanin-integrin binding was occurring, likely
through the presence of the RGD domain. The low binding inhibition seen in Colo-205
cells (~55% binding inhibition at 5 mM EDTA) compared to MCF-7 cells suggests that
tzabcanin binding is occurring in this cell line through a higher number of integrins,
requiring a higher concentration of EDTA to produce inhibition. Although tzabcanin
binds to both Colo-205 and MCF-7 cells, tzabcanin-induced binding inhibition of these
cell lines to fibronectin and vitronectin is not as potent as has been reported for some
other disintegrins. Differential potency may be cell line dependent; for example,
colombistatin had a potent inhibitory effect (IC50 = 33 nM) on SK-Mel-28 cell adhesion
to fibronectin, yet much higher concentrations (IC50 = 4.4 µM) of this disintegrin were
needed to inhibit T24 cells from binding to fibronectin [36]. A recombinant form of
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viridistatin-2 also showed varying binding inhibition of numerous cell lines to
fibronectin, with IC50 values ranging from 11 to 4450 nM [42]. Further, although
inhibition of cell adhesion was not as potent as other disintegrins, tzabcanin may exhibit
additional anti-metastatic properties by binding different integrin receptors. For example,
crotatroxin 2 failed to inhibit 66.3p cell adhesion to fibronectin, yet it significantly
inhibited cell migration in vitro and lung tumor colonization in vivo [40].
Colo-205 and MCF-7 cells express integrins α5β1, αvβ5 and αvβ6, as well as several
other α/β subunits [72–75]; however, the expression of these integrins and specific
subunits may drastically vary. For instance, Colo-205 cells show low levels of α5, but
moderate levels of αv, α1, and α3, and high levels of α2, α6 and β1 subunits [72], each
displaying specificity to one or several discrete ligands. Fibronectin is recognized by an
array of integrins including α5β1 and αvβ6, which were first characterized for their ability
to bind to this ECM protein [76–78]. Integrins αvβ3, αvβ5, α3β1 α4β1 and α8β1 are additional
receptors of fibronectin [79]. Fibronectin-integrin interactions contribute to numerous
stages of tumor development, including tumor migration, invasion and metastasis [80].
αvβ5 has classically been known as a vitronectin receptor [81,82] however, integrin αvβ6
has also been shown to adhere to vitronectin [83]. Therefore, Colo-205 and MCF-7 cells
express an array of integrins that show recognition to both fibronectin and vitronectin.
Because many disintegrins have the capability to recognize an array of integrins, the
relatively weak potency of tzabcanin suggest that this disintegrin may inhibit cell
adhesion by binding to a more select group of integrins, leaving other receptors available
for integrin-ECM interactions. Further, tzabcanin also contains an RGDN binding domain
which has been shown to exhibit higher affinity to integrin αvβ3 [31,60], an integrin not
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expressed on either Colo-205 or MCF-7 cells. Therefore, studies utilizing cell lines
expressing αvβ3 are predicted to demonstrate greater potency of tzabcanin.
Conclusions
This study reports the isolation and characterization of the most abundant
disintegrin, tzabcanin, from the venom of C. s. tzabcan. In addition, we report molecular
masses and cDNA sequences of five additional medium-sized disintegrin isoforms from
the same venom. The documented differences in integrin-binding affinity between
RGDW and RGDN disintegrins could represent distinct biological roles for these integrin
homologs and differential anti-cancer effects may also exist. Tzabcanin, a new RGD
disintegrin, was not cytotoxic to MCF-7 cells but produced a slight decrease in cell
viability in Colo-205 cells at high concentrations. This could be due to induction of
apoptosis by binding to an integrin(s) specifically expressed on Colo-205 cells that may
be absent on the MCF-7 cell line. By binding to integrins, tzabcanin also inhibited cell
adhesion of both cell lines to fibronectin and vitronectin. Although this inhibition was not
as potent as reported for other disintegrins, the binding domain (RGDN) of tzabcanin
suggests that it may have higher affinity towards αvβ3 integrins which are not present in
either Colo-205 or MCF-7 cells.
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Figures

Figure 5.1: Size Exclusion Chromatography of Crude C. s. tzabcan Venom. A total of
250 mg of crude venom was fractionated on a BioGel P-100 column. Fractions collected
and crude venom (CrV) were analyzed by SDS-PAGE (inset) under reducing conditions;
fraction 6 contained disintegrin-sized peptides.

110

Figure 5.2: RP-HPLC Purification and Mass Determination by MALDI-TOF-MS of C. s.
tzabcan Venom Disintegrins. (a) RP-HPLC of SE peak 6. 2 mL samples were injected
into a Phenomenex Jupiter C18 column and separated on a Waters 515 HPLC system.
Five protein peaks eluted between 22 and 26% solvent B. Fractions were collected and
analyzed by SDS-PAGE (inset) under DTT-reducing conditions. (b) Mass spectra of RPHPLC peaks 1-5; tzabcanin was present in peak 2 (m = 7105 Da), and peaks 3 and 4
yielded two masses as indicated.
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Figure 5.3: RP-HPLC Polishing and Mass Determination of Tzabcanin. (a) RP-HPLC
peak 2 was further purified using a very shallow gradient. One peak eluted at 23% ACN
and was assessed by MALDI-TOF mass spectrometry. (b) Mass determination of
tzabcanin by MALDI-TOF mass spectrometry analysis in positive linear mode indicated
a native mass of 7105 Da.
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Figure 5.4: cDNA Sequence and Predicted Amino Acid Sequence of C. s. tzabcan
Disintegrins. The cDNA sequence is located on the upper line and the corresponding
amino acid sequence is below. The cysteine residues are in bold print and the RGD
binding motif is in bold print and underlined.
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Figure 5.5: Amino Acid Sequence Comparison of C. s. tzabcan Disintegrins with
Selected Disintegrins. RGDN disintegrins are in the top group and RGDW disintegrins
are in the bottom diagram. One-letter code for amino acids is used. Cysteine residues are
shaded in gray, and the RGD binding motif is in bold print and underlined. Residue
differences from tzabcanin are shaded in yellow.
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Figure 5.6: Percent Cell Viability of Colo-205 and MCF-7 Cells. Cells were incubated
with either crude C. s. tzabcan venom (CV) or purified tzabcanin. * p < 0.05, **p < 0.01,
*** p < 0.001, compared to controls.
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Figure 5.7a: The Effect of Tzabcanin on Colo-205 and MCF-7 Adhesion to Fibronectin;
semilog plot. Various concentrations of tzabcanin (0.22 µM – 14 µM) were incubated
with Colo-205 and MCF-7 cells (5.0 x 105 cells/mL) prior to addition to 96-well culture
plates containing immobilized fibronectin. * p < 0.01, ** p < 0.001

Figure 5.7b: The effects of tzabcanin on Colo-205 and MCF-7 adhesion to Vitronectin;
semilog plot. Various concentrations of tzabcanin (0.22 µM – 14 µM) were incubated
with Colo-205 and MCF-7 cells (5.0 x 105 cells/mL) prior to addition to 96-well culture
plates containing immobilized vitronectin. * p < 0.05, ** p < 0.01, *** p < 0.001, relative
to controls.
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Figure 5.8: Percent Binding Inhibition of Cells to Immobilized Tzabcanin. Inhibition of
Colo-205 and MCF-7 cells to immobilized tzabcanin was measured following cell
incubation with the cation chelator EDTA; semilog plot. Colo-205 and MCF-7 cells (5.0
x 105 cells/mL) were incubated with various concentrations of EDTA (0.3 – 5 mM) prior
to addition to wells containing immobilized tzabcanin. * p < 0.01, ** p < 0.001, relative
to controls
A

B

Figure 5.9: Molecular Modeling of Tzabcanin. Space filling model (a) and stick model
(b) of tzabcanin showing the same face of the molecule. In both figures, the RGD domain
is shown in green, the N terminus is in yellow and the C terminus is shown in red.
Surface charge features of other residues are shown in red to blue shading. Models are
based on I-TASSER-derived modeling of tzabcanin and were constructed using
Accelerys Discovery Studio 3.1 software.
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Abstract
The role of integrins in cancer progression and invasion is critical to the
development of the disease, making these transmembrane proteins attractive targets in
drug development and design. Disintegrins are small (4-16 kDa), Arg-Gly-Aspcontaining proteins, common in the venoms of many viperid snakes. These nonenzymatic proteins inhibit integrin-mediated cell-cell and cell-extracellular matrix
interactions, making them potential candidates as therapeutics in cancer and numerous
other human disorders. The present study examines the anti-adhesion and migration
effects of a recently characterized disintegrin, tzabcanin, towards melanoma (A-375) and
lung (A-549) cancer cell lines. Tzabcanin inhibits adhesion of both cells lines to
vitronectin and exhibited weak cytotoxicity towards A-375 cells; however, it had no
effect on cell viability in A-549 cells. Further, tzabcanin inhibited adhesion of both cell
lines to the extracellular matrix protein vitronectin, and it significantly inhibited cell
migration in cell scratch wound assays. Flow cytometric analysis indicates that both cell
lines express integrin αvβ3, a critical integrin in tumor motility and invasion which is
identified here to be a binding site of tzabcanin. Tzabcanin blocks αvβ3, inhibiting cell
adhesion to vitronectin and migration in A-375 and A-549 cell lines, suggesting that it
may have utility for developing anticancer therapies.
Introduction
Integrins comprise an important family of cell surface receptors that mediate cellcell and cell-extracellular matrix (ECM) interactions (Hynes, 1987; Albelda and Buck,
1990). To date, 24 distinct integrin heterodimers have been described, based on the
appropriate noncovalent pairing of one of 18 α subunits with one of 8 distinct β-subunits
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(Hynes, 2002). The specific pairing of these subunits regulates which substrates a cell
will adhere to and migrate on, which will influence the activity of the cell (Aplin et al.,
1999). Typically the α-subunit dictates ligand specificity, whereas the β-subunit
associates with the downstream signaling pathway (Hynes, 2002; Barczyk et al., 2010).
Further, integrins have the ability to recognize a single, or several, ECM ligands or cell
membrane proteins, each contributing to the regulation of an array of cellular functions
(Plow et al., 2000; van der Flier and Sonnenberg, 2001; Humphries et al., 2006). For
example, integrins α5β1, α4β1 and αvβ3 recognize fibronectin, and αvβ3 in addition to αvβ5
show high affinity to vitronectin and fibrinogen. Integrins α2β1, α3β1 and α6β1 bind
laminin, and both α1β1 and α2β1 recognize collagen (Humphries et al., 2006). The integrin
αIIbβ3, which is expressed in platelets, binds to fibrinogen or von Willebrand factor, where
it assists in platelet aggregation (Bennet et al., 1982; Humphries et al., 2006).
Approximately one-third of the 24 integrins recognize these adhesive molecules through
the tripeptide Arg-Gly-Asp (RGD) binding sequence, while others bind the triple helical
GFOGER sequence present in collagen (Barczyk et al., 2010), or YIGSR in laminin
(Gehlsen et al., 1988). As integrins are critical to numerous aspects of cell function,
mutations targeting integrin receptors or integrin-related pathways are known to
contribute to numerous human disorders (Wehrle-Haller and Imhof, 2003).
It is well documented that several integrins play critical roles in cancer
progression (Desgrosellier and Cheresh, 2010; Rathinam and Alahari, 2010; Sun et al.,
2014), and they have a significant role in tumor angiogenic activity, proliferation,
survival and metastasis (Clark and Brugge, 1995; Serini et al., 2006). Further, expression
of these cell membrane proteins may vary significantly between normal and cancerous
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tissue, increasing their potential as selective targets in cancer therapy (Goodman and
Picard, 2002; Kumar 2003; Sun et al., 2014). Integrins α6β1, αvβ3 and αvβ6 are almost
undetectable in normal epithelial tissue (Desgrosellier and Cheresh, 2010), yet may be
highly over-expressed in cancerous cells (Gehlsen et al., 1992; Nam et al., 2010). Integrin
αvβ3 has been shown to increase 50-100 fold in melanoma (A-375) cells displaying an
increased metastatic phenotype, indicating that increased integrin expression is correlated
with advanced cancer states (Gehlsen et al., 1992). Tumor dependence on angiogenesis is
also well documented (Folkman, 1971, 2006, 2007) and this formation of new blood
vessels is required for delivering nutrients as well as providing a means of waste removal
for tumors. Although numerous integrins are involved in angiogenesis (Avraamides et al.,
2008), evidence indicates that αvβ3 is critical for tumor angiogenic activity (Brooks et al.,
1994; Varner et al., 1995), likely permitting angiogenic endothelial cells to recognize
proteins present in the tumor microenvironment (Desgrosellier and Cheresh, 2010). The
significance of integrins in cancer biology cannot be overemphasized, so the isolation and
characterization of compounds that have integrin-blocking activity and potential antiangiogenic functions may result in novel anti-neoplastic therapies and reveal new
approaches to controlling cancer cell proliferation and metastasis (Folkman, 2006).
The use of toxins as potential therapeutics has been an increasing emphasis of
biomedical research in the last decade, and several novel compounds developed from the
poisons and venoms of animals are currently in clinical trials and use (Fox and Serrano,
2007; Takacs and Nathan, 2014). Snake venoms in particular have been a promising
source of several protein drugs and additional protein drug leads (Vonk et al., 2011;
Saviola et al., 2014). Snake venoms consist of a complex mixture of proteins and
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peptides that exhibit an array of biochemical and pharmacological functions (Mackessy,
2010). As many of these proteins are often mimics of compounds with normal
physiological activities, but contain dramatically different pharmacologies, venom
components have been subjected to detailed examination for their potential in biomedical
or therapeutic use (Fox and Serrano, 2007; Lin et al., 2010; Mukherjee and Mackessy,
2013). One class of venom proteins, the disintegrins, are small, cysteine-rich, nonenzymatic proteins that result from the post-translational proteolytic processing of the
enzymatic P-II class of snake venom metalloproteinases (Kini and Evans, 1992; Calvete
et al. 2005). Many disintegrins contain an RGD-binding domain in the carboxyl terminal
portion of the molecule and were originally characterized due to their ability to inhibit
platelet aggregation by binding integrin αIIbβ3 (Haung et al., 1987). RGD disintegrins
have also been shown to bind integrins α5β1, α8β1, αvβ1, and αvβ3, and variants of this
tripeptide sequence demonstrate differing levels of selectivity to numerous integrin
receptors (Calvete et al., 2009).
Due to their potent integrin binding activity, disintegrins are continuously being
examined for their ability to reduce experimental metastasis. Contortrostatin, a
homodimeric RGD disintegrin from the venom of the Southern Copperhead (Agkistrodon
contortrix contortrix), has been shown to inhibit cell adhesion, migration, invasion and
angiogenesis in numerous cancer cell lines (Trikha et al., 1994; Zhou et al., 2000, 2001;
Lin et al., 2010). In addition, monomeric disintegrins such as crotatroxin 2 and
colombistatin have also been shown to exhibit various anti-cancer effects (Galán et al.,
2008; Sanchez et al., 2009). We previously reported the isolation and characterization of
a novel 7.1kDa, RGD-containing disintegrin from the venom of the Middle American
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Rattlesnake (Crotalus simus tzabcan). Tzabcanin was not cytotoxic, but it inhibited colon
(Colo-205) and breast (MCF-7) cancer cell adhesion to the ECM proteins fibronectin and
vitronectin (Saviola et al., in review). Analyses of cell adhesion assays suggest that
tzabcanin may bind αvβ5 and αvβ6, both of which are expressed in Colo-205 and MCF-7
cell lines (Agrez et al., 1996; Taherian et al., 2011), and both recognize VN and FN,
respectively. However, it has been reported that neither of these cell lines express the
integrin αvβ3. Since integrin αvβ3 has been shown to contribute significantly in the
progression of cancer (Gehlsen et al., 1992; Wong et al., 1998; Pecheur et al., 2002;
Sloan et al., 2006), the current study was designed to examine if tzabcanin inhibits αvβ3mediated cell adhesion and migration in two highly metastatic melanoma (A-375) and
lung carcinoma (A-549) cell lines which do express integrin αvβ3.
Materials and Methods
Snakes, Venoms and
Biochemicals
Venoms from two adult Middle American Rattlesnakes (Crotalus simus tzabcan)
housed individually at the University of Northern Colorado Animal Resource Facility
were extracted as previously described by Mackessy (1988). Venoms were centrifuged
(10,000 rpm for 5 min), lyophilized, and stored at -20°C until use. Matrigel (356234) was
purchased from BD Biosciences (Franklin Lakes, NJ, USA). αvβ3 antibody (sc-7312
FITC) conjugated with a FITC was purchased from Santa Cruz Biotechnology (Dallas,
TX, USA). Fibronectin (F0895), vitronectin (V8379), and all buffers and additional
reagents (analytical grade) were purchased from Sigma-Aldrich, Inc. (St. Louis, MO,
USA).
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Purification of Tzabcanin
Isolation and purification of tzabcanin was conducted as previously described
(Chapter V; Saviola et al., in review) by a combination of multistep size exclusion and
two steps of C18 reverse-phase liquid chromatography. Mass determination, purity and
identification of tzabcanin was ascertained by both SDS-PAGE and MALDI-TOF mass
spectrometry as described (Chapter V; Saviola et al., in review).
Cell Lines and Culture Conditions
Human malignant melanoma (A-375; ATCC CRL-1619) and human lung
adenocarcinoma (A-549; ATCC CCL-185) cell lines were purchased from American
Type Culture Collection (ATCC, Manassas, VA). A-375 cells were maintained in 75
cm2 flasks in Dulbecco’s Modified Essential Medium (DMEM) supplemented with 10%
fetal bovine serum (FBS) and maintained as a monolayer culture (<80% confluent) in a
humidified 5% CO2/air incubator at 37°C. A-549 cells were also maintained in 75
cm2 flasks with ATCC-formulated F-12K growth medium supplemented with 10% FBS
as a monolayer culture under the same conditions mentioned above. Subcultivation of
cells was performed according to ATCC instruction, using trypsin-EDTA (0.05% trypsin
and 0.02% EDTA). Cells were counted manually with a hemocytometer (4x, averaged)
and diluted to appropriate densities.
Cytotoxicity of Tzabcanin Towards
A-375 and A-549 Cells
Cytotoxicity of tzabcanin towards A-375 and A-549 cells was measured by the
colorimetric MTT [3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-teyrazolium bromide]
assay (Mossmann 1983; see also Bradshaw et al. in press). Both cell lines were
trypsinized and resuspended in complete media at a concentration of 5.0 x 105 cells/ml.
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One hundred microliter aliquots of A-375, and A-549 cell suspensions were plated in 96well cell culture plates with various concentrations of tzabcanin (0.22 – 14 µM) or 20 µg
of crude C. s. tzabcan venom and incubated at 37 °C for 24 hr. After 24 hours, 10 µL of
MTT reagent (ATCC) was added to the cells which were then returned to 37 °C for 2 hr.
Following incubation, 100 µL of Detergent Reagent (ATCC) were added to cells, which
were then incubated overnight in the dark at room temperature. The plate was gently
shaken and the absorbance read at 570 nm using a SpectraMax 190 spectrophotometer.
Assays at each concentration of tzabcanin were performed in triplicate and each assay
was repeated at least twice.
A-375 and A-549 Cell Adhesion
Assays
Triplicate wells of Immulon-II 96 well microtiter plates were coated with 100 µl
of either tzabcanin (2 µg per well), fibronectin (0.5 µg per well), vitronectin (0.3 µg per
well) or Matrigel (0.5 µg per well) which was dissolved in 0.01M PBS, pH 7.2; protein
was allowed to incubate overnight at 4°C. Excess proteins were washed away twice with
1% bovine serum albumin (BSA) in PBS and unbound sites were blocked with 100 µl
2.5% BSA in PBS and incubated at 37 °C for 1 hr. Cells were treated with various
concentrations of tzabcanin (7.8 nM – 2 µM) and allowed to incubate at 37 °C for 1 hr
immediately prior to seeding in treated plates. The blocking solution was aspirated, and
excess proteins were washed away twice with 1% BSA in PBS. One hundred microliters
of tzabcanin-treated cells (5 x 105/mL) were seeded in the coated microtiter plate wells
and returned to 37 °C for 1 hr. Unbound cells were washed away 3 times with 1% BSA in
PBS by filling and aspirating, and 100 µL of serum-free medium with 1% BSA
containing MTT (5:1 vol/vol) was added to wells and incubated at 37 °C for 2 hrs. One
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hundred microliters of Detergent Reagent was then added to the wells and cells were
incubated overnight in the dark at room temperature. The plate was gently shaken and the
absorbance read at 570 nm using a SpectraMax 190 spectrophotometer. The percent
inhibition of cell binding was calculated by [(absorbance of control-absorbance of
treatment)/absorbance of control] x 100. Assays at each tzabcanin concentration for all
cell lines were performed in triplicate and each assay was repeated at least three times.
Cell Migration/Scratch Assay
To measure the effects of tzabcanin on cell migration, a modified wound
healing/scratch assay was completed as previously described by Liang et al. (2007).
Twelve well Immulon-II plates were seeded with 1mL of A-549 or A-375 cells (5 x
105/mL) and allowed to grow to confluence at 37°C. The complete media was then
discarded and cells were starved in serum-free media for 48 hr at 37 °C, followed by 2 hr
incubation with 10 µg/mL mitomycin C in serum-free medium at 37°C. Mitomycin C
inhibits DNA synthesis and therefore was used to evaluate the contribution of cell
migration in the absence of cell proliferation to scratch wound healing. A scratch in the
cell monolayer was created with a 200 µL pipet tip, followed by extensive washing with
serum-free medium to remove cell debris. Cells were then incubated with either 10 µL of
tzabcanin (1 µg/µL) resuspended in PBS, or PBS alone as a control. Photographs were
taken at the same location of the culture well using an Olympus D21 camera attached to
an Olympus CKX41 inverted microscope at 4X magnification. Because tzabcanin
exhibited low cytotoxicity (see Results) towards A-375 cells, the migration evaluation for
this cell line was conducted at 24 hrs, with photographs taken at 0 and 24 hrs. However,
tzabcanin was not cytotoxic to A-549 cells, and therefore the migration assay for this cell
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line was conducted for an extended period, with photographs taken at 0, 24, 48, and 72 hr
intervals. Migration was measured by taking multiple measures of the width of the
scratch for each cell line, and calculated using the equation [(S-F)/S] x 100, where S is
the distance (mm) of the cell edge at 0hrs, and F is the distance (mm) of the cell edge at
24, 48, and 72 hrs (when possible). Assays were performed in triplicate and each assay
was repeated at least three times.
Competitive Binding Assay
A-375 and A-549 cells were resuspended in 1% BSA in PBS at a density of 1 x
106 cells/mL. One hundred µL cell aliquots were incubated with 0 (control) or 2 µg of
tzabcanin resuspended in PBS for 30 min at 37°C, followed by the addition of mouse
monoclonal anti-αvβ3 antibody conjugated with a FITC (10 µg/mL). After 30 min
incubation at room temperature in the dark, cells were gently pelleted and washed 3 times
with 1% BSA in PBS to remove unbound antibody, and the fluorescence intensity of the
cells was analyzed using flow cytometry (FACscan, Becton Dickinson, Bedford, MA).
Tests were performed in triplicate and all experiments were repeated twice.
Statistical Analyses
Cytotoxicity and cell adhesion data were analyzed by Analysis of Variance
(ANOVA) followed by Tukey’s post-hoc test using R version 2.15.2. Cell migration
assays were analyzed using a Student’s T-test, comparing the percent migration of the
treatment to the percent migration for the control for the respective time interval. All p
values <0.05 were considered as statistically significant.
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Results
Tzabcanin Binds to Both A-375
and A-549 Cells via Integrin(s)
Integrin-ligand interactions are cation-dependent (Mould et al. 1995), and to
confirm that cell recognition to tzabcanin in both A-375 and A-549 cells was via
integrins, tzabcanin was immobilized in 96-well microtiter plates, and cell adhesion was
measured following cell incubation with the cation chelator EDTA. A-375 and A-549
binding to tzabcanin was inhibited by EDTA in a dose-dependent manner (Figure 6.1),
with IC50 values of 2.4 mM and 3.23 mM, respectively. These results strongly indicate
that tzabcanin interacts with both cell lines through integrin receptors, likely by cell
recognition of the RGD binding region of tzabcanin.
Cytotoxicity Towards A-375 and
A-549 Cells In vitro
Crude C. s. tzabcan venom (20 µg/100 µL) showed significant cytotoxicity
toward A-375 cells, with approximately 13% cell viability remaining following 24 hr of
incubation (Figure 6.2; p < 0.001). In addition, tzabcanin appeared to exhibit a slight
dose-dependent decrease (~2-6% lower) in A-375 cell viability, and results were
statistically significant (p < 0.05, 0.44 µm to 14 µM) at all concentrations except 0.22
µM. In contrast, both crude C. s. tzabcan venom and tzabcanin failed to show any
significant decrease in A-549 cell viability (all p’s > 0.05).
Tzabcanin Inhibits Cell Adhesion
of A-375 and A-549 to Vitronectin
The ECM proteins fibronectin and vitronectin, and membrane matrix Matrigel, all
support adhesion to A-375 and A-549 cells. By treating both cell lines with various
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concentrations of tzabcanin, its ability to inhibit cell adhesion to these matrices was
evaluated. Results show that tzabcanin inhibits adhesion of both A-375 and A-549 cells
to vitronectin in a dose-dependent manner (Figure 6.3); however, this inhibition is much
more potent towards A-375 cells. The IC50 for A-375 cells was 747 nM, whereas A-549
failed to reach 50% binding inhibition even at 2 µM. Tzabcanin failed to inhibit adhesion
of either cell line to fibronectin or Matrigel (data not shown).
Tzabcanin Inhibits Cell Migration
Cell migration was measured following an in vitro scratch/wound healing assay.
Tzabcanin (10 µg/ml) inhibited A-375 cell migration by approximately 45% when
compared to the untreated control over 24 hr (Figure 6.4A; p < 0.01). Likewise, tzabcanin
inhibited cell migration of A-549 cells by 76, 47, and 37% over the 24, 48, and 72 hr time
intervals, respectively (Figure 6.4B; all p < 0.01). At 72 hr, all of the untreated A-549
controls had 100% closed.
αvβ3 is Identified as a Binding Site
For Tzabcanin on A-375 and
A-549 cells
Since tzabcanin inhibits binding of A-375 and A-549 cells to vitronectin, we
examined if tzabcanin binds to αvβ3, a vitronectin receptor (Horton, 1997). Flow
cytometry analysis demonstrates that both A-375 and A-549 cells express integrin αvβ3
(Figure 6.5), consistent with previously published reports (Gehlsen et al., 1992; Chetty et
al. 2010). When A-375 and A-549 cells were pre-treated with tzabcanin, the disintegrin
significantly inhibited anti-αvβ3 antibody binding (Figure 5), indicating that tzabcanin
binds to αvβ3 on both cell lines.
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Discussion
In 2014, it was estimated that over 585,000 deaths were expected from cancer in
the United States alone (Siegel et al., 2014). Although there appears to be declining or
stable trends among most cancers, melanoma incidences appear to be increasing, and
cancer of the lung and bronchus remains as the most common cause of cancer related
deaths in both men and women (Jemal et al., 2010; Siegel et al., 2104). The molecular
mechanisms involved in metastasis are complex, enabling cancerous cells to disseminate
from the primary tumor, invade local tissue, enter into circulation, and ultimately adhere,
proliferate, and stimulate angiogenesis at a distant site (Liotta et al., 1991). This ability
to metastasize is a significant cause of treatment failure and death in cancer patients
(Price et al., 1997). Therefore, there is a tremendous need to identify compounds that may
effectively arrest the numerous factors involved in metastasis.
Integrins mediate cell adhesion, migration, invasion, proliferation and
angiogenesis, and their roles in metastasis and tumor survival are now apparent
(Desgrosellier and Cheresh, 2010; Rathinam and Alahari, 2010). Further, integrin
expression levels may vary significantly between normal and cancerous tissues
(Desgrosellier and Cheresh, 2010), and additionally they are correlated with advanced
stages of disease progression. Further, it has been strongly implicated that in cancer cells
possessing them, tumor invasiveness is proportional to the expression levels of integrin
αvβ3 (Gehlsen et al., 1992; Liapis et al., 1997). However, numerous other integrin
subfamilies, such as α3, α5, α6, αv, β1 and β4, also enhance tumorigenesis (Rathinam and
Alahari, 2010). Our prior results demonstrated that tzabcanin, a 7.1 kDa, RGDN
monomeric disintegrin, inhibited adhesion of MCF-7 and Colo-205 cells to fibronectin
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and vitronectin through competitive binding to integrins (Chapter V; Saviola et al., in
review), although this inhibition was not as potent as has been previously reported for
other disintegrins (Zhou et al., 2001; Sánchez et al., 2009). Since the RGDN binding
region of disintegrins exhibits higher affinity towards αvβ3 (Scarborough et al., 1993), an
integrin not expressed on either Colo-205 or MCF-7 cells, it was postulated that
tzabcanin may demonstrate significantly higher affinity and anti-metastatic properties
towards cell lines expressing this receptor.
Immobilized tzabcanin supports adhesion of A-375 and A-549 cells,
demonstrating that these cells bind to this disintegrin. Because a cation chelator (EDTA)
significantly inhibited adhesion of both cell lines to tzabcanin, it is likely that tzabcanincell binding is primarily mediated via integrin receptors. Integrin-mediated cell adhesion
to the ECM proteins fibronectin and vitronectin is largely due to the presence of the RGD
region found in these proteins (Ruoslahti, 1992, 1996), with roughly one-third of all
identified integrins recognizing this binding sequence (Barczyk et al., 2010). Tzabcanin,
a RGD disintegrin, inhibited binding of both A-375 and A-549 cell lines to vitronectin,
but this inhibitory effect was significantly more potent for A-375 cells (IC50 = 747 nM).
Cell adhesion to vitronectin is mediated by integrins αvβ1, αvβ3, αvβ5, and αvβ8 (Barczyk et
al., 2010). Using an antibody against integrin αvβ3, our flow cytometric analysis indicates
that A-375 and A-549 cell lines are αvβ3 positive, results which are supported by previous
reports (Gehlsen et al., 1992; Chetty et al., 2010). However, A-375 cells appear to
express a higher percentage (29%, S.D. = 3.14%) of this receptor when compared to A549 cells (16%, S.D. = 3.7%), possibly explaining the weak inhibitory effect of tzabcanin
on A-549 cell binding to vitronectin. Flow cytometric analysis also indicated that
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tzabcanin binds to this receptor, inhibiting the binding of the FITC labeled anti-αvβ3
antibody and therefore also inhibiting cell adhesion to immobilized vitronectin during
adhesion assays. Despite this, it is hypothesized that because tzabcanin (at 2 µM) did not
inhibit 100% adhesion of either A-375 or A-549 cells to vitronectin, other integrin
receptors may participate in anchoring cells to this ECM protein. Therefore, complete
inhibition of attachment of A-375 and A-549 cells to vitronectin would require blocking
multiple integrins, and the possibility of other RGD-dependent integrins exhibiting
affinity towards vitronectin in A-375 and A-549 cell lines cannot be excluded.
Tzabcanin did not disrupt adhesion of either cell line to fibronectin or Matrigel at
concentrations as high as 14 µM. Fibronectin is a ligand for numerous integrins including
α4β1, α5β1, α8β1, αvβ1, αvβ3, αvβ6, and α4β7, which could explain why tzabcanin failed to
inhibit cell adhesion to this ECM protein (Barczyk et al., 2010). In addition, the major
components of Matrigel are laminin and type IV collagen (Hughes et al., 2010), which
are recognized by the β1 subclass of integrins (Barczyk et al., 2010). Therefore, tzabcanin
appears to show specificity towards αvβ3, likely accounting for the inhibitory effects of
adhesion of both cell lines to vitronectin but not to fibronectin or laminin.
Crude C. s. tzabcan venom was significantly cytotoxic to A-375 cells, results that
confirm those published by Bradshaw et al. (in press). However, crude venom failed to
exhibit any cytotoxic effects towards A-549 cells. This outcome was surprising due to the
potent toxicity of C. s. tzabcan venom toward several immortal cell lines and toward
mice (LD50 = 0.74 µg/g; Castro et al., 2013). Phenotypic differences between cell lines
could account for the drastic differences in toxic effects of crude venom. Although
purified tzabcanin failed to show a decrease in A-549 viability, there was a dose-
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dependent small decrease in A-375 cell viability. It is currently unknown if this decrease
is the result of apoptosis or necrosis. However, it has recently been shown that the
recombinant disintegrins r-mojastin 1 and r-viridistatin 2 induced apoptosis in
approximately 20% of human pancreatic adenocarcinoma (BXPC-3) cells at
concentrations of 5 µM following 24 hr incubation (Lucena et al., 2015).
Migration is a critical step in metastasis, and cancer cells express various
adhesion molecules facilitating movement from the primary tumor site to remote tissues
or organs. Expression and activation of αvβ3 has been shown to enhance migration
significantly in numerous cancer cell lines (Rolli et al., 2003; Dang et al., 2006; Sloan et
al., 2006; Fong et al., 2009). Tzabcanin (10 µg/mL) effectively inhibited cell migration in
both A-375 and A-549 cell lines, likely by blocking αvβ3-mediated adhesion. Upon
ligation, αvβ3 induces the myosin light chain kinase through ras/MAP kinase pathways,
causing an increase in phosphorylation of the myosin light chain kinase and leading to the
phosphorylation of myosin light chains, thereby influencing cell locomotion (Klemke et
al., 1997). It is hypothesized that by binding to αvβ3, tzabcanin inhibits this cell signaling
pathway and further reduces cell motility in A-375 and A-549 cells. Cell adhesion to
fibronectin and Matrigel was not inhibited, but inhibition of cell adhesion is not always
correlated with inhibition of cell migration (Bartsch et al., 2003; Galán et al., 2008). For
example, the disintegrin crotatroxin 2 from Crotalus atrox significantly inhibited
migration of the murine mammary breast carcinoma cells (by 66%) yet failed to inhibit
adhesion of this cell line to fibronectin or collagen IV and VI (Galán et al., 2008).
In conclusion, results from this study demonstrate that by binding integrin αvβ3,
tzabcanin supports adhesion to both A-375 and A-549 cell lines. The RGDN binding
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region present in tzabcanin may show specific affinity to integrin αvβ3, and not toward
other receptors, which would explain why tzabcanin failed to inhibit adhesion of either
cell line to fibronectin or Matrigel. However, by blocking αvβ3, tzabcanin inhibits A-375
and A-549 cell-mediated adhesion to vitronectin, as well as migration in both cell lines
over 24 (A-375) and 72 (A-549) hr periods. Further studies will assess the effects of
tzabcanin in vivo and against numerous other cancer cell lines.
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Figures

Figure 6.1: Percent inhibition of binding of A-375 and A-549 Cells to Immobilized
Tzabcanin. A-375 and A-549 cells (5.0 x 105 cells/mL) were incubated with various
concentrations of EDTA (0.3 – 5 mM) prior to addition to wells containing immobilized
tzabcanin. All treatments were significantly different from controls (*, p < 0.01; **, p <
0.001).
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Figure 6.2: Percent Cell Viability of A-375 and A-549 cells following exposure to crude
C. s. tzabcan venom or purified tzabcanin. *, p < 0.05, compared to controls.
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Figure 6.3: The Effects of Tzabcanin on A-375 and A-549 Adhesion to Immobilized
Vitronectin. Various concentrations of tzabcanin (7.8 nM – 2 µM) were incubated with
A-375 and A-549 cells (5.0 x 105 cells/mL) prior to addition to 96-well culture plates
containing immobilized vitronectin. * p < 0.001.
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Figure 6.4: Inhibition of A-375 and A-549 Cell Migration. Cells were maintained as a
monolayer in serum free medium for 48 hr before a 2 hr incubation with mitomycin-C. A
line was scratched through the cell monolayer (0 hr), and cultures were allowed to
migrate at 37°C in the presence of tzabcanin or a PBS control. Multiple measurements of
the width of the scratch were made for for each treatment. A) cell migration for A-375
cells after 24 hr. B) cell migration of A-549 cells at 24, 48, and 72 hr.
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Figure 6.5: Tzabcanin Inhibits Binding of Anti-αvβ3 to A-375 and A-549 Cells. The
natural fluorescence of A) A-375 melanoma cells and B) A-549 lung cancer cells is
shown (black line) and the fluorescence following incubation with αvβ3 antibody (green
line) indicates antibody-integrin binding. Tzabcanin added to cells prior to addition of the
αvβ3 antibody effectively inhibits antibody binding (red line), as demonstrated by a shift
of cell fluorescence back toward controls (black lines).
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Abstract
Here we describe and compare the venomic and antivenomic characteristics of
both neonate and adult Prairie Rattlesnake (Crotalus viridis viridis) venoms. Although
both neonate and adult venoms contain unique components, similarities among protein
family content were seen. Both neonate and adult venoms consisted of of myotoxin,
bradykinin-potentiating peptide (BPP), phospholipase A2 (PLA2), Zn2+-dependent
metalloproteinase (SVMP), serine proteinase, L-amino acid oxidase (LAAO), cysteinerich secretory protein (CRISP) and disintegrin families. Quantitative differences,
however, were observed, with venoms of adults containing significantly higher
concentrations of the non-enzymatic toxic compounds and venoms of neonates
containing higher concentrations of pre-digestive enzymatic proteins such as SVMPs. To
assess the relevance of this venom variation in the context of snakebite and snakebite
treatment, we tested the efficacy of the common antivenom CroFab® for recognition of
both adult and neonate venoms in vitro. This comparison revealed that many of the major
protein families (SVMPs, CRISP, PLA2, serine proteases, and LAAO) in both neonate
and adult venoms were immunodepleted by the antivenom, whereas myotoxins, one of
the major toxic components of C. v. viridis venom, in addition to many of the small
peptides, were not efficiently depleted by CroFab®. These results therefore provide a
comprehensive catalog of the venom compounds present in C. v. viridis venom and new
molecular insight into the potential efficacy of CroFab® against human envenomations by
one of the most widely distributed rattlesnake species in North America.
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Introduction
Produced and stored in a pair of highly specialized cephalic gland, snake venoms
represent a complex mixture of bioactive proteins and peptides that exhibit diverse
biochemical and pharmacological functions [1]. Venoms likely evolved via the co-opting
and secondary modification of endogenous proteins with normal physiological functions
early in the evolution of advanced snakes [e.g., 2 but see 3, 4], enabling the transition
from a mechanical (constriction) to a chemical (venom) means of subduing prey [5]. The
complexity of venoms, coupled with the fact that many snake species specialize on
specific prey, has led to selective pressures resulting in the evolution of advantageous
venom phenotypes that may vary based on phylogenetic affinities [1, 6, 7], geographic
localities [8, 9], snake age [10, 11, 12] and diet [13, 14]. It is this variation and
complexity that has continuously led researchers to examine snake venoms and the
evolution of venom systems. Research into the origin and evolution of snake venoms
offers remarkable insights into the biological roles of venom compounds [15, 16] and
potential avenues for novel drug discovery [17, 18, 19], as well as addressing the evergrowing concern for effectively treating human snakebite [20, 21]. Proteomic analyses of
venoms, termed “venomics”, is significantly expanding our knowledge and
understanding of these oral secretions [e.g., 22, 23], which are not only critical to the
foraging success of the snakes, but may also be of potential value or threat to humans.
Within the superfamily Caenophidia, the family Viperidae consists of
approximately 260 species within four subfamilies: Azemiopinae, Causinae, Crotalinae
and Viperinae. Of these subfamilies, the Crotalinae (pit vipers) is the most speciose, and
currently comprises over 200 species distributed among 28 genera. In the Americas, the
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only viperids are the monophyletic pit vipers, which appear to have dispersed into the
New World during the late Oligocene to early Miocene approximately 22-24 mya [24].
Among New World pit vipers, the genus Crotalus currently comprises 30-36 species of
venomous snakes distributed throughout much of South, Central and North America
(http://www.reptile-database.org). The Prairie Rattlesnake (Crotalus viridis viridis) is a
medium-sized terrestrial pitviper commonly exceeding 100 cm snout-vent length (SVL)
[25]. The range of this species spans much of the Great Plains of the central United
States, northwestern Mexico and southwestern Canada, making it one of the most widely
distributed rattlesnake species in North America (Fig.1). Due to this wide geographic
distribution, and the sometimes large home ranges, C. v. viridis may occur in close
proximity to housing developments and are often found migrating into human-inhabited
areas [26], increasing the possibility of encounters with humans. Terrestrial habitats
occupied by C. v. viridis range from semi-desert and plains grasslands to pinion-juniper,
mountain shrublands and montane woodlands, up to 2740 m in elevation [25, 27]. In
grasslands habitat, C. v. viridis is a frequent inhabitant of prairie dog towns where
burrows are commonly used for prey ambush sites, predator avoidance, and hibernation
[26]. Like many other rattlesnake species, the diet of C. v. viridis shifts with snake age,
generally focusing on small ectothermic prey and newborn rodents as neonates, and
switching to larger endothermic prey (small mammals and occasionally birds) as adults
[10, 27].
Viperid venoms contain an abundance of proteins which interfere with
homeostasis and with the blood coagulation cascade, ultimately leading to the
immobilization, killing and predigestion of prey. Individual venom may contain well over
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100 proteins and peptides (including various protein isoforms); these compounds can,
however, generally be classified into 10-15 protein families, such as the enzymatic Lamino acid oxidases (LAAOs), metalloproteinases (SVMPs), phospholipases A2 (PLA2)
and serine proteases, as well as the non-enzymatic peptide myotoxins, C-type lectins,
cysteine-rich secretory proteins (CRISPs) and disintegrins, among others [1]. Venom
composition, especially in viperid species, can be classified based on enzymatic activity
and toxicity, which are generally inversely correlated [7, 28]. For species classified as
having type I venom, neonate and juvenile snakes have venoms exhibiting increased
toxicity with lower SVMP and serine protease activity, whereas adults have lower
toxicity (>1.0 µg/g mouse body weight) but higher SVMP activity [29]. Type II venoms,
on the other hand, have been suggested to be paedomorphic [7, 28, 30, 31] since
neonates, juveniles and adults all exhibit low SVMP activity but are higher in toxicity (<
1.0 µg/g mouse body weight), retaining similar venom characteristics throughout the life
history of the snake.
Previous studies of the venom of C. v. viridis have shown moderate to high
activity levels of LAAO, kallikrein, plasmin, and thrombin-like serine proteases, SVMP,
PLA2 and phosphodiesterase enzymes [28, 32]. Gel electrophoresis and mass
spectrometry indicate that myotoxins, CRISPs and disintegrins are also abundant
compounds in the venom of C. v. viridis. Venom yields from adult C. v. viridis may vary
from 40 mg to well over 100 mg of dry venom in Colorado populations [28, 33], while
neonate snakes may yield only 2-4 mg venom. Further, Mackessy [28] reported mouse
intravenous LD50 values at 1.55 µg/g of mouse body weight, making it one of the more
toxic rattlesnake species in the Western rattlesnake complex.
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It is estimated that there are over 9000 venomous snake bites in the United States
annually [34], with roughly 99% of these bites from snakes of the family Viperidae [35].
These human envenomations may be characterized by edema, erythema, clotting
disorders, hypofibrinogenemia and local tissue necrosis [36, 37]. Bites may pose a
serious or potentially deadly emergency, and early therapeutic administration of
antivenom is necessary if severe envenomation is suspected. In the United States, the
antivenom CroFab® (Crotaline Polyvalent Immune Fab (ovine)) is commonly
administered during envenomation cases. CroFab® is produced from sheep immunized
with one of the following North American snake venoms: Agkistrodon piscivorus (Water
Moccasin), Crotalus adamanteus (Eastern Diamondback rattlesnake), Crotalus
atrox (Western Diamondback rattlesnake) and Crotalus scutulatus (Mojave rattlesnake)
[38]; serum collected from hyperimmune animals is affinity purified using columns
containing the same immobilized venom, and hyperimmune sera are then mixed to
produce a polyvalent antivenom. Surprisingly, in spite of its wide distribution in North
America, C. v. viridis is not one of the species utilized for CroFab® production. Adequate
treatment of snakebite is dependent on the ability of the antivenoms to reverse the
pathological symptoms induced by venom by immunologically binding to venom
components, facilitating their removal and degradation. Therefore, knowledge on venom
composition and inter- and intra-specific venom variability is critical for assessment of
antivenom efficacy and treatment of snakebite. The present work was designed to provide
a comparative analysis of the venom proteomes of neonate and adult C. v. viridis, to
determine venom composition and to investigate the immunoreactivity profile of the
commercially available antivenom CroFab® against these venoms.
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Materials and Methods
Venoms and Antivenoms
The venoms of fourteen neonate, twelve subadult and twelve adult C. v. viridis
(equal numbers of female and male snakes) were manually extracted from wild-caught
specimens (Weld Co., Colorado, USA). Age classes of snakes were based on snout-vent
lengths from a large dataset of mark-recaptures from the same population (Mackessy,
unpub. data); snakes <300 mm were considered neonates, snakes 500-540 mm were
considered subadults and snakes >800 mm were considered adults. Following extraction,
snakes were in captivity for no more than 3 days and were released to the exact location
of capture. Venoms were immediately centrifuged at 10,000 x g for 5 min to pellet
insoluble material, frozen, lyophilized and stored at -20°C until used. CroFab® was
donated by Dr. Robert Palmer of the Rocky Mountain Poison and Drug Center, and antimyotoxin a antibodies were a gift of Dr. Charlotte Ownby (Oklahoma State University).
RP-HPLC Fractionation
Venom proteins were separated by reverse-phase high-performance liquid
chromatography (RP-HPLC) using a Teknokroma Europa C18 (250 x 4 mm, 5 µm
particle size, 300 Å pore size) column and an ETTAN™ LC HPLC System (GE
Healthcare). Two mg of venom from adult (2 samples, one male (specimen 281), one
female (specimen 288) or 1.5 mg neonate (2 samples, one male (specimen 280), one
female (specimen 249) were dissolved in 300 µL of 0.05% trifluoroacetic acid (TFA) and
5% acetonitrile, and insoluble material was removed by centrifugation in an Eppendorf
centrifuge at 13,000 g for 10 min at room temperature. The flow-rate was set to 1 mL/min
and the column was developed with a linear gradient of 0.1% TFA in water (solution A)
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and acetonitrile with 0.1% TFA (solution B). Elution was achieved as follows: isocratic
at 5% solution B for 5 min, followed by 5–25% B for 10 min, 25–45% B for 60 min, and
45–70% for 10 min. Protein detection was carried out at 215 nm and peaks were collected
manually and dried using a Speed-Vac (Savant) for subsequent characterization. These
four venom samples were considered the primary samples.
Characterization of RP-HPLC
Fractions
Fractions obtained from RP-HPLC (primary samples) were further separated by
SDS-PAGE under reduced and non-reduced conditions, using 15% gradient
polyacrylamide gels. Chromatographic fractions containing peptides (m/z ≤ 1700) were
loaded in a nanospray capillary column and subjected to peptide sequencing using a
QTrap™ 2000 mass spectrometer (Applied Biosystems) equipped with a nanospray
source (Protana, Denmark). Doubly- or triply-charged ions were selected for collisioninduced dissociation (CID) MS/MS analysis. Production spectra were interpreted
manually or using the on-line form of the MASCOT program at
http://www.matrixscience.com against a private database containing viperid protein
sequences deposited in the SwissProt/TrEMBL database plus the protein sequences
translated from the species-specific venom gland transcriptome. MS/MS mass tolerance
was set to ± 0.6 Da. Carbamidomethyl cysteine and oxidation of methionine were fixed
and variable modifications, respectively. Spectra producing positive hits were manually
inspected. Good quality spectra that did not match any known protein sequence were
interpreted manually to derive de novo amino acid sequences. Amino acid sequence
similarity searches were performed against the available databanks using the BLAST
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program [39] implemented in the WU-BLAST2 search engine at http://www.bork.emblheidelberg.de.
Protein bands of interest were excised from a Coomassie Brilliant Blue-stained
SDS-PAGE gel and subjected to in-gel reduction (10 mM dithiothreitol) and alkylation
(50 mM iodacetamide), followed by overnight sequencing-grade trypsin digestion (66
ng/µl in 25 mM ammonium bicarbonate, 10% acetonitrile; 0.25 µg/sample) in an
automated processor (using a Genomics Solution ProGest Protein Digestion Workstation)
following the manufacturer's instructions. Tryptic digests were dried in a vacuum
centrifuge (SPD SpeedVac®, ThermoSavant), redissolved in 15 µL of 5% acetonitrile
containing 0.1% formic acid, and submitted to LC-MS/MS [40, 41]. To this end, tryptic
peptides were separated by nano-Acquity UltraPerformance LC® (UPLC®) using a
BEH130 C18 (100 µm x 100 mm, 1.7µm particle size) column in-line with a Waters
SYNAPT G2 High Definition Mass Spectrometry System. The flow rate was set to 0.6
µl/min and column was developed with a linear gradient of 0.1% formic acid in water
(solution A) and 0.1% formic acid in acetonitrile (solution B) at 1% B for 1 min,
followed by 1-12% B for 1 min, 12-40% B for 15 min, 40-85% B for 2 min. Doubly and
triply charged ions were selected for CID MS/MS. Fragmentation spectra were
interpreted i) manually (de novo sequencing), ii) using the on-line form of the MASCOT
program at http://www.matrixscience.com against the NCBI non-redundant database, and
iii) using Waters Corporation's ProteinLynx Global SERVER 2013 version 2.5.2. (with
Expression version 2.0) against the species-specific venom gland cDNA-derived toxin
sequences. MS/MS mass tolerance was set to ± 0.6 Da. Carbamidomethyl cysteine and
oxidation of methionine were selected as fixed and variable modifications, respectively.
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The relative abundances (expressed as percentage of the total venom proteins) of
the different protein families were calculated as the ratio of the sum of the areas of the
reverse-phase chromatographic peaks containing proteins from the same family to the
total area of venom protein peaks in the reverse-phase chromatogram [40, 41]. When
more than one protein band was present in a reverse-phase fraction, their proportions
were estimated by densitometry of Coomassie-stained SDS-polyacrylamide gels using
ImageJ version 1.47 (http://rsbweb.nih.gov/ij). Conversely, the relative abundances of
different proteins contained in the same SDS-PAGE band were estimated based on the
relative ion intensities of the three more abundant peptide ions associated with each
protein by MS/MS analysis. Finally, protein family abundances were estimated as the
percentages of the total venom proteome.
To evaluate population-level variation in venom composition, and to confirm that
trends observed in the primary samples were representative of the population, 34
additional samples (secondary samples) were subjected to RP-HPLC fractionation as
above, using a Waters 2485 HPLC system, Empower software and a Phenomenex Jupiter
C18 (4.0 x 250 mm, 5µm) column. Characterization of these samples was based on the
detailed characterizations of the primary samples, and peak identifications were
determined by comparison of elution times and visual inspections of chromatograms with
the primary samples. These samples consisted of 10 adult, 12 subadult and 12 neonate
venom samples for each sex, collected from the same population as the four primary
samples. Data from these 34 secondary samples were used to determine protein family
abundances as a percent of total venom proteins, with a particular emphasis on two of the
most abundant protein families (SVMPs, peptide myotoxins). Combined samples for each
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age class were also subjected to RP-HPLC fractionation as above to obtain a population
average. One hundred fifty µg from each of 12 individuals (per age class) were
combined, fractionated on RP-HPLC and compared to primary samples.
Antivenomics
A second-generation antivenomics approach [42] was utilized to examine the
paraspecific immunoreactivity of commercially available CroFab® against both neonate
and adult C. v. viridis venom (primary samples). For preparation of the antivenom
affinity column, 500 µL of NHS-activated Sepharose 4 Fast Flow (GE Healthcare) matrix
was packed in a Pierce centrifuge column and washed extensively with 10 matrix
volumes of cold 1 mM HCl followed by two matrix volumes of coupling buffer (0.2 M
NaHCO3, 0.5 M NaCl, pH 8.3) to adjust the pH of the column to 7.0-8.0. Sixty
milligrams of CroFab® was then dissolved in 250 µL coupling buffer and incubated with
matrix for 4 h at room temperature. The amount of antivenom coupled to the matrix was
estimated by measuring the amount of non-bound antivenom by quantitative SDS-PAGE
band densitometry (MetaMorph software, MDS Analytical Technologies) of CroFab®,
which consists almost entirely of fragment antigen binding antibodies (Fab); the amount
remaining in the coupling buffer was subtracted from the starting amount (60 mg),
providing an estimate of approximately 16.4 mg (27%) of CroFab® antivenom bound to
column matrix. The non-reacted groups were then blocked with 500 µL of 0.1 M TrisHCl, pH 8.5 at room temperature for 4 h. The column was alternately washed with three
500 µL volumes of 0.1 M acetate containing 0.5 M NaCl, pH 4.0-5.0, and three 500 µL
volumes of 0.1 M Tris-HCl, pH 8.5; this was repeated 6 times. The column was then
equilibrated with 5 volumes of working buffer solution (20 mM phosphate buffer, 135
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mM NaCl, pH 7.4; PBS). For the immunoaffinity assay, 300 µg of neonate (male) or
adult (male) C. v. viridis venom were dissolved in ½ matrix volumes of PBS and
incubated with the affinity matrix for 1 h at room temperature using an orbital shaker. As
specificity controls, 500 µL of Sepharose 4 Fast Flow matrix, without or with 16 mg of
immobilized control IgGs purified from non-immunized horse serum, were incubated
with venom and the columns developed in parallel to the immunoaffinity experiment.
Following elution of the non-retained fractions with 500 µL of PBS, the column was
washed with 2.5 volumes of PBS, and the immunocaptured proteins were eluted with 5
volumes of elution buffer (0.1 M glycine-HCl, pH 2.0) and neutralized with 500 µL 1 M
Tris-HCl, pH 9.0. The non-retained and the immunocaptured venom fractions were
fractionated by reverse-phase HPLC using a Discovery® BIO Wide Pore C18 (15 cm x 2.1
mm, 3 µm particle size, 300 Å pore size) column and an Agilent LC 1100 High Pressure
Gradient System equipped with a DAD detector. The flow rate was set to 0.4 mL/min and
the column was developed with a linear gradient of 0.1% TFA in water (solution A) and
0.1% TFA in acetonitrile (solution B): isocratic at 5% solution B for 1 min, followed by
5-25% solution B for 5 min, 25-45% solution B for 35 min, and 45-70% solution B for 5
min. Protein detection was carried out at 215 nm with a reference wavelength of 400 nm.
Western Blot Analysis
Venoms (16 µg/lane) were from the four specimens of C. v. viridis characterized
here, plus venom from one C. o. helleri and one C. s. scutulatus (both from Los Angeles
County, CA, USA), and purified myotoxin a (from this source population of C.v. viridis
in Colorado; 3 µg/lane); each sample was subjected to Western blot analysis following
reducing SDS-PAGE on 12% acrylamide NuPAGE® Bis-Tris precast gels. Proteins were
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blotted to nitrocellulose (150 mA for 1.5 hr), and the membrane was rinsed in Milliporefiltered water (18.2 MΩ·cm MilliQ™ H2O) and then blocked in PBS-buffered 3% BSA
(Sigma Fraction V) for 1hr at room temperature (RT). The membrane was cut so that
one-half of the myotoxin a lane was retained on each part of the membrane. Membranes
were rinsed three times in PBS and then incubated with 15 mL primary antibody
(CroFab® - 1.0 mg/mL 3% BSA in PBS; or specific anti-myotoxin a antibodies raised in
rabbits, 5 µL in 15 mL 3% BSA in PBS) overnight at RT with constant gentle shaking.
The membranes were rinsed three times with Tris buffered saline (TBS, 0.05 M Tris-HCl,
0.15 M NaCl, pH 7.4) and then secondary antibody (5 µL donkey anti-sheep IgG
conjugated with alkaline phosphatase for CroFab®; 5 µL goat anti-rabbit IgG conjugated
with alkaline phosphatase for anti-myotoxin a) in 15 mL TBS was incubated with the
appropriate membrane for 60 min at RT with gentle shaking. Membranes were then
washed four times with TBS and alkaline phosphatase substrate (SIGMAFAST™
BCIP®/NBT) in 10 mL of Millipore-filtered water (18.2 MΩ·cm MilliQ™ H2O) was
added. The color reaction was stopped with 20 mM disodium EDTA in PBS after ~5 min.
Membranes were washed in MilliQ™ H2O, dried and photographed. The same venoms
(16 µg/lane) and myotoxin a (1, 3 and 5 µg/lane) were also run on a second 12%
acrylamide NuPage gel under reducing conditions. This gel was stained with 0.1%
Coomassie Brilliant Blue, destained and photographed. The 34 secondary samples were
also subjected to electrophoresis using 12% acrylamide NuPage gel under reducing
conditions.
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SVMP Activity Assay
SVMP activity of crude neonate (n=12), subadult (n=12), and adult (n=12) C. v.
viridis venoms was measured colorimetrically using azocasein as a substrate. Briefly, 2.5
µL of crude C. v. viridis venom (4 µg/µL), or 2.5 µL MilliQ H20 as a control, was added
to 247.5 µL of azocasein (2 mg/ml) resuspended in assay buffer (50 mM HEPES, 100
mM NaCl, pH 8.0). The reaction mixture was then incubated at 37 °C for 30 min. The
assay was terminated by the addition of 125 µL of 0.5 M trichloroacetic acid, vortexed at
room temperature, and centrifuged at 2000 x g for 5 min. Following centrifugation, 100
µL of supernatant was mixed with 100 µL of 0.5 M NaOH and the absorbance was
determined at 450 nm using a SpectraMax 190 plate reader. Assays for each sample were
performed in triplicate, and activity was reported as ΔA450nm/min/mg protein.
Statistical Analysis
The percent abundance of myotoxin a and SVMP from all RP-HPLC runs was analyzed
by Analysis of Variance (ANOVA) followed by Tukey’s post-hoc test using R version
2.15.2. Similarly, SVMP activity was also analyzed by ANOVA and Tukey’s post-hoc
comparison. Comparisons between age classes and between sexes were also analyzed by
ANOVA and Tukey’s post-hoc comparison and two-tailed t-test. All p values <0.05 were
considered as statistically significant.
Results and Discussion
The Venom Proteome of
C. v. viridis
In the current study, venoms of both male and female neonate and adult C. v.
viridis, obtained from snakes from approximately the center of the species’ distribution
(Fig.7.1), were characterized by venomics analysis. These four (primary) venom samples
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(Fig.7.2), as well as the 34 additional (secondary) samples (Fig. 7.3), exhibited similar
chromatographic profiles and toxin family composition (Table 7.1), but there is apparent
variation in concentrations of specific toxins and protein families (Table 7.1). Venoms
from all C. v. viridis examined shared compounds from 10 protein classes (Table 7.1; Fig.
7.3), which are typically abundant in rattlesnake venoms [7]. In addition, some molecules
were detected in only a subset of venoms, including an ohanin-like toxin [~ L. muta
Q27J48], PI-SVMP [~ C. atrox Q90392], phospholipase B [~ C. adamanteus F8S101], an
acidic PLA2 [P0DJM5], and the tripeptide inhibitors of SVMPs, ZNW and ZQW (Table
7.1) [43-46]. Both endogenous inhibitors were primarily detected in neonate venoms
(peaks 39* and 40* in panels C and D of Fig.2). Only ZQW was observed in adult female
venom (peak 4, Fig. 7.2B), whereas tripeptide inhibitors were not seen in adult male
venom (Table 7.1). Consistent with previous reports [44], the concentration of
endogenous inhibitors correlates with the abundance of SVMPs in the venoms, as overall
SVMPs (PI, PII, and PIII classes) were detected in higher percentages in both neonate
venoms when compared to adult venoms (Table 7.1). This observation supports the view
that the relatively low affinity endogenous tripeptides (Ki = 0.20-0.95 mM) [43] keep
SVMPs functionally silent in the venom gland, and disengagement of this control occurs
spontaneously at the time of the snakebite.
The major toxins present in both adult and the neonate male venoms were peptide
myotoxins (Table 7.1). There were no statistically significant differences in myotoxin a
or SVMP content, or SVMP activity of crude venom, with regards to sex of the snake (all
p’s > 0.05). However, there was a significant age-related change in myotoxin a content of
the venoms, and neonate venoms contain significantly less myotoxin a than adult venoms
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(Fig. 4; p = 0.05). Further, there was no significant difference between neonate and
subadult (p = 0.74) or subadult and adult (p = 0.23) myotoxin a concentration. Both
myotoxin a [P01476] and myotoxin 2 [P63175] were detected in adult male C. v. viridis
venom, whereas only myotoxin a was found in adult female and neonate venoms. Small
basic myotoxins represent a Nearctic and Neotropical crotaline innovation of a protein
fold acting on the Ca2+-ATPase of skeletal muscle sarcoplasmic reticulum [47] and
voltage-sensitive Na+ channels [12, 48-51]. These myonecrotic toxins primarily serve two
biological roles: to limit the flight of prey by causing tetanic paralysis of the hind limbs,
and to promote death by paralysis of the diaphragm [52, 53].
SVMPs are present in the venoms of all families of venomous snakes, and
analysis of this activity in all samples of C. v. viridis venom showed a significant agerelated decrease (Figs. 7.4A and 7.4B). For overall SVMP abundance, ANOVA showed
significant differences when comparing neonate to subadult (p = 0.02) and neonate to
adult venoms (p = 0.002), yet comparison of subadult to adult venoms was not
statistically significant (p = 0.69). SVMP activity assays further support these results with
both subadult and adults venoms showing significantly less activity when compared to
neonate C. v. viridis venoms (both p’s < 0.001). There was no difference in SVMP
activity between subadult and adult venoms (p = 0.61). Tryptic peptides recovered after
in-gel digestion yielded ions matching the highly hemorrhagic PIII atrolysin-A [Q92043],
first characterized from the venom of C. atrox [54], in the venoms of all four C. v. viridis
examined here. Adult and neonate male venoms also yielded peptides matching an
additional PIII-SVMP [Q9DGB9] from C. atrox, and one other PIII-SVMP in the 36 kDa
range [C9E1S0] was detected in the venom of the neonate male. Peptides of PI-SVMPs,
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which are less hemorrhagic than the higher molecular weight PIII-SVMPs [55], were
only detected in the adult male and neonate male venoms (Table 7.1). However, analyses
of peak 9 from all four individuals yielded a 3 kDa protein band (see Fig. 7.2 panel A,
protein band 9) that was subjected to tryptic peptide mass fingerprinting, producing the
ion YIELVVVADHR that matches a C. atrox PI-SVMP [Q90392]. The early HPLC
elution of this peptide compared to the other SVMPs, in addition to the low molecular
mass of the protein band, suggests possible degradation of these PI-SVMP enzymes,
which exhibit an intact mass of 20-24 kDa.
Disintegrins are platelet aggregation inhibitors commonly found in viperid
venoms as the result of the post-translational proteolytic processing of PII-SVMPs [56].
In Crotalus, these non-enzymatic toxins have been shown to range from 0.1% of the
venom proteome of C. tigris [57] to over 6% of the total venom proteome in C. atrox
[58]. Stage-dependent down-regulation of the precursor metalloproteinases in C. viridis
may account for the lower abundance of disintegrins in adult compared with neonate
venoms.
C-type lectin-like molecules (CTLs), also known as snaclecs (snake venom Ctype lectins), are also present in C. v. viridis venoms (Table 7.1). Snaclecs have been
reported to bind in a Ca2+-independent manner and via protein-protein interactions with
coagulation factors IX/X, X and II, impairing their physiological roles in hemostasis.
Snaclecs also reduce platelet function by inhibiting surface receptors such as the von
Willebrand receptor, GPIb, and the collagen receptor, integrin α2β1, or by activating
platelets via clustering of the collagen receptor GPVI so that they are removed from the
circulation, producing thrombocytopenia [59]. Whether this class of toxins participates in
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age- and gender-dependent prey-securing strategies, and how they participate, deserves
further investigation.
Phospholipase A2 (PLA2) enzymes are one of the most heavily-studied venom
toxin families to date [60] and contribute to local tissue damage due to myonecrosis,
edema, and inflammation. However, a single venom may contain numerous PLA2
isoforms, and each may exhibit varying biological effects. In this respect, protein masses,
in addition to tryptic peptides, indicate the presence of multiple PLA2 isoenzymes in all
four venoms examined. Thus, tryptic peptides matching that of the D49-PLA2 [Q9I8F8]
were found in adult male venom (Fig.2A, peak 13); D49-PLA2 [Q800C3] was found in
venoms belonging to both adult and neonate male snakes (Figs.7.2A and C, peaks labeled
11). Peptides representing another D49-PLA2 [Q800C4] were seen in the adult male and
female venom samples (Figs.7.2A and 7.2B, peaks 19 and 19a/b, respectively), and ions
for D49-PLA2 [Q71QE8] and acidic PLA2 [P0DJM5] were present in the adult female
venom (Fig.7.2B, peak 32*).
Cysteine-rich secretory proteins (CRISPs), which comprise 1.8 to 7.3% of the
venom proteome of adult and neonate C. v. viridis (Table 1), represent another widely
distributed protein family in snake venoms [61, 62]. Reported activities of some CRISPs
include inhibition of smooth muscle contraction and cyclic nucleotide-gated ion channels;
however, their role in envenomation and prey capture has not been established.
L-amino acid oxidases are flavoenzymes that catalyze oxidative deamination of
L-amino acids to form corresponding α-keto acids, hydrogen peroxide and ammonia. Due
to their wide distribution in snake venom, LAAOs are thought to contribute to the
toxicity of the venom due to the production of hydrogen peroxide during the oxidation
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reaction. In addition, LAAOs have been reported to induce platelet aggregation in
platelet-rich plasma [63, 64], although the overall functional contribution to the
envenoming process remains elusive.
Several somewhat unusual venom constituents, including glutaminyl cyclase
(GC) and phospholipase B, were found within the venoms of C. v. viridis and deserve
further discussion. GCs may contribute indirectly to overall venom toxicity by
catalyzing the N-terminal formation of pyroglutamate characteristic of several snake
venom toxin families [65, 66] and thereby stabilizing them to endogenous scavenging
mechanisms. These cyclases have also been documented in the proteomes of C. atrox
[58, 67] and C. d. terrificus [68], as well as in the transcriptomes of C. adamanteus [69],
B. jararaca [70] and the colubrids Boiga dendrophila and B. irregularis [71]. Snake
venom gland GC is also likely involved in the biosynthesis of pyroglutamyl peptides such
as bradykinin-potentiating peptides (BPPs) [72] that contribute to symptoms of
hypotension experienced by snakebite victims [73], and of endogenous inhibitors of
metalloproteinases, ZQW and ZNW, discussed above [44, 45]. Although GCs are found
in low concentrations in snake venoms, the enzyme may play a significant role in posttranslational modifications of functionally important and abundant venom proteins. Thus,
mature PIII-SVMPs and other venom proteins, eg. svVEGF
(http://www.ncbi.nlm.nih.gov/protein/?term=svVEGF) and colubrid three-finger toxins
[19], usually contain an N-terminal pyroglutaminyl residue, indicating that the action of
glutaminyl cyclase is downstream of the proteolytic processing of the pre-pro-precursors.
Reverse-phase peak 28 of venom samples from the adult female and both neonate
C. v. viridis (Figs. 7.2B-D) yielded numerous ions matching a phospholipase B (PLB)
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from C. adamanteus (F8S101, J3S4V6; supplemental Table 1). The occurrence of PLB in
snake venoms was initially reported by Doery and Pearson [74] and was characterized as
being responsible for the high direct hemolytic activity of several Australian elapid
venoms [75-77]. PLB molecules have been identified in the venom proteome of the C.
adamanteus [78], B. atrox, B. jararacussu, B. jararaca, B. neuwiedi, B. alternatus, and B.
cotiara [79], and Porthidium lansbergii [80]. The functional relevance of this class of
proteins in envenomation, represents another intriguing topic that requires future detailed
study.
C. v. viridis Exhibits a Novel
Pattern of Ontogenetic
Venom Proteome
Changes
The ontogenetic compositional shift in C. v. viridis venom is characterized by a
stage-dependent decrease of the relative content of SVMPs, disintegrins, catalytically
active D49-PLA2s, and L-amino acid oxidase, and the concomitant increase in the
relative abundance of small basic myotoxins, serine proteinases and an ohanin-like toxin
(Table 7.1; Figs. 7.3-7.5). We focused on SVMPs and myotoxin a levels as these
ontogenetic venom shifts may represent an age-dependent “strategy” for effectively
securing prey, because the snake prey regime switches with age from newborn rodents
and small ectothermic prey to larger endothermic prey.
PIII-SVMPs are often highly hemorrhagic, promoting prey immobilization and
tissue necrosis by degradation of the basement membrane surrounding capillary vessels
[81]. SVMPs occur in venoms of all families of advanced snakes, suggesting the
recruitment and modification of an ADAM (A disintegrin and metalloproteinase)-like
gene early in the evolutionary history of venomous snakes [82, 83]. Although these
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enzymes are generally highly expressed in venoms within the Viperidae [84, 85], the
venom of the Black-speckled Palm Pitviper, Bothriechis nigroviridis, a neotropical
arboreal pit viper from Costa Rica, does not possess detectable Zn2+-dependent
metalloproteinases and is unique among Bothriechis species by possessing a high content
of neurotoxic PLA2 and vasoactive peptides [86]. These data suggest that distinct
evolutionary solutions have evolved within the arboreal genus Bothriechis for the same
trophic purpose, and it underscores the versatility of viperid venoms as adaptive traits.
The evolutionary justification for the ontogenetic decrease of PIII-SVMP hemorrhagins
in C. v. viridis is elusive, although it is tempting to hypothesize that their biological role
has been successfully replaced by the paralytic action of small basic myotoxins, the
locomotion-disrupting and hyperalgesia-inducing ohanin-like protein [87], and the
hemostasis-disrupting serine proteinases [88]. These latter enzymes comprise the second
most abundant venom protein family in both adult male (26.82%) and female (26.86%)
C. v. viridis (Table 1).
Variation in the biochemical composition of venoms from different geographic
locations and with age has long been appreciated by herpetologists and toxinologists [10,
89-91]. Stage-specific venom proteins differentially expressed during ontogenetic
development have been reported in just a few species, and in each taxa investigated a
somewhat different pattern of ontogenetic changes has been described. The ontogenetic
shifts reported here for C. v. viridis represent a novel pattern of age-related venom
compositional transitions among viperid species. For example, in Bothrops asper, major
ontogenetic changes involve a shift from a PIII-SVMP-rich to a PI-SVMP-rich venom
and the secretion in adults of a distinct set of PLA2 molecules than in the neonates [8];
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ontogenetic changes in the toxin composition of L. stenophrys venom results in the net
shift from a vasoactive (bradykinin-potentiating and C-type natriuretic) peptide (BPP/CNP)-rich and serine proteinase-rich venom in newborns and 2-year-old juveniles to a
(PI>PIII) SVMP-rich venom in adults [92]; age-dependent venom changes in C. simus
involve a shift from a neurotoxic to a hemorrhagic venom phenotype [29]; conversely,
Sistrurus m. barbouri showed little evidence for an ontogenetic shift in venom
composition [93].
Although the environmental and molecular mechanisms that generate this agedependent venom diversity remain unclear [94], age-dependent changes in the
concentration of venom gland microRNAs have recently been shown to influence the
translation of venom proteins from genes transcribed in the venom gland [29]. While the
generalization of this finding requires additional study in other species,
posttranscriptional modulation of the venom transcriptome could conceivably contribute
broadly to differential venom composition without large-scale alterations of the
underlying gene expression machinery.
Assessment of the
Immunoreactivity
of CroFab®
In the United States, human envenomation due to snakebite is relatively rare, and
CroFab® is the antivenom administered universally to treat bites. CroFab® is produced
utilizing venoms from four different North American viper species, A. piscivorus, C.
adamanteus, C. atrox and C. scutulatus. Venomic profiles of all four species used in
producing CroFab® have been published (A. piscivorus: [95]; Crotalus adamanteus: [78];
C. atrox: [58]; C. scutulatus: [49]), and these species collectively show varying relative
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concentrations of typical viperid venom protein families. For example, in C. atrox, the
venom proteome consisted of nearly 50% PI and PIII-SVMPs, with approximately 20%
serine proteases and 7% PLA2s [58]; this species lacked small basic myotoxins, which
represent approximately 22% of the venom proteome of C. adamanteus [78]. In addition
to small basic peptide myotoxins, PLA2s and SVMPs represent a significant proportion
(~59%) of the overall venom composition of C. adamanteus. Further, venomics analysis
of A. piscivorus showed that over 75% of venom proteins consisted of PLA2 (33.6%),
SVMP (33.1%), and serine protease (13.2%) [95]. However, C. scutulatus shows
significant venom compositional diversity, with several distinct venom phenotypes
varying in overall composition and toxicity [49]; venoms containing high amounts of the
presynaptic neurotoxin Mojave toxin are typically used in the production of CroFab®
(pers. comm., SPM: R. Straight).
Our antivenomic assessment of C. v. viridis venoms against CroFab® (Fig.7.6)
showed that significant amounts of the peptides and proteins in early eluting HPLC
fractions (1-8 of adult and neonate venoms, and peaks 39* and 40* of neonate samples)
were not immunocaptured by CroFab® affinity chromatography (Figures 7.6C and 7.6F);
several additional downstream protein peaks were also not immunodepleted from neonate
venom (Fig. 7.6F). Our venomic analyses indicate that these non-depleted HPLC
fractions consist of bradykinin inhibitory peptides, myotoxins a and 2, and SVMP
inhibitors. It has recently been shown that the BPP family of venom proteins from
Lachesis species were also not immunocaptured by antivenoms developed at Instituto
Vital Brazil (IVB) and Instituto Clodomiro Picado (ICP). In spite of this, caudal vein
injection of BPP proteins in mice failed to demonstrate toxicity or elicit abnormal
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behavior [96], suggesting that BPPs, even if not recognized by antivenoms, may not
contribute to the often severe pathologies seen in viperid envenomations.
The immunoaffinity antivenomics assessment of CroFab® indicated that it
exhibits partial immunoreactivity towards small basic myotoxin a (Fig.7.6, panels C and
F). However, Western blot analysis shows that CroFab® does recognize myotoxin a in the
crude venoms of several species as well as the purified toxin from C. v. viridis venom, as
does a specific anti-myotoxin a antibody (Fig. 7.7). Myotoxin a produces rapid tetanic
contraction of skeletal muscles in prey [97], leading to rapid immobilization of prey, and
the poor immunodepletion by the CroFab® affinity column suggests that this should be
problematic during human envenomations. However, the amount of CroFab® utilized was
relatively small compared to human dosages, and so if anti-myotoxin a antibodies
represent only a small percentage of CroFab® antibodies, this deficit may be compensated
by high clinical dosages. Further, case log data from the American Association of Poison
Centers for rattlesnake bites in Colorado (C. v. viridis is the most probable source of
bites) over four years (2010-2013) indicated no fatalities (0/175 cases); unfortunately,
long-term data for snakebites is generally lacking from all health databases, so chronic
effects cannot be evaluated. These data suggest that in spite of minimal
immunodepletion, CroFab® did provide sufficient protection for patients. Although
quantitative estimates of anti-myotoxin a antibodies are not yet available for CroFab®,
our data show that CroFab® does contain significant amounts of antibody which
recognize myotoxin a, whereas the antivenom previously used in the United States
(Wyeth polyvalent Crotalidae) was shown to contain very low titers to myotoxin a [98].
The low recovery of SVMPs in the immunocaptured and the non-bound fractions of both
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adult and neonate venoms contrasts with the clear immunoreactivity towards these
components exhibited by CroFab® in Western blot analysis. This indicates that the high
binding affinity of the antivenom for SVMPs likely prevents their elution from the
column.
The antivenomic analysis also indicated that CroFab® effectively recognizes and
depletes other potent and abundant venom components, including PLA2s, serine
proteases, LAAOs and SVMPs, indicating that the similarity in venom protein family
representation in C. v. viridis venom and venoms of the four species utilized in CroFab®
production is reflected in the immunoreactivity of this antivenom. While comparing the
levels of immune recognition gathered from antivenomics with the in vivo neutralization
capacity of an antivenom is not straightforward, since both experiments involve radically
different protocols, in our experience, even a moderate immunocapturing capability of
~20%–25% correlates with a satisfactory outcome in the in vivo neutralization tests [99].
Consistent with these observations, CroFab® shows high efficacy in treatment of human
and domestic animal envenomations by C. v. viridis, including snakes from Colorado
[100, 101], so even partial binding/recognition of myotoxin a by Fabs appears sufficient
to ameliorate symptoms effectively.
Concluding Remarks
In this study we conducted venomic and antivenomic analyses of C. v. viridis
(Prairie Rattlesnake), one of the most widely distributed rattlesnake species in North
America. The previously reported LD50 of 1.55 µg/g (inbred mice) for C. v. viridis,
coupled with the SVMP concentrations detected here, confirms C. v. viridis as possessing
type I venom as described previously [7]. Ontogenetic variation in prey preference has
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been reported in C. viridis [10, 27] and changes in diet are correlated with ontogenetic
changes in venom composition in Pacific Rattlesnakes [10]. These age-related changes in
venom composition may facilitate prey handling and possibly digestion [10, 11].
Although a common ontogenetic trend documented in rattlesnake venoms is a shift from
a type II venom composition (high toxicity, low SVMP activity) in neonates to a type I
venom in adults (lower toxicity, high SVMP activity), our results clearly indicate the
opposite relationship for C. v. viridis, with overall SVMP concentrations being lower in
venoms from adult snakes, and myotoxin (a and 2) concentrations being higher in adult
samples. Further, classic venom paedomorphism [11, 12, 30] does not occur in this
population, as venoms analyzed here do show age-related changes in composition. It
should be noted, however, that total SVMP activity of venoms from this population of C.
v. viridis are not particularly high when compared with several type I venoms [7, 10].
Our antivenomics results show that CroFab®, developed against venom of three
Crotalus and one Agkistrodon species, efficiently immunodepleted many of the major
compounds present in C. v. viridis venom. Our antivenomics results show that CroFab®,
developed against venom of three Crotalus and one Agkistrodon species, efficiently
immunodepleted many of the major compounds present in C. v. viridis venom. Myotoxin
a, abundant in both adult and neonate C. v. viridis venoms, did not appear to be
efficiently immunocaptured during the antivenomics experiment, but Western blot
analysis indicated that it is recognized by CroFab® as well as by the specific myotoxin a
antibody. Considering the high efficacy of CroFab® in treating C. v. viridis snakebites, it
appears that the relatively low immunoreactivity of CroFab® to myotoxin a is indeed
sufficient for effective treatment of snakebite. The current study defines the venom
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proteome of a discrete population of C. v. viridis from Colorado, but a more detailed
population venomics study evaluating venom composition, and antivenom reactivity, of
this species throughout its entire range (spanning 22° of latitude) may demonstrate
distinct regional differences in venom protein family distribution, concentration, and
immunoreactivity against existing antivenoms.
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Table
Table 7.1: Percent Abundance of Protein Families in C. v. viridis Venom. --, not detected;
M ± SD, mean ± standard deviation
Adult
Male

Neonate

Female M (±SD)

Protein Family
BPP
Disintegrin
CRISP
C-type lectin
PLA2
• D49 PLA2
• Acidic PLA2
Ohanin-like Toxin
Myotoxin
• Myotoxin a
• Myotoxin 2
Serine Proteinase
LAAO
SVMP
• PIII SVMP
• PII SVMP
• PI SVMP
• PI SVMP fragments

Male

Female

M (±SD)

% of total venom proteins
8.2
0.1
3.9
1.8
7.7
7.7
-0.5
38.1
37.5
0.6
26.8
1.9
11.0
3.1
0.9
0.2
6.6

6.5
0.1
2.1
3.3
10.6
10.2
0.4
0.6
35.6
35.6
-26.9
2.5
11.4
4.9
3.7
-2.9

7.4 (0.8)
0.1 (0.0)
3.0 (0.9)
2.6 (0.7)
9.2 (1.4)
9.0 (1.3)
0.2 (0.2)
0.5 (0.1)
36.9 (1.2)
36.6 (1.0)
0.3 (0.3)
26.8 (0.1)
2.2 (0.3)
11.2 (0.2)
4.0 (0.9)
2.3 (1.4)
0.1 (0.1)
4.8 (1.9)

6.4
0.8
4.0
7.3
10.9
10.9
--25.2
25.2
-18.2
7.6
14.2
8.4
1.7
0.8
3.4

Glutaminyl Cyclase

0.1

0.1

0.1 (0.0)

Phospholipase B

--

0.1

0.1 (0.1)

SVMP Inhibitor

--

< 0.10

• ZNW

--

--

• ZQW

--

< 0.10

0.1 (0.1)
-0.1 (0.1)

11.2
0.7
4.8
1.9
16.3
16.3
-0.2
5.7
5.7
-20.6
11.9
18.0
8.8
6.9
-2.3

8.8 (2.4)
0.7 (0.1)
4.4 (0.4)
4.6 (2.7)
13.6 (2.7)
13.6 (2.7)
-0.1 (0.1)
15.5 (9.7)
15.5 (9.7)
-19.4 (1.2)
9.8 (2.1)
16.1 (1.9)
8.6 (0.2)
4.3 (2.6)
0.4 (0.4)
2.9 (0.6)

0.8

0.1

0.5 (0.4)

0.3

0.1

4.5

8.5

6.5 (2.0)

3.0

5.7

4.4 (0.3)

1.5

2.8

2.2 (0.6)

0.2 (0.1)

___________________________________________________________________________________
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Figures

Figure 7.1: Geographic Distribution of C. v. viridis. Venoms from C. v. viridis used in the
proteomic characterizations reported here were collected from Weld County, Colorado
(indicated by the black dot).
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Figure 7.2: Characterization of the Venom Proteomes of C. v. viridis. Panels A-D display
reverse-phase HPLC separations of the venom proteins from an adult male, adult female,
neonate male and neonate female snake, respectively. Fractions were collected manually
and analyzed by SDS-PAGE (insets) under non-reduced (top gel panel) and βmercaptoethanol-reduced (bottom gel panel) conditions.
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Figure 7.3: Combined Samples Representing Three Age Classes of C. v. viridis. These
chromatograms essentially represent a graphical average of 12 individual venoms for
each age class. A. Adult venoms. B. Subadult venoms. C. Neonate venoms. D. Overlay of
chromatograms A-C; adult – black line; subadult - green; neonate - blue. Note that
significant differences exist between adults and neonates, in particular the myotoxin a
(myo a) and metalloproteinase (SVMP) peaks.
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Figure 7.4: Age-related Changes in SVMP and Myotoxin a abundance in C. v. viridis
venoms. A. SVMP and myotoxin a content of all 38 venoms analyzed (12 adult and
subadult, 14 neonate) by RP-HPLC. Adult and neonate venoms differ in SVMP (p =
0.002) and myotoxin a (p = 0.05) content; SVMP content of subadult venoms also
significantly differed when compared to neonate venoms (p = 0.02), however there was
no difference between subadult and adult venoms for myotoxin a or SVMP content (p’s =
0.23 and 0.69, respectively). B. SVMP activity toward azocasein substrate. Consistent
with the RP-HPLC-based content differences, neonate venom activity levels also differ
statistically when compared to subadult and adult venoms (p < 0.001). SVMP activity
was not significantly different between subadult and adult venoms (p = 0.61).
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Figure 7.5: Protein Family Composition of Primary C. v. viridis venoms (adult male 281;
adult female 288; neonate male 280; and neonate female 249). Pie charts represent the
relative occurrence of proteins from the different toxin families as identified in the
current work. Percentages below protein families represent the percent of the total RPHPLC-separated components found in C. v. viridis venom. BPP, bradykinin-potentiating
peptide; Disi, disintegrin; CRISP, cysteine-rich secretory proteins; CTL, C-type lectinlike; PLA2, phospholipase A2; LAAO, L-amino acid oxidase; SVMP, snake venom
metalloproteinase; GC, glutaminyl cyclase; PLB, phospholipase B.
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Figure 7.6: Antivenomic Analysis on a CroFab® Affinity Column. Panels A and D, RPHPLC separation of the venom proteins of one adult and one neonate male C. v. viridis.
Panels B and C show, respectively, reverse-phase HPLC separations of the components
of adult male C. v. viridis recovered in the bound and the flow-through fractions of the
affinity column. Panels E and F show the affinity column immunocaptured and nonretained protein fractions of neonate C. v. viridis venom, respectively. Protein peaks are
labeled as in panels A (adult male) and C (neonate male) of Fig.2. Supplemental Table S1
lists the proteins found in each chromatographic fraction. BiP, bradykinin inhibitory
peptide; OHA, ohanin-like protein. Other acronyms as in the legend of Fig.3.
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Figure 7.7: Western blot and SDS-PAGE Analysis.Panel A, venoms and myotoxin a on
nitrocellulose were detected with either CroFab or specific anti-myotoxin a antibodies
(rabbit). Note that myotoxin a is detected by both CroFab® and specific anti-myotoxin a
antibodies. Panel B, SDS-PAGE analysis of the same venoms (16 µg/lane) and myotoxin
a (1, 3 and 5 µg/lane) as in A. For both panels A and B, C. o. helleri and C. s. scutulatus
venoms were included as myotoxin a-positive and negative controls, respectively.
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Figure 7.8: Reducing SDS-PAGE of Secondary Venom Samples - 16 µg/lane. Protein
families found in bands of specific masses [1,7] are indicated on the right. Note that
although most bands are shared between all individuals, differences in intensities
(representing differing concentrations) exist, particularly among P-III metalloproteinases,
PLA2s and myotoxin a bands.
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CHAPTER VII
CONCLUSION
As with so many disciplines in biological sciences, the fields of herpetology and
toxinology have grown tremendously over the last few decades, largely due to advances
in laboratory techniques. As venoms are shaped by numerous biological factors, most
importantly diet, significant venom variation may be documented, at times even between
individuals of the same species as they mature. These ontogenetic shifts in venom
composition often accompany changes in diet and may correlate with a shift to more
complex prey-handling behaviors (Mackessy 1988; Hammerson 1999; Hayes 1992).
Chapter II of this dissertation clearly shows that chemosensory responses to prey-derived
cues shift with snake age in C. v. viridis. In neonates, rates of tongue flicking were
significantly higher to natural lizard stimuli when compared to tongue flick rates in subadult or adult snakes. This response declined as snakes increased in size, however, and
tongue flicking to natural rodent cues was significantly higher when compared to those of
neonates. Chapter III provides additional evidence that these chemosensory behaviors are
innate, and although responses to prey cues may be learned over time, the sample of
stunted C. v. viridis analyzed, which never encountered natural prey items, responded
significantly to natural prey stimuli. Being gape-limited predators, neonate rattlesnakes
are limited primarily to taking small ectothermic prey, which they often obtain by a
strike -and-hold predatory behavior. However, it is likely that small ectothermic prey are
not energetically favorable prey items for adult Prairie Rattlesnakes, and larger
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endothermic prey would be more metabolically advantageous for these snakes to
consume. Yet, predatory encounters between adult rattlesnakes and larger endothermic
prey present the risk of prey retaliation, which may be threatening to the snake.
Therefore, adult rattlesnakes often utilize a strike-and-release mode of prey
envenomation, which minimizes contact with potentially dangerous prey, yet creates the
additional task of locating prey that has wandered from the attack site. Although it is
reasonable to assume that snakes are opportunistic feeders in the wild, the ability to
discriminate between chemical stimuli not only leads to location and capture of preferred
prey, it also assists in the location of envenomated prey following the predatory strike.
This ability to release potentially dangerous prey during predatory episodes, and
then relocate this prey once it has succumbed to venom, is a remarkable behavioral
adaptation seen among adult viperid snakes. In Chapter IV, I identify crotatroxin 1 and 2
as the molecular components, disintegrins, of venom allowing for prey relocation in
rattlesnakes. The downstream signaling that is the result of disintegrin-integrin
interactions, ultimately leading to the release of chemical odor(s) detectable by
rattlesnakes during prey relocation, deserves further attention. It is possible that upon
disintegrin binding, a downstream signaling cascade causes a release of novel odors, or
increase of already present odors, that are detectable by the snakes. Since disintegrins
appear to be present in all viperid snakes, but absent from venoms of all other advanced
snakes, it is hypothesized that the presence of this compound in venom has led to the
evolution of the complex strike-and-release behavior. Further, as several species of vipers
contain non-RGD and dimeric disintegrins, further studies should examine if these
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compounds exhibit the same prey-relocation response as the monomeric disintegrins
present in C. atrox.
Disintegrins function by blocking an array of integrin receptors (Scarborough et
al. 1993; Calvete et al. 2009), and the roles of integrins in numerous human pathologies is
being examined continuously (Wehrle-Haller and Imhof 2003; Desgrosellier and Cheresh
2010). The recognition that disintegrins have unique anti-cancer activity (e.g., Trikha et
al. 1994) has led to a plethora of studies examining the therapeutic potential of these
compounds (Zhou et al. 1999, 2000; Sánchez et al. 2009; Galan et al. 2008; Lucena et al.
2011, 2012, 2015). In spite of these numerous studies, significant differences with
regards to disintegrin binding affinity towards specific integrin receptors provides a
strong motivation to continue to examine snake venoms for novel disintegrins that may
have application in biomedical research. In Chapter V, I use a combination of molecular
and proteomics techniques to screen the venom of C. s. tzabcan for disintegrins,
identifying six novel disintegrin sequences and isolating and characterizing the dominant
isoform, named tzabcanin. Tzabcanin, a 7.1 kDa RGDN-containing disintegrin, showed
only slight cytotoxicity toward human colon cancer (Colo-205) cells, but it inhibited cell
adhesion of both breast (MCF-7) and colon (Colo-205) cancer cells to fibronectin and
vitronectin. Although I was unable to identify the specific integrin(s) tzabcanin was
binding to in these two cell lines, in Chapter VI integrin αvβ3 was identified as a binding
site for tzabcanin in human melanoma (A-375) and lung (A-549) cancer cell lines.
Further, by binding αvβ3, tzabcanin inhibited adhesion of both cell lines to the
extracellular matrix protein vitronectin, and it inhibited cell migration over 24 hrs in A375 and 72 hrs in A-549 cells. These results support the potential for tzabcanin, and

196
perhaps other C. s. tzabcan venom disintegrins, to provide useful information toward the
development of novel drug therapies.
Venomics (venom proteomics) is a relatively new method for probing venom
proteomes, and it provides in-depth analyses of venom composition which is a necessary
early step toward identifying compounds that have potential medicinal value, and by
coupling this with antivenomic methods, one can gain significant insight into antivenom
efficacy and more effective methods for antivenom production (Calvete et al. 2009;
Calvete 2010). The final research chapter of my dissertation (Chapter VII) examined the
venom proteome of a very wide-spread species, C. v. viridis, revealing a unique pattern of
ontogenetic shift in venom composition. In rattlesnakes, venom compositions often shift
from neonates containing high toxicity and low metalloproteinase activity, to a lower
toxicity and higher metalloproteinase activity seen in adults. However, venomic analyses
of the current C. v. viridis samples indicate the opposite relationship, with overall
metalloproteinase concentrations being lower in venoms from adult snakes, and myotoxin
a and 2 (two potent rodent-specific toxins) concentrations higher in adult venom samples.
Further, some unusual venom compounds were identified in the C. v. viridis venom
proteome, such as phospholipase B and ohanin-like toxin. Although the biological roles
of these two compounds remains largely unknown, the presence of these two proteins,
combined with the novel ontogenetic shift in overall composition, may be correlated with
prey preference for this population of C. v. viridis. Toxins with prey specificity have been
documented (Pawlak et al. 2009), and it is hypothesized that the presence of specific
compounds in the venom proteome of C. v. viridis are there to target distinct prey items.
Further, antivenomics results suggested that CroFab® does not appear to immunocapture
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myotoxins and other small peptides efficiently; however, Western blot analysis does
indicate that these compounds are recognized by CroFab®. When considering the
reasonably high efficacy of CroFab® in treating viperid snakebites, including those by C.
v. viridis, it is likely that the relatively low immunoreactivity of CroFab® to myotoxin is
indeed sufficient enough for effective clinical treatment following envenomation.
In conclusion, the results from this dissertation provide a unique look into
numerous facets of biological and toxinological research, from the feeding ecology and
behavior of rattlesnakes, to the individual biological roles of venom components
(disintegrins), to the anti-cancer effects of a single venom protein. Due to the presence of
disintegrins in venom, rattlesnakes can use their exquisite chemosensory recognition
abilities to distinguish between envenomated and non-envenomated prey. Interestingly,
the same protein family that allows for prey relocation in rattlesnakes also exhibits
unique anti-cancer functions by blocking integrin receptors, and disintegrins may provide
a novel therapy for cancer treatment. Finally, proteomic analyses of C. v. viridis venom
demonstrated a novel ontogenetic shift in venom composition and identified several less
well known and less abundant venom compounds. Advancements in laboratory
techniques will continue to unravel the mysteries of the many venom compounds, which
still exhibit unknown functions, and may provide greater insights on the biological roles
and potential medicinal values of this highly complex mixture of proteins and peptides.
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APPENDIX
INSTITUTIONAL ANIMAL CARE AND USE
COMMITTEE APPROVAL
All animal research conducted was carried out under protocol #1302D-SM-S-16
(S.P.M) approved by the Institutional Animal Care and Use Committee of the University
of Northern Colorado.
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